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The central nervous system is formed from epiblast precursor cells through 
Neurulation. Neural induction can be studied in its main aspects in vitro. However, 
the process is poorly understood, especially in regard to when and how a cell 
becomes specified, and then committed, to be a neural cell. It is, on the other hand, 
well established that neural formation requires absence or, inhibition of the BMP 
signalling both in vivo and in vitro. 
ID1 is a direct target of BMP signalling with major influence on in vitro neural 
differentiation. A cDNA library screen, looking for transcription factors negatively 
regulated by ID1, reported TWIST1, along with only two other proteins. Twist1 
expression is upregulated during in vitro neural differentiation. Furthermore, targeted 
deletion of Twist1 has dramatic consequences on anterior neural development. Twist1 
knock-out mice fail to form the closed neural tube in the prospective brain, followed 
by exencephaly and, early embryonic death. 
 
In this thesis I investigate the influence on in vitro neural differentiation of a 
TWIST1 constitutively active form, insensitive to ID1 inhibition. I report that this 
transcriptionally active TWIST1 accelerates neural differentiation, in vitro and, biases 
it, towards dorsal phenotypes. I provide, for the first time, evidence for Twist1 
expression in the neural tissue, observed weakly in a restricted domain, temporally 
and spatially, in the dorsal part of the neural tube. I propose a new model for TWIST1 
influence at this level. I also investigate how TWIST1 actions depend on levels of 
expression and dimer choice. I found that, TWIST1 can exert its neural modulating 
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Bmpr1b Alk6 
bone morphogenetic protein receptor, type 
1B Mus musculus 




UVO cadherin 1 Mus musculus 
Cdh11 
osteoblast 
cadherin cadherin 11 Mus musculus 
Cdh2 Ncad cadherin 2 Mus musculus 
Cdh20 Cdh7 cadherin 20 Mus musculus 
Cdkn1a P21 cyclin-dependent kinase inhibitor 1A (P21) Mus musculus 
Cdkn2a p16 cyclin-dependent kinase inhibitor 2A Mus musculus 
Cer1 Cerr1 cerberus 1 homolog (Xenopus laevis) Mus musculus 
Chrd  chordin Mus musculus 
Chrdl1 neuralin 1 chordin-like 1 Mus musculus 
Churc1  churchill domain containing 1 Mus musculus 
Ctnna1 
alpha E-
catenin catenin (cadherin associated protein), alpha 1 Mus musculus 
Ctnnb1 
beta 
catenin catenin (cadherin associated protein), beta 1 Mus musculus 
ctnnb1b  catenin (cadherin-associated protein), beta 1 Xenopus laevis 
Cx3cl1 neurotactin chemokine (C-X3-C motif) ligand 1 Mus musculus 
da  daughterless Mus musculus 
Disp1  dispatched homolog 1 (Drosophila) Mus musculus 
Dkk1  dkk1 homolog 1 (Xenopus laevis) Mus musculus 
Dlx5  distal-less homeobox 5 Mus musculus 
Dnajc2 MIDA1 
DnaJ (Hsp40) homolog, subfamily C, 
member 2 Mus musculus 
Ebf1 
O/E-1, Ofl-
1 early B cell factor 1 Mus musculus 
Egfr  epidermal growth factor receptor Mus musculus 
Eomes Tbr2 eomesodermin homolog (Xenopus laevis) Mus musculus 
 xxvi 
ERNI  early response to neural induction ERNI Gallus gallus 
Esrrb  estrogen related receptor, beta Mus musculus 
Fgf2 bFGF fibroblast growth factor 2 Mus musculus 
Fgf4 kFGF fibroblast growth factor 4 Mus musculus 
Fgf5  fibroblast growth factor 5 Mus musculus 
Fgf8  fibroblast growth factor 8 Mus musculus 
Fgfr1  fibroblast growth factor receptor 1 Mus musculus 
Fgfr2  fibroblast growth factor receptor 2 Mus musculus 
FKBP1A FKBP12 FK506 binding protein 1A, 12kDa Homo sapiens 
Fn1  fibronectin 1 Mus musculus 
Foxa2 
HNF-3beta, 
Tcf-3b forkhead box A2 Mus musculus 
Foxd3  forkhead box D3 Mus musculus 




furin (paired basic amino acid cleaving 
enzyme) Mus musculus 
Fut4 
SSEA-1, 
CD15 fucosyltransferase 4 Mus musculus 
Fzd9  frizzled homolog 9 (Drosophila) Mus musculus 
Gata2  GATA binding protein 2 Mus musculus 
Gata6  GATA binding protein 6 Mus musculus 
Gli1 Zfp-5 GLI-Kruppel family member GLI1 Mus musculus 
Gli2  GLI-Kruppel family member GLI2 Mus musculus 
Gli3  GLI-Kruppel family member GLI3 Mus musculus 
Grem1  gremlin 1 Mus musculus 
Gsc  goosecoid homeobox Mus musculus 
Gsk3b GSK3 glycogen synthase kinase 3 beta Mus musculus 
h  hairy 
Drosophila 
melanogaster 
Hes1  hairy and enhancer of split 1 (Drosophila) Mus musculus 
Hesx1 HES-1 homeobox gene expressed in ES cells Mus musculus 
Hey  Hairy/E(spl)-related with YRPW motif 
Drosophila 
melanogaster 
hh  hedgehog 
Drosophila 
melanogaster 
Hhex Hex, Hex1 hematopoietically expressed homeobox Mus musculus 
Hif1a  hypoxia inducible factor 1, alpha subunit Mus musculus 
Id1  inhibitor of DNA binding 1 Mus musculus 
Id2  inhibitor of DNA binding 2 Mus musculus 
Id3  inhibitor of DNA binding 3 Mus musculus 
Id4  inhibitor of DNA binding 4 Mus musculus 
Il1 Il-1 interleukin 1 complex Mus musculus 
Il6 Il-6 interleukin 6 Mus musculus 
Inhba  
inhibin beta-A, Two INHBA subunits form 
an ACTIVIN molecule Mus musculus 
Kitl  kit ligand Mus musculus 
Klf4  Kruppel-like factor 4 (gut) Mus musculus 
Lefty1  left right determination factor 1 Mus musculus 
Lhx1  LIM homeobox protein 1 Mus musculus 




low density lipoprotein receptor-related 
protein 5 Mus musculus 
Lrp6 crooked 
low density lipoprotein receptor-related 
protein 6 Mus musculus 
Mad 
MAD, 
Smad1 Mothers against dpp 
Drosophila 
melanogaster 
Map2k1 Mek1 mitogen-activated protein kinase kinase 1 Mus musculus 
Map2k2 Mek2 mitogen-activated protein kinase kinase 2 Mus musculus 
Mapk1 ERK mitogen-activated protein kinase 1 Mus musculus 
Mapk14 
p38, 
p38MAPK mitogen-activated protein kinase 14 Mus musculus 
Max MAX 




Msx1 Hox7 homeobox, msh-like 1 Mus musculus 
Myc c-myc myelocytomatosis oncogene Mus musculus 
Mycn n-Myc 
v-myc myelocytomatosis viral related 
oncogene, neuroblastoma derived (avian) Mus musculus 
Myf5  myogenic factor 5 Mus musculus 
Myod1  myogenic differentiation 1 Mus musculus 
Myog myo Myogenin Mus musculus 
Nanog  Nanog homeobox Mus musculus 
Ncam1  neural cell adhesion molecule 1 Mus musculus 
Nes  nestin Mus musculus 
Neurod1  neurogenic differentiation 1 Mus musculus 
Neurod4 
Math3, 
bHLHa4 neurogenic differentiation 4 Mus musculus 
Neurod6 
Math2, 
bHLHa2 neurogenic differentiation 6 Mus musculus 
Neurog1  neurogenin1 Mus musculus 
Nkx6-2 
Gtx, 
Nkx6.2 NK6 homeobox 2 Mus musculus 
Noda  nodal Mus musculus 
Nog  noggin Mus musculus 
Notch1  notch 1 Mus musculus 
Ocln  occludin Mus musculus 
Olig1 bHLHe21 oligodendrocyte transcription factor 1 Mus musculus 
Olig2 bHLHe19 oligodendrocyte transcription factor 2 Mus musculus 
Olig3 bHLHe20 oligodendrocyte transcription factor 3 Mus musculus 
Otx2  orthodenticle homolog 2 (Drosophila) Mus musculus 
Pax3  paired box gene 3 Mus musculus 
Pax6  paired box gene 6 Mus musculus 
Pax7  paired box gene 7 Mus musculus 
Pcsk6 
SPC4, 
Pace4 proprotein convertase subtilisin/kexin type 6 Mus musculus 





3/4 POU domain, class 5, transcription factor 1 Mus musculus 
Ptch1  patched homolog 1 Mus musculus 
Shh  sonic hedgehog Mus musculus 




Smad1  SMAD family member 1 Mus musculus 
Smad2  SMAD family member 2 Mus musculus 
Smad3  SMAD family member 3 Mus musculus 
Smad4  SMAD family member 4 Mus musculus 
Smad5  SMAD family member 5 Mus musculus 
Smad9 Smad8 SMAD family member 9 Mus musculus 
Smo  smoothened homolog (Drosophila) Mus musculus 
Snai1 Sna, Snail snail homolog 1 (Drosophila) Mus musculus 
Snai2 SLUG snail homolog 2 (Drosophila) Mus musculus 
Sox1  SRY-box containing gene 1 Mus musculus 
Sox2  SRY-box containing gene 2 Mus musculus 
Sox3  SRY-box containing gene 3 Mus musculus 
Sox9  SRY-box containing gene 9 Mus musculus 
Sox10 Sox21 SRY-box containing gene 10 Mus musculus 
Sox11  SRY-box containing gene 11 Mus musculus 
Stat3  
signal transducer and activator of 
transcription 3 Mus musculus 
T  brachyury Mus musculus 
Tbp  TATA box binding protein Mus musculus 
Tcf3 
E2A, E12, 
E47 transcription factor 3 Mus musculus 
Tcf4 E2.2 transcription factor 4 Mus musculus 




transcription factor 7 like 1 (T cell specific, 
HMG 
box) Mus musculus 
Tcf12 HEB transcription factor 12 Mus musculus 
Tcf15 
Meso1, 
paraxis transcription factor 15 Mus musculus 
Tdgf1 cripto teratocarcinoma-derived growth factor 1 Mus musculus 
Tfap2a 
AP-2, 
AP2alpha transcription factor AP-2, alpha Mus musculus 
Tfap2c Ap-2.2 transcription factor AP-2, gamma Mus musculus 
Tgfb1  transforming growth factor, beta 1 Mus musculus 
Tgfb1  transforming growth factor, beta 1 Mus musculus 
Tgfbr1 ALK5 transforming growth factor, beta receptor 1 Mus musculus 
Trp53 p53 transformation related protein 53 Mus musculus 
Tubb3 
betaIII 
tubulin tubulin, beta 3 class III Mus musculus 
twi  twist 
Drosophila 
melanogaster 
Twist1  twist homolog 1 (Drosophila) Mus musculus 
Vav3  vav 3 oncogene Mus musculus 
Vim  vimentin Mus musculus 
Wnt1  wingless-related MMTV integration site 1 Mus musculus 
Wnt3  wingless-related MMTV integration site 3 Mus musculus 
Wnt3a  wingless-related MMTV integration site 3A Mus musculus 
Wnt8a Wnt8 
wingless-type MMTV integration site family, 




Tcf8 zinc finger E-box binding homeobox 1 Mus musculus 
Zeb2 
ZFHX1B, 
Sip1 zinc finger E-box binding homeobox 2 Mus musculus 
Zfp521  zinc finger protein 521 Mus musculus 
Zic1  zinc finger protein of the cerebellum 1 Mus musculus 
Zic2 Ku zinc finger protein of the cerebellum 2 Mus musculus 
Zic3  zinc finger protein of the cerebellum 3 Mus musculus 
Zic5 Opr zinc finger protein of the cerebellum 5 Mus musculus 
 
 






Stem cells offer great promise for regenerative medicine. This promise, in all its 
forms: in vitro generation of transplantable cells and tissues, disease modelling and, 
drug testing, relies on good control of the differentiation process in vitro. While 
important progress has been made in the recent years, pluripotent cell differentiation 
control is still far from the desired levels. Reasons for current deficiencies include the 
complexity of the differentiation process, the insufficient understanding of the in vivo 
differentiation, as well as the fact that, in the embryo and in the culture dish, cells 
differentiating along multiple lineages coexist in the same location and, seem to be 
subject to similar inductive signals. 
 
Neural differentiation has been considered as one of the simplest differentiation 
pathways and thus, ideal for investigating differentiation. Dubbed “the default fate” it 
was thought that all pluripotent cells are fated to become neural unless instructed 
otherwise and, the naïve epiblast could be turned to neural fate simply by inhibiting 
the BMP signalling [Munoz-Sanjuan and Brivanlou, 2002]. Since, according to the 
default model, the control of neural differentiation is essentially neural fate inhibition 
by BMP, attention has been turned to the pathways downstream BMP. It was shown 
that BMP enacts neural inhibition by activating ID proteins, negative regulators of 
bHLH transcription factors [Ying et al., 2003a]. However, the specific role of IDs in 
this process is less clear. 
 
A cDNA library screen from the Lowell lab indicated that one of the putative 
transcriptional targets of IDs in pluripotent cells could be TWIST1, a bHLH factor 
with roles in gastrulation, somitogenesis, neural tube formation and neural crest 
specification and differentiation [Barnes and Firulli, 2009]. In this chapter I present a 
brief literature overview on Stem Cells, followed by a section on bHLH factors with 
an emphasis on ID proteins. A special section is dedicated to Twist1 describing its 
role in development, expression pattern, the pathology linked with Twist1 mutations 
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and its molecular mechanism of action. Next, I describe the developmental processes 
which lead to neural tissue formation in mouse. Parallel formation of non-neural 
tissues is also briefly described. A particular attention is paid to neural crest, a tissue 
in which Twist1 role has long been recognised. Mutant analysis indicated that Twist1 
is involved in correct neural tube formation and dorso-ventral patterning. These 
processes are described in detail. Finally, I summarize the questions still unanswered 
regarding Twist1 role in neural specification and neural tube formation. 
 
 
I2 Stem Cells 
 
I2.1 Stem Cell Beginnings 
 
The advent of stem cells began with the discovery of a bone marrow population 
which is able to repopulate the hematopoietic system of irradiated mice [Till and 
McCulloch, 1961]. Soon after, hematopoietic progenitors could be cultured and 
differentiated in vitro, though they could not be maintained in the undifferentiated 
state in these conditions [Bradley and Metcalf, 1966]. About the same time bone 
marrow was shown to be the host of another interesting cell type; this cell, which also 
has the ability to generate colony forming units (CFUs) in vivo and in vitro, could be 
separated from hematopoietic cells by its property of adhering to plastic and could be 
differentiated into bone, both in vivo and in vitro [Friedenstein et al., 1968; 
Friedenstein et al., 1970]. This cell which was later named as Mesenchymal Stem 
Cell and more recently was suggested to be the pericyte [Schwab and Gargett, 2007; 
Crisan et al., 2008; Crisan et al., 2011] had been just the first in a long line of tissue 
stem cells. These cells have limited capacity of self-renewal and, are normally 
restricted in differentiation to cells belonging to the tissue of origin; however, in vitro, 
their differentiation capacity can be significantly expanded [Serafini and Verfaillie, 
2006]. 
 
It was only in 1981 that a cell with unlimited self renewal capacity, which was 
not of malignant origin, could be isolated and cultured [Evans and Kaufman, 1981; 
Martin, 1981], thus moving the medical research into the Embryonic Stem Cell era. 
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I2.2 Embryonic Stem Cells 
 
I2.2.1 Mouse ES Cells 
 
Embryonic Stem (ES) cells can be isolated from the Inner Cell Mass of pre-
implantation blastocyst; it seems to be possible to propagate these cells indefinitely in 
vitro, while retaining normal differentiation capability and karyotype [Evans and 
Kaufman, 1981; Martin, 1981]. ES cells can be differentiated in cells belonging to all 
the three germ layers derived from early epiblast [Smith A.G., 2001], including germ 
cells [Bradley et al., 1984]. A key feature of ES cells is that they can contribute to all 
embryonic lineages in chimeras. However, in these conditions their contribution is 
very limited towards the extraembryonic lineages: primitive endoderm and especially 
trophectoderm [Beddington and Robertson, 1989]. When transplanted into adult mice 
ES cells generate teratocarcinomas, often containing cells from two or three germ 
layers [Evans and Kaufman, 1981; Martin, 1981]. Interestingly, undifferentiated 
embryonic carcinoma cells can produce embryoid bodies also containing yolk sac and 
trophectoderm derivates [Kleinsmith and Pierce, 1964]. 
 
I2.2.1 Maintaining Pluripotency of ES Cells 
 
Initial derivation and culture conditions involved feeder layers from irradiated 
fibroblasts [Evans and Kaufman, 1981; Martin, 1981]. Subsequently, it was shown 
first, that the feeder cells role was to maintain the undifferentiated ES cells by 
secreting factor tethered to their membrane [Smith and Hooper, 1987] and second, 
that this factor was leukaemia inhibitory factor (LIF) [Williams et al. 1988, Smith et 
al. 1988], a member of  the interleukin 6 (IL6) family of cytokines [Taga and 
Kishimoto, 1997]. LIF was reported to act through activation of STAT3 and this 
process is indispensable for ES cell maintenance under conventional culture 
conditions [Burdon et al., 1999a; Matsuda et al. 1999]. However, Stat3 is not required 
for epiblast formation, as indicated by studies in knock-out mice [Burdon et al., 
1999a; Matsuda et al., 1999]. On the other hand, Pou5f1 has been reported as the 
necessary factor for ES cell formation and maintenance in vivo [Nichols et al., 1998]. 
Furthermore, NANOG, a divergent homeodomain protein, can maintain POU5F1 
	   4	  
levels and bypass STAT3 requirements for ES cell clonal expansion [Chambers at al., 
2003]. Of note, Nanog is dispensable for formation of pluripotent cells capable of 
differentiating cells from the three germ layers, but is required for germ cell 
formation [Chambers at al., 2007]. 
 
Another important discovery was the fact that the main anti-differentiating 
activity of the serum is being held by Bone Morphogenic Proteins (BMPs), and that 
ES cells can be maintained using LIF and BMPs as the only exogenous instructive 
signals [Ying et all., 2003a]. The same authors showed that BMPs block ES cell 
differentiation primarily through ID proteins. 
 More recent reports indicate that the extrinsic signalling can be by-passed 
altogether, in ES cell maintenance, provided that mitogen-activated protein kinase 
(MAPK) pathway and glycogen synthase kinase 3 beta (GSK3B) pathway are 
inhibited [Ying et al., 2008].  
 
I2.2.3 Human ES cells; Epiblast Stem Cells 
 
Significant differences exist between mouse and human ES cells in culture 
conditions requirements as well as signalling properties. Consequently, the long time 
required for isolation of the latter cells [Thomson et al., 1998]. While human ES cells 
are not responsive to LIF, they can be maintained either with feeder cells [Prelle et 
all, 1999; Pera et al., 2000] or using conditioned medium from feeder cells [Xu et al., 
2001]. Interestingly, they require FGF2 [Kang et al., 2005; Greber et al., 2007] and 
subsequent activation of MAPK1 pathway, a signalling cascade which induces 
differentiation in mouse ES cells [Burdon et al., 1999b]. 
 
Recently, pluripotent self renewing cells were derived from mouse epiblast of 
post-implantation embryos. These cells were named Epiblast Stem Cells [EpiSCs], 
after their origin; unlike mouse ES cells that depend on LIF for their self renewal., 
EpicSCs rely on FGF and ACTIVIN, resembling human ES cells [Brons et al., 2007; 
Tesar et al., 2007]. Moreover, the similarity with hES cells and divergence between 
mouse ES and EpiSCs was also confirmed at the level of differentiating instructive 
signals [Vallier et al., 2009]. For instance, the authors found that in the case of 
mEpiSCs inhibition of ACTIVIN/NODAL signalling leads to rapid loss of 
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pluripotency markers and induction of neural differentiation, as in the case of hESCs, 
and that a three step protocol, developed for induction of mesoderm and definitive 
endoderm from hESC could be successfully used in the case of mEpiSCs but not 
mESCs [Vallier et al., 2009]. 
 
 
I3. Basic Helix-Loop-Helix Family of Transcription 
Factors 
 
The basic Helix Loop Helix (bHLH) family represents a large group of 
transcription factors involved in many developmental pathways such as lineage 
commitment, differentiation, proliferation, sex determination in organisms ranging 
from yeast to human [Massari & Murre, 2000].  
 
The importance of bHLH domains were first appreciated in Tcf3 (also known as 
E2A) gene products (E12 and E47 proteins), which were discovered by their ability to 
bind to E-boxes [Murre et al., 1989]. At that time, Myod1 and Myc in mouse and 
daughterless, achaete-scute and twist in Drosophila had already been discovered, 
though the relation between them was not yet clear [Davis et al., 1987; Hayward et 
al., 1981; Caudy et al., 1988; Campuzano et al., 1985; Thise et al., 1987]. The E-
boxes had been previously identified as DNA cis elements present in immunoglobulin 
enhancers [Ephrussi et al., 1985]. 
 
bHLH proteins have two functionally distinct domains comprised in a highly 
conserved region of approximately 60 amino acids. At the N-terminal end of the 
region there is the basic domain which binds DNA in the major groove at the E 
consensus sequence [Jones S., 2004]. The second domain, placed at the C-terminal 
end of the region, consists mainly of hydrophobic residues and it acts by facilitating 
protein-protein interaction, resulting in dimerization of the bHLH factors. This motif 
contains two amphipathic α-helixes separated by a short loop and it spans for 
approximately 50 amino acids [Atchley & Fitch, 1997; Fig I1].  
 
 







Figure I1. bHLH domain strucure and its interaction with DNA.  
 
A bHLH heterodimer binds DNA at the major groove. H1-first helix, H2-second 
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However DNA binding by the basic region and consequently activation of target 
genes requires as a first step homo- or hetero-dimerization through the HLH region.  
 
On the contrary, in the absence of basic region the HLH dependent dimerization 
is not disrupted [Voronova & Baltimore, 1990]. This feature is employed by ID 
proteins (dominant negative bHLH like proteins, that lack the basic motif) to drive 
passive inhibition of their binding partners [Benezra et al., 1990]. 
 
I3.1 bHLH Superfamily Classification 
 
The transcription factors belonging to the large bHLH family were classified 
based on their tissue distribution, dimerization capabilities and DNA-binding 
specificities into 7 classes (I to VII) [Murre et al., 1994]. Subsequently, a 
phylogenetic classification was proposed, dividing the bHLH proteins into 4 classes 
(A to D) [Atchley and Fitch, 1997], with two more classes (E and F) added later 
[Ledent et al., 2002], Table I1. 
 
Class I bHLH proteins is represented by E proteins, it includes E12, E47, 
TCF12 (also known as HEB), TCF4 (also known as E2.2) and DAUGHTERLESS. 
E12 and E47 represent spliced variants of Tcf3 gene. These proteins are expressed 
promiscuously throughout many tissues, can form homo- and hetero- dimers and bind 
DNA to the E-box sites alone.  
Class II includes protein like MYOD, MYOGENIN, ATONAL, NEUROD1; 
they have a tissue restricted pattern of expression and do not form homodimers with 
very few exceptions (notably TWIST1). They form heterodimers with the E proteins 
and hence bind to the E –boxes [Massari & Murre, 2000]. Class I and II form 
phylogenetic group A.  
Class III include the MYC family and is characterized by the presence of a 
leucine zipper motif after the second helix of the bHLH domain.  
Class IV include proteins like MAD and MAX. These proteins can contain a 
leucine zipper motif, form homodimers, or heterodimers with other members of the 
class, or with MYC. Together, class III and IV form phylogenetic group B. It is 
believed that, group B hold the ancestral sequence of bHLH [Jones, 2004].  
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Murre et al., 
1994 
Examples of classified 
proteins (family names) 
A Bind to CAGCTG or CACCTG I, II MYOD1, TWIST 
B Bind to CACGTG or CATGTTG III, IV MAD, MAX, MYC 
C Bind to ACGTG or GCGTG. 
Contains a PAS domain 
VII Single-minded (SIM), aryl 
hydrocarbon receptor 
(AHR) 
D Lack a basic domain and hence do 
not bind to DNA but form protein-
protein dimers that function as 
antagonists of group A proteins 
V ID 
E Bind preferentially to N-box 
sequences CACGCG or CACGAC. 
Contain an orange domain, involved 
in dimerization and DNA binding 
VI HAIRY 
F Contain an additional COE domain, 




Table I1. Comparison between two bHLH classifications. Adapted from Jones S., 
2004 
 
Class V, are the dominant negative ID proteins and they form evolutionary 
group D.  
Class VI, contain an Orange domain and a proline in their basic domain. The 
Orange domain might be involved in transcription repression as well as dimerization. 
This class include HAIRY, HEY, HES proteins; form phylogenetic group E, bind 
preferentially to N-boxes and were initially assigned by Atchley and Fitch to group B 
[Atchley & Fitch, 1997; Jones, 20004].  
Class VII include transcription factors like aromatic hydrocarbon receptor 
(AHR), hypoxia inducible factor (HIF), Single-minded and Period. These proteins 
contain a PAS (Period-AHR-Single-minded) domain (260-310 aa) carboxy-terminal 
from the second helix, which is involved in dimerization. This class form 
phylogenetic group C [Massari & Murre, 2000; Jones, 2004]. 
	   10	  
I 3.2 ID Negative Factors of bHLH Transcription Regulation 
 
Soon after the discovery of HLH as a homology domain between multiple 
transcription factors [Davis, et al., 1987], the first Id was identified in a cDNA library 
screen in murine erythroleukemia cells, using a probe homologous to the second helix 
common for Myc, Myod1 and Myog [Benezra et al., 1990]. In mammals there are 4 
ID proteins: IDl, ID2 [Sun et al., 1991], ID3 [Christy et al., 1991], and ID4 
[Riechmann et al., 1994].  
 
The expression pattern of these transcripts has been investigated in 
embryogenesis starting at early gastrulation [Duncan et al., 1992; Wang et al., 1992; 
Evans and O’Brien, 1993; Jen et al., 1996]. Briefly, Ids start by being expressed in 
extraembryonic tissues. Then, as gastrulation proceeds, they become highly expressed 
throughout epiblast and its derivates. Later on, expression decreases and becomes 
tissue specific [Wang et al., 1992]. From the 4 described Ids; Id1, Id2 and Id3 have a 
significantly overlapping expression, but different than that of Id4. Id1, Id2 and Id3 
are expressed at sites with active morphogenic activities, while Id4 is expressed in 
more mature tissues, with the notable exception of developing CNS where all Id 
genes are expressed [Jen et al., 1996]. During gastrulation, Id1 and Id3 are expressed 
in the epiblast and its derivates, while Id2 is expressed in trophectoderm. 
Subsequently, Id1, Id2 and Id3 are expressed in neural crest, neural crest derived 
mesoderm and paraxial mesoderm. They are expressed highly at sites of 
chondrogenesis, but not in dermatome or myotome [Wang et al., 1992, Evans and 
O’Brien 1993, Jen et al., 1996]. Regarding neural differentiation, neural precursors 
express all Ids, while in mature neurons Id4 becomes the main Id player [Nagata and 
Todokoro, 1994; Jen et al., 1996]. 
 
The studies presented here were performed at late developmental stages relative 
to an eventual role for ID proteins in pluripotent cells in vivo and early differentiation 
events. While it is difficult to perform such studies in the developing early embryo, 
single cells analysis indicated that Id1 and Id2 are upregulated during in vitro 
outgrowth from ICM [Tang et al., 2010] and Id2 was found to be the earliest marker 
of the outer cell domain (prospective trophoblast) [Guo et al., 2010]. 
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I3.2.1 IDs Mechanism of Action 
 
One of the best described mechanism of actions for IDs is their binding to TCF3 
proteins and preventing formation of active dimers with tissue specific bHLH factors 
like MYOD1 [Jen et al., 1992; Kurabayashi et al., 1994; Peverali et al., 1994]. TCF3 
bind ID proteins with higher affinity than MYOD [Goldfarb et al., 1996], and IDs 
bind TCF3 with higher affinity than MYOD [Loveys et al., 1996]. Interestingly, ID 
proteins were shown to block function and DNA binding of some non-bHLH 
transcription factors as well, like the retinoblastoma protein, or PAX factors [Iavarone 
et al., 1994; Shoji et al., 1995; Yates et al., 1999; Roberts et al., 2001]. 
 
I3.2.2 Ids Induction by BMP 
 
TGFB signalling has two branches. On one branch TGFB, ACTIVIN and 
NODAL bind to TGFBR1 (TGFb receptor 1, also known as ALK5), ACVR1B 
(Activin A receptor type 1B, also known as ALK4) and ACVR1C (Activin A receptor 
type 1C, also known as ALK7); this will induce activation of SMAD2 and SMAD3. 
On the other branch BMPs/GDFs bind BMPR1A (BMP receptor 1A, also known as 
ALK3), BMPR1B (BMP receptor 1B, also known as Alk6) and ACVR1 (activin A 
recptor type 1, also known as ALK2); this will induce activation of SMAD1, 5 and 9 
[Miyazono and Miyazava, 2002; Ruzinova and Benezra, 2003]. 
 
BMP can induce Id through activation of SMAD1/SMAD5 [Hollnagel et al., 
1999; Korchynskyi and ten Dijke, 2002; Lopez-Rovira et al., 2002]. Unlike BMP, 
TGFB1 activates SMAD2/SMAD3 together with a transcriptional repressor ATF3. 
ATF3 cooperates with SMAD3 and represses Id expression [Kang et al., 2003]. 
However, in some cellular context TGFB1 can induce Id genes [Hacker et al., 2003; 
Sugai et al., 2003; Ruzinova and Benezra, 2003] or have a biphasic effect, activating 
or repressing Ids depending on TGFB1 concentration [Goumans et al., 2002]. The 
described induction/repression has been reported for Id1, Id2 and Id3. It is unclear if 
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I3.2.3 IDs Regulate E Protein Activity 
 
Tcf3 knockout mice are born at lower frequency than expected Mendelian ratio. 
The new-borns, which survived, presented with growth retardation, no B-lymphocyte 
formation and, most of them died in the first 2 weeks postnatally. The few who 
survived, presented a high incidence T cell lymphoma after three months of life [Bain 
et al., 1994; Zhuang et al., 1994; Yan et al., 1997]. Id1 knockout mice are born at the 
expected ratio and show no obvious anomalies, suggesting compensation from other 
Id proteins. Generation of Tcf3/Id1 compound knockouts partially rescued growth 
retardation and reduced survival at, and after birth compared to Tcf3 single 
knockouts. However, the absence of B cell and later formation of T cell tumours 
could not be influenced [Yan et al., 1997]. Together these data indicate that ID 
proteins bind to TCF3 as well as to other members of the E protein class (TCF4 and 
TCF12) and that reducing the overall levels of ID proteins by knocking out Id1 (in 
Tcf3-/- background) releases some of the negative pressure on other E proteins, 
partially rescuing growth retardation. On the other hand, proper B and T cell 
differentiation seem to be strictly dependent on TCF3 activity [Yan et al., 1997]. 
 
I3.2.4 Ids in Development: Insights from Knock-out Studies 
 
Mice knockout for Id3 like those for Id1 are born normally and show no overt 
developmental anomalies. However, unlike Id1, Id3 knockout present haematological 
perturbation in B and T cell lineage differentiation [Pan et al., 1999]. Strikingly, 
Id1/Id3 compound knockout are not viable and they die at 13.5 dpc of cranial 
haemorrhages. Starting at 11.5 dpc these embryos show growth retardation, and 
notably smaller brains, with fewer proliferating cells. Marker analysis showed 
expanded domains of Atoh1 (also known as Math1), Neurod4 (also known as Math3) 
and Neurod6 (also known as Math2) indicating premature neuronal differentiation 
[Lyden et al., 1999]. 
 
Id2 knockout mice are born normally, but subsequently show retarded growth 
with increased neonatal lethality. Phenotypically, they present megacolon and 
absence of the Payer plates and lymph nodes. On the hematologic lineage complete 
alymphoplasia and important reduction in natural killer cell number were observed 
	   13	  
[Yokota et al., 1999]. Furthermore, female mice Id2-/- have a defect in mammary 
gland pregnancy associated expansion, and they are never able to foster their pups 
[Mori et al., 2000]. Interestingly, in chick overexpression of Id2 on embryo surface 
induces transformation of the ectoderm overlaying the neural tube into neural crest 
and overgrowth and premature neurogenesis of the neural tube [Martisen and 
Bronner-Fraser, 1998].  
 
Id4 knockout mice survive postnatally, but they present significantly smaller 
brains compared to wild type. The reduction in brain size starts to be noticeable at 
11.5 dpc and, it was accompanied by precocious differentiation of early cortical 
progenitors, as indicated by increased expression of Tubb3 (bIII-tubulin) and 
Neurod1 [Yun et al., 2004]. Furthermore, Id4 is involved in mammary gland cell 
proliferation in response to estrogen or progesterone by inhibiting MAPK14 [Dong et 
al., 2011], suggesting a redundant role with Id2. 
 
ID proteins role in blocking differentiation and sustaining proliferation, already 
discussed in neural development, has been shown in many other contexts, 
physiological and pathological [Norton JD, 2000; Ruzinova and Benezra, 2003]. ID 
proteins delay senescence by suppressing CDK1A (also known as p21) and CDK2A 
(also known as p16) cyclin dependent kinase inhibitors [Ohtani et al., 2001;Ouyang et 
al., 2002; Prabhu et al., 1997]. Furthermore, ID proteins are upregulated in many 
cancers and this phenomenon is associated with poor prognosis [Israel et a, 1999; 
Lyden et al., 1999]. Since IDs main role is to bind and sequester E proteins it is 
thought that this mechanism is employed for cell cycle control as well. However, 
there are some problems with this hypothesis. First, proposing that IDs act by 
sequestering E proteins and preventing them to form active dimers does not clarify 
which active dimers would be involved in a particular process. Second, it has been 
shown that at least in some cases IDs use different pathways; for instance only 
repression of CDK1A but not CDK1B is TCF3 dependent [Prabhu et al., 1997; 
Ohtani et al., 2001]. Furthermore, in erythroleukaemia cells, ID1 associate with 
DNAJC2 (also known as MIDA1) and helps rather than prevents DNAJC2 specific 
DNA binding [Inoue et al., 1999]. 
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I4 Twist1 in Mouse Development 
 
I4.1 Twist1 Expression in Mouse Embryogenesis 
 
I4.1.1 Twist1 Expression in The Pre-Implantation and Early Post-
Implantation 
 
Twist1 transcripts are first detected after implantation in the ectoplacental cone 
by in situ hybridization [Stoezel et al., 1995]. More recently q-PCR data shows that 
the gene is transcribed at low levels in ES cells and its expression increases during 
differentiation [Aiba et al., 2009; Schulz et al., 2009]. However, our preliminary data 
[Aliaxandra Radzisheuskaya] indicate that mRNA for Twist1 can be detected only at 
very low levels in mouse blastocyst, and that it increases to significant levels in 
embryos starting at 7.5 dpc. 
In the primitive streak embryo (7 – 7.5 dpc) Twist1 is expressed weakly in 
“ectodermal cells of the embryo proper and subjacent mesoderm at the side of 
primitive streak formation” [Stoetzel et al., 1995]. Interestingly, these findings could 
not be confirmed by other researchers who found Twist1 signal in the mesoderm, only 
at some distance from the primitive streak with intense labeling for the anterior 
mesodermal cells [Füchtbauer, 1995]. At this stage Twist1 is expressed more 
abundantly in extra-embryonic ectoderm derived from ectoplacental cone [Stoetzel et 
al., 1995], and in extra-embryonic mesoderm lining the exocoelom as well as in the 
allantois [Stoetzel et al., 1995; Füchtbauer, 1995].  
 
I4.1.2 Twist1 Expression in The Somitic Embryo 
 
At 8 dpc Twist1 is expressed in the head mesenchyme, somites and somatic part 
of the lateral plate [Stoetzel et al., 1995; Füchtbauer, 1995]. “In the unsegmented 
paraxial mesoderm it is detectable only in the most anterior region which will form 
the next somite” [Füchtbauer, 1995]. At this stage Twist1 expression is no longer 
detected in ectoplacental cone [Stoetzel et al., 1995] but it continues in extra-
embryonic mesoderm, amnion and allantois [Stoetzel et al., 1995; Füchtbauer, 1995]. 
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It is not expressed in ectoderm or embryonic endoderm, nor in the non-somitic 
mesoderm or in the tail [Stoetzel et al., 1995; Füchtbauer, 1995]. 
As the somitogenesis progresses the Twist1 signal becomes restricted to the 
ventral medial half of the anterior somites, which will give rise to sclerotome 
[Füchtbauer, 1995]. At 8 – 8.5 dpc Twist1 is strongly expressed in the first branchial 
arches. At 9 dpc it appears in the anterior limb rudiment [Stoetzel et al., 1995; 
Füchtbauer, 1995]. At 9 – 9.5 dpc “the sclerotome cells continue to express Twist1, 
but now the signal is again detected in the dermatomyotome thus, leaving only, as a 
small stripe, the Myf5 expressing myotome without Twist1 expression”. [Füchtbauer, 
1995]. Now, the signal appears in the posterior limb (at the time of the third and 
fourth branchial arch formation. The level of expression decreases in the first and 
second branchial arches [Stoetzel et al., 1995]. 
 
Twist1 is not expressed in the early myocardium, but it is detected between 10 – 
13 dpc in the atrioventricular cushion [Stoetzel et al., 1995; Füchtbauer, 1995]. It is 
excluded from the areas of myogenic and chondrogenic differentiation but it is 
strongly expressed close to chondrogenic differentiating cells. It is also expressed in 
the mesenchyme underlining the epidermis with a gradual reduction of the message 
“with increased distance from the epithelium” [Füchtbauer, 1995]. 
 
Twist2 shows a very high degree of conservation with Twist1 in the bHLH 
domain and has been reported to act in a redundant manner with TWIST1 [Sosic et 
al., 2003]. However, Twist2 expression in the embryo has only been reported at later 
stages, starting with 10 dpc [Li et al., 1995]. Interestingly, a gene trap experiment 
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I4.2 Twist1 Mutants 
 
I4.2.1 Twist1 Null a Lethal Phenotype 
 
Twist1 null mice die at 11.5 dpc. Their neural tube fails to close in the cranial 
region, resulting in exencephaly. Focal haemorrhages are consistently observed at this 
level. 
 
In Twist1 null embryos cranial neural tube cannot initiate fusion. However, the 
neural folds in the trunk region and hindbrain caudal of rhombomere 4 close and form 
the neural tube [Chen and Behringer, 1995; Fig I2]. The defects observed in the 
cranial neuroepithelium were preceded by mesenchyme abnormalities. The 
mesenchymal cells in this region presented an abnormal round morphology, with 
reduced cellular contacts and increased extracellular space [Chen and Behringer, 
1995]. Gene expression analysis by in situ hybridization of Twist1 null mutants 
showed that “the loss of TWIST1 function in the head mesenchyme impacts on 
dorsoventral but not the anteroposterior patterning of the cephalic neural tube” [Soo 






















Figure I2. Twist1 null a lethal phenotype.  
 
Twist1 null embryos display severe malformations during gastrulation. White arrow 
indicates the open neural tube. Black arrows point to the underdeveloped limb buds. 










































	   19	  
I4.2.2 Mesenchymal Anomalies in Twist1 Null Embryos 
 
The mandibular arches in the Twist1 null embryos were straight and 
disorganization (similar to that in the forebrain) was observed in the branchial arches 
mesenchyme [Chen and Behringer, 1995]. The neural crest cells migrating towards 
the first and second branchial arches were not restricted to the subectodermal 
mesenchyme, but invaded the paraxial mesenchyme [Soo et al., 2002]. The impaired 
homing ability appeared to be the consequence of non-autonomus Twist1 cell effects, 
as wild type neural crest cell scattered widely in the cranial mesenchyme, when 
transplanted into Twist1 null embryos [Soo et al., 2002]. Moreover, Twist1 knockout 
induced downregulation of Cdh11 (involved in cell-cell adhesion). Taken together, 
these results indicate that alteration in mesenchyme cell adhesion contributes to 
defective migration and that “Twist1 is required in the paraxial mesoderm for proper 
guidance of neural crest cell migration” [Soo et al., 2002]. 
 
The overall growth of the Twist1 null embryos was similar to that of their wild-
type litter mates until day 10.5 dpc. However, large pools of blood could be found in 
the region of the unfused neural tube. At 11.5 dpc all mutant embryos were dead. It is 
presumed that death was due to multiple cranial focal hemorrhages and that the 
integrity of the blood vessels was affected by the disorganization of the surrounding 
mesenchyme [Chen and Behringer, 1995]. 
 
 
I4.2.3 Twist1 Knock-out Induces Somite Disorganization 
 
Twist1 is normally expressed at high levels in the newly formed somites, but 
these structures were formed in all Twist1 null embryos and seemed superficially 
normal [Chen and Behringer, 1995]. However, the somatic cells were less well 
segregated and packed than the wild type ones, and the individual domains were less 
distinct. Myog expression at the appropriate time in the myotome indicated that 
Twist1 is not required for initial steps of somite differentiation [Chen and Behringer, 
1995]. Interestingly, teratoma experiments indicate that tumors generated from Twist1 
mutant ES cells contain less cartilage, extremely low levels of trabecular bone, and 
scarcely any muscle or tooth buds [Soo et al., 2002]. Significant numbers of apoptotic 
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cells were detected in Twist1 null somites, especially in the sclerotome suggesting 
that Twist1 might be required for cell growth and survival [Chen and Behringer, 
1995].  
 
I4.2.4 Saetre-Chotzen Syndrome – a Human Genetic Disease Linked to 
Twist1 
 
Unlike homozygous null mutants, heterozygous Twist1 mutants live into 
adulthood and present an incompletely penetrant and variable phenotype that 
resembles human Saetre-Chotzen syndrome (SCS) [Bourgeois et al., 1998]. This 
syndrome is classified as acrocephalosyndactyly type III and consists of a variable 
phenotype whose main features are: asymmetrical craniosynostosis, flat forehead, 
straight nasal bridge, ptosis, low hairline, facial asymmetry, small round ears, mild 
syndactyly of the second interdigital space, short thumbs and broad hallux, or hallucal 
duplication [Reardon and Winter, 1994].  
 
The great phenotypic variability of Twist1 heterozygous mutations is in stark 
contrast to the uniform lesions of homozygotes. In humans, the severity of the 
syndrome does not seem to correlate with the specific genetic defect. In patients with 
both mild and severe symptoms various point mutations have been identified as well 
as large gene deletions. The only correlation could be found with intellectual deficits, 
which are rarely found in SCS, but so far, when they appeared, they were only found 
in patients with large gene deletions [Gripp et al., 2000]. 
 
I4.2.5 Mapping Twist1 Gene to SCS Syndrome 
 
The history of human SCS syndrome and what was initially unrelated genetic 
mouse research, is most intriguing. The initial cases of the syndrome were reported in 
the first part of the XX century [Saethre H., 1931; Chotzen F., 1932]. The variability 
of the symptoms led to a lengthy controversy which lasted for more than 50 years 
regarding the precise features and classification of SCS. A review in 1994 shows, that 
by that time, the syndrome was loosely linked to deletions in the chromosome 7: “The 
precise location of and extent of deletion required for craniosynostosis is the focus of 
some debate among cytogeneticist, some favouring 7p15 as the likely critical area and 
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others considering the 7p21 region to be more important” [Reardon and Winter, 
1994]. However, no later than 1995 the first Twist1 null mouse was produced [Chen 
and Behringer, 1995], by 1997 the first heterozygouse mutant was analysed 
[Bourgeois et al., 1998] and even before that genetic tool was made public the link 
between human Twist1 mutations and SCS was reported [Ghouzzi et al., 1997]. 
 
I4.2.6 Heterozygous Mice for Twist1 Deletion 
 
While Twist1 null heterozygous mice are viable and fertile, there is some pre 
and perinatal lethality as 40% wild type mice were recovered instead of the predicted 
Medelian ratio of 33% [Bourgeois et al., 1998]. Mutant mice have accelerated or 
delayed ossifications in some bones of the skull. At day 7 dpn (days post-natal) the 
parietal and frontal bones have grown more rapidly in mutants while the 
supraoccipital bone was already formed and ossified at day 17.5 dpc in wild type, but 
not in mutant mice. However this difference was mostly recovered by 7 dpn with only 
5% reduction in size for heterozygous mutants at that time point [Bourgeois et al., 
1998]. Another finding is that 59% of the mutants present hallux duplication on either 
one or both hindfeet with a supernumerary condrification center present at 13.5 dpc. 
All heterozygotes with hallux duplication presented skull abnormalities. In rare cases 
face asymmetry was observed due to deviation of nasal septum and palate bones 
[Bourgeois et al., 1998]. 
 
I4.3 Molecular Mechanisms for TWIST1 Activity 
 
TWIST1 belongs to a class of bHLH transcription factor that forms active 
dimers with E proteins. TWIST1, E proteins and ID proteins are expressed in 
calvarial mesenchyme [Rice et al., 2000]. In a protein-protein interaction revealed by 
non-reducing PAGE electrophoresis it was shown that TWIST can also form 
homodimers, albeit not with as high an affinity as TWIST-E (TW-E) heterodimers. 
Moreover, ID proteins compete with TWIST1 for dimerization with E proteins, thus 
favoring the TWIST1-TWIST1 (TW-TW) dimers [Connerney et al., 2006]. 
Interestingly, in humans Twist1 haploinsuficiency generation of craniosynostosis is 
mimicked by mutations in the fibroblast growth factor receptors (Fgfr2) [Bellus et al., 
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1996] and there is some indication that TWIST1 regulates Fgfr2 expression. In 
Twist1 heterozygous mice Fgfr2 expression is expanded into the mid suture [Rice et 
al., 2000], as well as the phosphorylation of MAPK1 in response to FGFR2 activation 
[Connerney et al., 2008]. TW-TW and TW-E dimers were found to have opposing 
activities. Thus, TW-TW but not TW-E induces expression of FGFR2 in 10T1/2 
cells, while TW-E blocks induction of FGFR2 expression by BMP7 [Connerney et 
al., 2006]. Based on these data, the authors concluded, that in Twist1 heterozygouse 
mice the balance between TW-TW and TW-E dimers is shifted in favor of TW-TW 
formation. 
 
I4.3.1 TWIST1 Induces Epithelial to Mesenchymal Transition 
 
TWIST1 has been associated with epithelial to mesenchymal transition (EMT) 
both in development and in pathological processes. In Drosophila TWIST ortholog 
induces EMT in the migrating cells from the ventral furrow, a process essential for 
mesodermal specification [Hay E.D., 1995]. EMT is also essential for cancer cell 
progression through metastasis and in mouse mammary cancer cell lines Twist1 
mRNA expression correlated with tumor invasion and metastasis [Yang et al., 2004]. 
When Twist1 was expressed in MDCK (a non malignant cell line) it was observed 
that the cobblestone-like morphology of the epithelial cells was replaced by a spindle-
like fibroblastic appearance, with reduction in cell-cell contacts. This process 
correlated with the loss of epithelial markers: CDH1 (also known as E-cadherin), 
CTNNA1 and up-regulation of mesenchymal markers: CDH2 (also known as N-
cadherin), VIM and FN1 [Yang et al., 2004]. 
 
I4.3.2 TWIST1 an Antiapoptotic Molecule 
 
MYC and MYCN are oncoproteins that are expressed at high levels in many 
types of cancer and have been shown in vitro to stimulate both cell growth and 
apoptosis [Evan et al., 1992; Fulda et al., 1999]. It is considered that the activation of 
apoptosis is a fail-safe mechanism against carcinogenesis and that only cancer cell 
that are able to suppress this mechanism can form successful tumors, with a poor 
prognosis for the patient. In human neuroblastoma cells, it was shown that, MYCN is 
activated only if Twist1 is expressed in the same time and, downregulation of Twist1 
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by siRNA induces rapid cell death through TRP53 (also known as p53) pathway 
[Valsesia-Wittmann et al., 2004]. TWIST1 inhibits MYC induced apoptosis in rat 
cells by downregulating Cdkn2a which is an apoptotic effector up-stream of Trp53 
[Maestro et al., 1999]. Together these data show that TWIST1 has antiapototic 
activity in early embryo development and that it might be involved in mesenchymal 
cell migration. It can be inferred that one of its actions is to block apoptosis induced 
by loss of cell-cell contact, a necessary step prior to cell migration, and that cancer 
cell use these feature abnormally up-regulating Twist1 expression. 
 
 
I5 Early Development in Mouse 
 
I5.1 Epiblast Patterning: Proximal vs. Distal 
 
In the pre-gastrulating embryo the epiblast monolayer is fated to generate all the 
future embryonic tissues plus the extra-embryonic mesoderm and the amnion 
ectoderm [Gardner and Rossant, 1979]. However, even at this early stage, the embryo 
patterning has already begun with the formation of a Proximal-Distal (P-D) gradient 
of morphogenic molecules: NODAL, BMP and WNT. All these molecules have their 
highest activity in the proximal part of the epiblast. The net result of this gradient is 
the formation around 5.0-5.5 dpc of the Distal Visceral Endoderm (DVE) which 
underlines the distal most part of the epiblast [Rossant and Tam, 2009]. The fate of 
DVE will be to migrate proximally in the next 12 hours, turning into Anterior 
Visceral Endoderm (AVE). The side where DVE/AVE migrates becomes the anterior 
region of the embryo, with the opposite region becoming posterior [Arnold and 
Robertson, 2009]. DVE was identified as a thickening of the visceral endoderm (VE), 
due to the fact that endoderm cells in this region adopt a columnar morphology 
[Thomas et al., 1998; Rivera-Perez, 2003]. Furthermore, DVE is characterized by 
expression of specific markers: Hhex, Lefty1 and Cer1; while other markers like Otx2, 
Gsc, and Foxa2 are also expressed in the Node, another region with organizer activity 
in the mouse [Zernicka-Goetz M., 2002]. 
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I5.1.1 DVE Formation: Nodal Signalling 
 
NODAL, a TGF beta ligand, which binds to ACVR2B, has a twofold role in 
early epiblast and primitive endoderm (PrE). In early epiblast the role of NODAL is 
to maintain its undifferentiated status, since in Nodal knockouts, the epiblast 
prematurely acquires a neural fate [Brennan et al., 2001; Camus et al., 2006] and the 
epiblast expresses both Nodal and its co-receptor Tdgf1 (also known as cripto) from 
preimplantation stages (3.5-4.5 dpc) [Mesnard et al., 2006; Granier et al., 2011]. As 
the epiblast mass increases under NODAL influence, the embryo shape becomes 
more cylindrical and the portion of the PrE at the midline is placed further away from 
Extra Embryonic Ectoderm (ExE) influences. Here is where DVE forms and surgical 
ablation of posterior ExE at 5.5 dpc leads to a dramatic expansion of the DVE/AVE 
in the next few hours, while in explants cultured with posterior ExE, DVE markers 
domain is significantly reduced [Rodriguez et al., 2005; Richardson et al., 2006]. 
Furthermore, if Nodal or Smad2 are mutated DVE is not patterned within the PrE 
[Brennan et al., 2001] and removal of ExE is not sufficient to rescue DVE in Nodal 
mutants [Mesnard et al., 2006].  
 
Interestingly, NODAL downstream gene and, DVE marker, Lefty1 is expressed 
asymmetrically in the PrE before implantation and it was suggested that the Anterior-
Posterior axis might originate at this early time point [Takaoka et al., 2006]. 
However, while the early expression of Lefty1 as well as that of Hhex (PrE and DVE 
marker) was confirmed in the PrE of the preimplantation embryo, both these markers 
are downregulated immediately after implantation, only to be re-expressed, together 
with Cer1, at 5.5 dpc at the moment of DVE formation, [Mesnard et al., 2006]. Thus, 
even though it is possible that the early expression of Lefty1 could have patterning 
influences on epiblast and/or PrE, it seems that the key structure: DVE, only forms 
after implantation. 
 
It is noteworthy, that even though NODAL signalling is required for DVE 
formation, one of the inhibitory influences from which DVE is protected, by being 
placed at a safe distance from ExE, might be NODAL itself. This can be inferred 
from the fact that within the epiblast/PrE NODAL signalling is the lowest in the 
vicinity of DVE [Beck et al., 2002], an activity gradient which is achieved in spite of 
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NODAL being expressed uniformly throughout the epiblast. How does this happen? 
NODAL is first secreted as a pro-protein which requires cleavage from the subtilisin-
like proprotein convertases (SPC), FURIN (also known as SPC1) and PCSK6 (also 
known as SPC4 or Pace4), and if the SPC cleavage site in NODAL is mutated AVE 
markers Cer1 and Hesx1 are absent [Guzman-Ayala et al., 2004]. SPC expression in 
the epiblast has not been reported, but they were found in the trophectoderm and PrE 
before implantation (4.5 dpc). After implantation their expression becomes more 
restricted, namely to the ExE and the visceral endoderm of the extraembrionic 
compartment (ExVE) (5.5 dpc) [Mesnard et al., 2006]. Furthermore, NODAL 
uncleaved form is sufficient to induce secretion of SPCs in ExE and NODAL acts 
through FGF4 to maintain the ExE niche [Guzman-Ayala et al., 2004; Ben-Haim et 
al., 2006]. Thus, at 5.5 dpc, when DVE appears, active NODAL is formed in 
proximal part of the epiblast from where it diffuses to the rest of the epiblast and VE. 
It is also possible the SPCs diffuse as well and cleave NODAL throughout the 
epiblast, but either way the highest concentration of active NODAL must be in the 
proximal region.  
 
I5.1.2 DVE Formation: BMP and WNT Signalling 
 
Another type of signalling molecules expressed chiefly in the proximal epiblast 
at E5.5 are Wnts. NODAL activates BMP signalling in ExE from where BMP induces 
Wnt3 expression in the proximal epiblast. Furthermore, Wnt3 activates the proximal 
epiblast enhancer element within the Nodal locus [Ben-Haim et al., 2006] and 
Catnnb1 (also known as β-catenin) signalling induces Tdgf1 (also known as Cripto, a 
NODAL coreceptor) [Morkel et al., 2003], thus establishing a positive feedback loop. 
In Catnnb1 mutants (where canonical WNT signalling is disrupted), DVE is formed 
albeit incompletely, thus Cer1 and Lhx1 are expressed in the distal part of the VE, but 
Hhex is not; subsequently DVE fails to migrate anteriorly [Huelsken et al., 2000]. If a 
Catnnb1 negative regulator: adenomatous polyposis coli (APC) is disrupted in 
embryos, DVE fails to form [Chazaud and Rossant, 2006]. Together, these data 
indicate that a precise level of Wnt activation is required for correct embryo 
patterning at the time of DVE formation. On the other hand, it is also possible that 
WNT directly blocks DVE, and thus limits its expansion towards proximal VE, while 
positively influencing DVE formation only indirectly through NODAL [Fig I3]. 





Figure I3. DVE formation as a result of a signalling network in the 
gastrulatimg embryo.  
 
DVE, characterised by expression of Lefty1 and Cer, forms in the distal most part of 
the visceral endoderm and, will migrate to the prospective anterior. DVE fromation is 
dependent on the interplay between BMP, WNT and NODAL signalling.  
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I5.1.3 DVE Migration: Generation of Anterior Identity 
 
In the next hours after its formation DVE migrates towards the anterior side of 
the embryo, thus becoming AVE [Rivera-Perez, 2003; Srinivas et al., 2004]. It is 
unclear at this point how the decision of which side is anterior is being made, in other 
words, if AVE is being “called” to a prepatterned anterior, or if AVE “decides” where 
anterior is, simply by it migrating there. However, it was noted, that at the time of its 
formation DVE is already asymmetrical, with Lefty1 and Cer1 being expressed at 
slightly higher levels towards the prospective anterior [Yamamoto et al., 2004].  
 
As previously stated, WNT and CTNNB1 (beta catenin) constitutive signalling 
blocks AVE migration. Furthermore, in Otx2 mutants a similar effect of impaired 
AVE migration was observed [Kimura-Yoshida et al., 2005]. One of OTX2 function 
is to induce expression of Dkk1, a WNT antagonist and, forced expression of Dkk1 or, 
knocking out one allele of Ctnnb1 can rescue the AVE phenotype [Kimura-Yoshida 
et al., 2005]. This would indicate a general requirement for WNT downregulation, 
without clarifying what are the determinants for the anterior-posterior (A-P) axis. 
Since CER1 is a NODAL, BMP and WNT antagonist [Picolo et al., 1999], perhaps its 
higher expression towards the prospective anterior provides the directional cues, 
while still not being strong enough to completely block WNT without help from other 
antagonists. 
 
It should be noted, that NODAL/SMAD2 signalling induces Foxa2 and Lhx1 
transcription factors, which trigger production of BMP, WNT and NODAL 
antagonists like: DKK1, LEFTY1 and CER1 [Perea-Gomez et al., 1999; Waldrip et 
al., 1998; Arnold and Robertson, 2009]. It cannot be ignored that BMP, WNT and 
NODAL signalling characterize the posterior proximal epiblast (PPE). Thus,  another 
possibility would be that the A-P axis forms under antagonistic cues from AVE and 
PPE and that each is established where the signal of the other is weakest, following a 
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I5.2 Primitive Streak 
 
I5.2.1 Primitive Streak: General Description 
 
Starting at 6.0 dpc gastrulation begins with the formation, in the next few hours, 
in the PPE, of the primitive streak (PS), under the influence of NODAL, BMPs and 
WNTs which are now confined to this region. This combined signalling determines 
differentiation of the epiblast in this region towards mesoderm, while anterior epiblast 
is maintained undifferentiated by AVE [Rivera-Perez and Magnuson, 2005]. Next, PS 
extends distally having at its anterior tip the organizer/node, up until 7.5 dpc when the 
node lies at the distal tip of the embryo, approximately above the position where DVE 
once stood in the visceral endoderm [Robb and Tam, 2004]. The epiblast cells which 
ingress through the anterior most part of PS give rise to anterior axial mesoderm: 
prechordal plate, anterior part of the notochord and the node [Arnold and Robertson, 
2009, Yamanaka et al., 2007]. The anterior axial mesoderm is a source of NODAL, 
BMP and WNT antagonists, thus reinforcing the protective signals from AVE. 
Furthermore, cells ingressing through PS at this level, also migrate in the endodermal 
layer, partially displace and intermingle with AVE cells and form anterior definitive 
endoderm (ADE) [Kwon et al., 2008]. Under the combined influence of AVE/ADE, 
Node and mesoderm, the anterior epiblast undergoes neural differentiation in the 
medial region while, the lateral region differentiates towards surface ectoderm. 
 
I5.2.2 Primitive Streak: Inducing Signals 
 
TGF beta signalling: 
NODAL, now located in the PPE region is, as mentioned previously, the master 
determinant of PS formation, by indcing BMP4 in the ExE, which in turn activates 
WNT signalling in PPE [Ben-Haim et al., 2006]. It is noteworthy that in Nodal null 
mutants, posterior markers: T (alsow known as Brachyury), Fgf8 and Wnt3 are absent 
[Brennan et al., 2001; Ben-Haim et al., 2006] and, PS and consequently mesoderm 
don not form [Conlon et al., 1994]. Furthermore, if the SPC cleavage site in NODAL 
is mutated, PS markers expression T, Fgf8 and Wnt3 is severely reduced and/or not 
confined to the PS/prospective mesoderm region [Guzman-Ayala et al., 2004].  
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The importance of BMP signalling in PS formation is stressed by the fact that 
Bmp4 null mutants fail to gastrulate and do not express T [Winnier et al., 1995]. 
Furthermore, mesoderm formation is under the influence of TGF beta signalling, with 
ACTIVIN A treatment inducing anterior mesoderm formation, while BMP is 
important for generation of posterior and ventral mesoderm, including hematopoietic 
progenitor formation [Johansson and Wiles, 1995; Finley et al., 1999].  
 
WNT signalling: 
The first marker to show proximal posterior regionalization is Wnt3 which is 
expressed in this region at 5.75 dpc, before AVE has finished its anterior migration 
[Rivera-Perez and Magnuson, 2005]. The importance of this signalling molecule is 
underscored by the fact that mutating it alone is sufficient to block formation of PS 
and its derivates: mesoderm and notochord [Liu et al., 1999]. The same effect on this 
developmental structure can be generated by mutating Ctnnb1 [Huelsken et al., 2000], 
or both WNT co-receptors: Lrp5 and Lrp6 [Kelly et al., 2004]. Furthermore embryos 
lacking Wnt3a, as well as embryos knockout for Lrp6 only, have a milder posterior 
phenotype consisting of axis truncation [Takada et al., 1994; Pinson et al., 2000]. 
Together these data confirm the importance of WNT signalling for PS formation and 




Another signalling molecule downstream NODAL/SMAD2 is FGF8 [Waldrip 
et al., 1998] and, in Fgf8, or Fgfr1 mutants PS forms but cells fail to leave the 
epiblast to ingress and to generate the mesodermal layer [Sun et al., 1999; Yamaguchi 
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I6 In Vivo and In Vitro Neural Induction 
 
I6.1 Neural Induction; a Job for an Organizer 
 
After the generation of the PS neural tissue is formed in the anteriorly specified 
epiblast under the influence of the organizer, which has the ability to induce a 
secondary axis including a nervous system when transplanted to ectopic position in 
the embryo. This property has been conserved for many vertebrates: amphibians 
[Spemann and Mangold, 1924]; fish [Oppenheimer, 1936]; birds [Waddington, 1933] 
and mammals [Waddington, 1936].  
 
Following many decades of intense efforts, and only after the advent of 
molecular biology it could be determined that the organizer neural inducing signals 
consist of antagonists of BMP, WNT and NODAL signalling [De Robertis E.M, 
2009]. However, in the mouse the concept of an organizer proved to be more complex 
when notochord and anterior mesoderm were shown to be important in neural 
induction (vertical signals) [Sharpe and Gurdon, 1990; Ruiz I Altaba and Melton, 
1989, Frohman et al., 1990] as well as the node and adjacent ectoderm (horizontal 
signals) [Ruiz I Altaba A., 1990; Ruiz I Altaba A., 1992; Keller et al., 1992]. 
 
When the first morphologically recognizable mouse organizer, the node, was 
transplanted to lateral epiblast of late streak embryos, it induced a secondary axis 
lacking anterior structures [Beddington R.S., 1994]. Corroborating with this, it was 
found that in Foxa2 mutant mice, where the node is absent, anterior neural structures 
form relatively correctly patterned [Ang and Rossant, 1994; Klingensmith et al., 
1999]. Thus it appeared that in mouse another structure assumed the role of anterior 
organizer, with the most likely candidate being AVE, which secretes BMP inhibitors. 
This was confirmed, when mouse AVE heterotopically transplanted to chick could 
induce formation of forebrain, a property not shared by the chick AVE [Knoetgen et 
al., 1999]. Interestingly, mouse and rabbit nodes can induce a full axis in chick, 
demonstrating that the absence of induced anterior structures in mice is not an 
intrinsic deficiency in the mouse node [Knoetgen et al., 2000]. 
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Nevertheless, a small group of cells placed immediately anteriorly to the distal 
tip of PS, secretes BMP antagonists long before the formation of the node [Robb and 
Tam, 2004]. Thus when this region from early streak embryos, dubbed early gastrula 
organizer (EGO) was transplanted to lateral epiblast of late streak embryos it could 
induce a secondary axis, but it too was lacking the anterior structures. On the 
contrary, when the distal PS of mid streak embryos, mid gastrula organizer (MGO) 
was transplanted it could induce a full secondary axis [Tam et al., 1997]. As already 
described, AVE signalling is strengthened by cells from PS forming the anterior axial 
mesoderm and ADE. Anterior mesoderm induces Otx2 in adjacent cells, while 
posterior mesoderm represses it [Ang et al., 1994]. Fate mapping revealed that the 
majority of these cells ingress from the anterior PS of mid gastrula stage [Kinder et 
al., 1999; Kinder et al., 2001]. Thus, while posterior notochord is a node derivative, 
anterior notochord forms by condensation of cells of the anterior axial mesoderm, 
which are already placed between the AVE and prospective anterior neural tissue at 
the time of node formation [Yamanaka et al., 2007]. 
 
I6.2 Modelling Neural Induction 
 
I6.2.1 The “Default Model” 
 
An essential observation regarding in vitro manipulation of neural induction, 
before the first identification of organizer secreted molecules [Smith and Harland, 
1992; Sasai et al., 1994; Hemmati-Brivanlou and Melton, 1994; Bouwmeester et al., 
1996], was that in Xenopus, animal cup explants form epidermis, unless the cells are 
dissociated, in which case they form neural tissue [Grunz and Tacke, 1989]. Later it 
was proposed that this phenomenon is due to dilution of BMP signalling when cells 
are dissociated [Hemmati-Brivanlou and Melton, 1994; Wilson and Hemmati-
Brivanlou, 1995]. Furthermore, BMP inhibitors or depletion of multiple BMP ligands 
leads to conversion of the entire ectoderm into neural tissue even in the absence of the 
organizer [Lamb et al., 1993; Reversade et al., 2005]. Thus, the idea of the default 
model was born, according to which the default fate of all epiblast cells is to become 
anterior neural cells and active inhibition of this pathway, by BMP, is required for the 
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generation of other cell types [Munoz-Sanjuan and Brivanlou, 2002; Levine and 
Brivanlou, 2007].  
 
I6.2.2 A Chick Strikes at The Default Model 
 
The first serious challenge to the “Default Model” came from work in chick. 
While in Xenopus, BMP antagonist Chordin is sufficient to induce CNS formation in 
ecotdermal explants [Sasai et al., 1995], the same is not true in chick embryos [Streit 
et al., 1998]. It was found that in order to respond to BMP antagonists, chick epiblast 
need to be exposed to FGF8 signalling, which transiently induces an Early Response 
to Neural Induction gene (Erni) [Streit et al., 2000]. The Erni upregulation in the 
prospective neural plate starts before gastrulation and it has been proposed to be 
under the control of FGF8, a molecule secreted by the Node. In an attempt to explain 
how Erni can be induced before Node formation, it was proposed that a group of 
prospective Node cells express Fgf8 before gastrulation and, that this is the source of 
neural priming signal [Streit et al., 2000]. 
 
I6.2.3 The Default Model Counterattacks on All Fronts  
 
A possible explanation would be that work on two model organisms revealed an 
evolutionary change: namely that in lower vertebrates neural induction is solely 
dependent on BMP inhibition, while in higher vertebrates the mechanism is more 
complex. However, this does not seem to be the case, since in mouse, loss of Bmpr1a 
leads to conversion of the entire epiblast to anterior neural tissue and, inhibition of 
FGF signalling does not block neural induction [Di-Gregorio et al., 2007]. The 
default model is strengthen by the evolutionary development of redundancy in BMP 
inhibitors and, while downregulation of single BMP antagonists in Xenopus has 
minimal consequences, depletion of Fst (follistatin), Chrd (chordin) and Nog (noggin) 
together “results in catastrophic failure in dorsal development” [Khokha et al., 2005]. 
Furthermore, in mice, deletion of both Chrd and Nog, which are secreted from the 
node but not AVE, leads to impairment of forebrain formation [Bachiller et al., 2000]. 
  
The defenders of the Default Model further charged, by showing that in 
Xenopus cell dissociation does not work through reducing BMP signalling, which 
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continue in an autocrine fashion, but by activating FGF signalling. However, this 
FGF/MAPK acts by phosphorylating and inhibiting SMAD1. Thus, FGF is just 
another BMP antagonist [Kuroda et al., 2005]. Moreover, IGF, another neural inducer 
[Pera et al., 2001], works by the same mechanism of MAPK dependent SMAD1 
phosphorylation and, IGF and FGF signalling integration at SMAD1 level is required 
for CHRD induction of neural fate [Pera et al., 2003]. In chick, FGF was also found 
to be required for acquisition of neural fate through inhibition of BMP [Wilson et al., 
2000] and in salamanders lateral epiblast can be induced to neural by MAPK1 
pathway [Hurtado and DeRobertis, 2007]. 
 
I6.2.4 The Default Model Under The Scrutiny of In Vitro Investigation 
 
Similarly to Xenopus dissociated animal cup cells, mouse ES cells cultured at 
low density in minimal conditions rapidly and spontaneously undergo neural 
differentiation [Tropepe et al., 2001; Smukler et al., 2006]. Furthermore, while 
removal of BMP is sufficient for ES cells to progress towards neural, differentiation 
along this line cannot progress if FGF receptor is blocked and this cannot be rescued 
by inhibiting BMP signalling [Ying et al., 2003b]. The requirement for FGF 
signalling is restricted to a time within the first 24h of ES cells differentiation and 
could be as short as just 1h [Stavridis et al., 2007]. This observation was correlated 
with chick data showing that FGF inhibition only blocks neural induction before the 
late streak stages [Stavridis et al., 2007] and in Xenopus, Fgf is required in pre-
gastrula stages [Delaune et al., 2005]. Moreover, another key player, NOTCH, 
increased neural differentiation of ES cells and inhibition of this pathway resulted in a 
major reduction, although not complete block, of neural differentiation [Lowell et al., 
2006]. 
 
I6.2.5 Neural Induction: The Field Is Getting Crowded with Players 
 
The cooperation between Fgf and Bmp inhibitors in Xenopus neural induction is 
not a new finding [Lamb and Harland, 1995]. Interestingly, a more recent report 
showed that Xenopus Bmp inhibition can induce neural formation only in the 
presence of Fgf signalling; that Bmp inhibition induces fgf4 and that, Bmp inhibition 
further induce some neural genes like zic1, while Fgf4 induce a different set of neural 
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genes one example being zic3. Zic1 and zic3 are both required for neural specification 
[Marchal et al., 2009]. Induction of a different set of neural genes by Bmp inhibition 
and Fgf activation has since been confirmed [Rogers et al., 2011]. It is of note that in 
the future years a much more complicated picture could emerge. For instance, it was 
showed, that while Sox3 is uniformly expressed in the mouse developing central 
nervous system (CNS), its expression is nevertheless dependent on multiple 
molecular regulators, with a regional characteristic pattern [Brunelli et al., 2003].  
 
This intensive research on neural induction established beyond any question the 
central role played by BMP inhibition in the process. It also provided strong evidence 
for the fact that while the final outcome, i.e. the CNS of different vertebrates may 
look very different; the mechanisms of initial neural specification are evolutionarily 
conserved. 
Thanks to the large body of work we have now a more complete understanding 
of the process, mainly concerning the early requirement for FGF signalling, which 
complements BMP inhibition, as well as the fact, that other pathways like IGF and 
NOTCH integrate into a final tightly regulated neural induction. It seems that all these 
data strengthens rather than challenges the default model. Surely, the default model 
could have never been understood as the absence of all signalling pathways. In order 
for an alternate model to be proposed it should have been shown not only that other 
signalling present at the level of undifferentiated cells is important for the induction, 
but also, that in the embryo, an extrinsic signalling centre for such pathways exists. 
The closest to come to such evidence was the group of Claudio Stern [Streit et al., 
2000; Stern C.D., 2006] who proposed the prospective organizer group of cells as the 
source of early FGF signalling. However, even though the requirement for such an 
early signalling is not a matter of controversy, the fact that the FGF8 secretion by 
those cells is in any way biologically significant, has not been shown. Furthermore, 
there is no evidence that the intrinsic epiblast cells signalling is not enough to make 
them responsive to BMP inhibition. 
 
Interestingly, in amniotes epiblast cells undergo extensive polonaise movements 
prior to gastrulation and, these movements have been characterized as having a 
precise pattern [Voiculescu et al., 2007].  It is thus possible that all prospective neural 
plate cells are primed before gastrulation, by passing in the proximity of prospective 
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organizer cells expressing Fgf8, while the later signals from the Node, Notochord, 
mesoderm and AVE have the role to confirm and stabilize the initial program. 
However, at this time, the developmental significance of epiblast cell movements is 
only a matter of speculation. 
 
I6.3 ES Cells as a Model of Neural Induction 
 
I6.3.1 Embryoid Body Technique 
 
Mouse ES cells can be differentiated along multiple cell lineages using the 
embryoid body (EB) technique. In this method, ES cells are cultured in media without 
LIF and on a substrate to which they cannot attach and, in these conditions, a low 
percentage differentiate along neural lineage [Zhuang et al., 1992]. Efficiency of 
neural differentiation could be increased by adding retinoic acid (RA) after the first 4 
days of culture and allowing cells to attach after another 4 days (4-/4+ protocol) [Bain 
et al., 1995]. A protocol in which RA was maintained only for the first 2 days of 
differentiation has been attempted as well [Fraichard et al., 1995]. The efficiency was 
further increased in the 4-/4+ protocol by actively dissociating the embryoid bodies 
and plating them on laminin coated dishes in serum free defined medium containing 
DMEM/F12 and N2 supplement [Li et al., 1998]. 
 
I6.3.2 Neural Differentiation in Monolayer Technique 
 
Although the use of EB solved the problem of generating large number of 
neural progenitors/neurons in vitro, this method does not allow for the investigation 
of the critical steps of neural specification. Within the rather complex environment of 
the embryoid body neural cells are generated following obscure intercellular 
signalling which can not be easily investigated or controlled. To address this, a 
monolayer differentiation protocol was proposed, taking advantage of the previously 
discussed minimal inductive signalling required for neural differentiation. Thus, 
mouse ES cells were differentiated on cultured dishes, coated with gelatine in a 
defined media with the N2/B27 mixture. This medium necessarily contains signalling 
molecules required to help support cell health and survival (e.g. insulin, estrogen, 
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progesterone), and could in principle contain signals that help promote a neural fate, 
notably retinoic acid (RA). It was shown to support efficient neural differentiation as 
assessed by Sox1 upregulation, a specific marker of neural ectoderm [Wood & 
Episkopou, 1999]. It was observed that BMP, or serum signalling fully blocks neural 
differentiation by inducing ID proteins and, that neural differentiation is dependent on 
autocrine FGF signalling [Ying et al., 2003a; Ying et al., 2003b].	  
Interestingly, BMP4 blocks FGF dependent MAPK1 activation in ES cells but 
not in EpiSC. BMP4 also blocks MAPK1 in EpiSCs differentiating towards neural 
while, in N2B27 BMP stimulates MAPK1 in ES at 24 hours [Zhang et al., 2010]. 
This indicates that the interplay between BMP and FGF is cell context dependent. 
 
After generating neural stem (NS) cells during 7 days in the monolayer 
protocol, they can be propagated on laminin under the influence of FGF2 (Conti et 
al., 2005) and addition of FGF2 in culture (after 7 days) induces markers 
differentially upregulated during neural conversion like: Cd44, Adam12, Cdh20, 
Cx3cl1, Egfr, Fzd9, Kitl, Olig1, Olig2 and Vav3 [Pollard et al., 2008]. Furthermore, 
FGF2 binds to heparan sulphate (HS) on the cell surface, HS sulfation status changes 
during neural differentiation and, in the absence of HS, ES cells cannot differentiate 
in the monolayer protocol [Johnosn et al., 2007]. 
 
I6.3.3 Neural Differentiation of hESCs 
 
hESC could also differentiate to neurons when allowed to form embryoid bodies 
[Zhang et al., 2001], however, this method has the already mentioned disadvantage 
that the signalling pathways involved cannot be either controlled or dissected. hESC 
can be maintained as undifferentiated monolayer on fibroblast cells, though they have 
a tendency to differentiate towards primitive endoderm. When BMP signalling was 
blocked, in these conditions, by addition of NOG, endoderm differentiation was 
abolished and instead cells differentiated towards neural [Pera et al., 2004]. In defined 
condition hESC can be cultured on matrigel and, in these conditions they require 
supplementation of N2/B27 with NOG and FGF2 for induction of a neural cells 
expressing both Pax6 and Sox1 [Yao et al., 2006]. RA which has been shown to be 
important for neural differentiation of mouse ES cells [Stavridis et al., 2010], only has 
the role to bias hESC neural differentiation towards a caudal phenotype and this 
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effect was only observed when starting from early neural rosettes, which are Pax6+ 
and Sox1- (first 8 to 10 days) [Li et al., 2005]. When both branches of TGF beta 
signalling were blocked, using NOG and SB431542 (a ACVR1B and ACVR1C 
inhibitor) neural cells could be induced efficiently and rapidly; Pax6 being 
upregulated between days 5 to 7 and Sox1, the earliest marker in these conditions, 
being upregulated between days 3 to 5 [Chambers et al., 2009]. Interestingly recent 
reports suggest that FGF2 maintains pluripotency of hESC by inhibiting neural 
differentiation, in particular the induction of Pax6 [Greber et al., 2008; Greber et al., 
2010]. Furthermore, it was found that the most effective neural induction, with 
upregulation of Pax6 between day 3 and 5, can be achieved by a triple inhibition of: 
BMP/SMAD1 with NOG, TGF-beta/SMAD2 with SB431542 and FGF/MAPK with 
PD0325901 [Greber et al., 2011]. 
 
Taken together, in vitro work in mouse and human ES cells confirmed the role 
proposed in the embryo of BMP inhibition on neural differentiation. It confirmed as 
well, the importance of FGF signalling, albeit there seem to be contradictions 
between mouse and humans. However, these could possibly be explained by the 
concept of a cell on the road to differentiation captured in different stages, with 
different requirements. As pointed out by the in vivo work, FGF stimulation is critical 
at very early stages. It is possible that after an intermediate stage when FGF is 
normally downregulated, it is again involved in specification of certain neural types. 
The possibility cannot be excluded either, that generating neurons in the most rapid 
way, may not necessarily be the best way. In this context, FGF function could be to 
prolong the life and expand the pool of progenitors. It should also be noted that the 
key aspect of BMP inhibition has not been investigated yet beyond its relation with Id 
upregulation. 
 
I6.3.4 Cadherin1 is Downregulated Early in Neural Differentiation 
 
ES cells express CDH1 which functions in maintaining pluripotency and, CDH1 
is downregulated during differentiation [Soncin et al., 2009]. Furthermore, CDH1 is 
reexpressed during fibroblast reprogramming to induced pluripotent cells: in the 
absence of CDH1 fibroblast cannot be reprogrammed while, expression of Cdh1 can 
replace Pou5f1 during the discussed process [Redmer et al., 2011]. 
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A detailed analysis of ES monolayer neural differentiation indicated a 
sequential marker dynamic: loss of Pou5f1, loss of Cdh1, loss of Fut4 (also known as 
SSEA-1). The last step coincides with downregulation of Sox1 and formation of 
neurons. Furthermore, FGF signalling transiently amplifies the FUT4+ CDH1- 
population, corresponding to neural progenitor cells [Sterneckert et al., 2010]. 
Furthermore, during in vitro neural differentiation of mouse ES cells CDH1 is 
lost from the cell surface before the upregulation of Sox1 [Kamiya et al., 2011]. 
 
I6.3.5 In Vivo Switch from CADHERIN1 to CADHERIN2 during Neural 
Differentiation 
 
Epiblast cells differentiating towards neural progenitors switch from CDH1 to 
CDH2. Initially neural plate is specified in CDH1 positive cells domain, but as neural 
folds invaginate, at 8.5 dpc, they express CDH2, starting from the deepest region of 
the neural groove, future floor plate [Hatta and Takeichi, 1986].  
 
This switch from CDH1 to CDH2 is dependent on EMT inducer Zeb2 (also 
known as Sip1 – SMAD interacting protein 1, or Zfhx1b) [Van de Putte et al., 2003]. 
Interestingly, cells ingressing through PS also express CDH2, although later on, this 
marker is specific to neural derivates, with the exception of the heart and lens [Hatta 
and Takeichi, 1986].  
 
It is of note that while PS cells undergo a full EMT and migrate away from the 
epiblast, neural progenitors only upregulate some EMT markers, while remaining a 
morphological epithelial sheet. Only at the time of neural crest migration, some of 
these cells will upregulate Snai2 and break away from epithelial cell to cell contact. 
 
Furthermore, induction of Zeb2 in the neural plate downstream of 
FGF/CHURCHILL has been shown to block mesoderm fate at the midline [Sheng et 
al., 2003]. In hESCs and mouse EpiSCs, Zeb2 inhibits ACTIVIN/NODAL induced 
mesoderm fate, without interfering with the maintenance of pluripotency and, Zeb2 
protects neuroectoderm fate agains BMP inhibition [Chnq et al., 2010]. Future 
research will probably determine if Zeb2 influence on EMT and, its anti BMP and 
SMAD activity are two independent or related processes.  
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I7 Neural Crest at The Border between Prospective 
Epidermis and Neural Tissue 
 
I7.1 Neural Crest: Overview 
 
Neural crest cells are a vertebrate specific cell type, though evidence for the 
existence of neural crest like cells has been presented for primitive chordates [Baker 
and Bronner-Fraser 1997b]. Neural crest cells are specified in the lateral parts of the 
neural plate, near the border with the surface ectoderm; they delaminate around the 
time of neural tube closure, migrate extensively and differentiate in a wide range of 
cells such as peripheral neurons, glia, melanocytes, smooth muscle, cartilage and 
bone [Baker and Bronner-Fraser 1997a]. 
 
Neural crest cells were first identified by their ability to migrate from the dorsal 
edge of the neural folds (the crest) [His, 1868; Hörstadius, 1950; Weston, 1963]. 
However, putative neural crest markers are detected prior to this event. A synopsis of 
such molecules is presented below. 
 
I7.2 Neural Crest: Markers 
 
Dlx5: 
One of the earliest detected markers in mouse is the neural crest associated 
homoeobox gene Dlx5, a transcription factor known to interact with MSX1 [Yang et 
al., 1998]. It is expressed in mouse at the anterior neural ridge (ANR) at late streak 
stages and marks the lateral edges of the anterior neural plate, presumptive neural 
crest, at the head fold stage. This later signal disappears soon after the neural tube 
closure, while the one in the ANR continues [Yang et al., 1998]. Furthermore, fate 
map indicates that the ANR Dlx5 domain does not generate any neural crest cells 
[Cajal et al., 2012]. In Xenopus it marks the neural/ectoderm border, as well as 
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Tfap2a: 
Tfap2a (also known as AP2 alpha) was found in mouse to be expressed starting 
at 8.5 dpc in neural crest and its main derivates, including sensory ganglia and facial 




The homeobox gene Msx1 has been reported in 9.5 dpc mouse embryos in the 
lateral domain of the trunk neural plate before closure and, in the dorsal-most neural 
tube after closure [Hill et al., 1989].  
 
Pax3: 
The paired box gene Pax3 is first detected at 8.5 dpc in the dorsal parts of the 
neuroepithelium with a second expression domain in the developing somites. 
Subsequently it marks specific brain and spinal cord neurons, as well as neural crest 
cells in the craniofacial domain, limb mesenchyme and spinal ganglia [Goulding et 
al., 1991]. More recent reports indicate that Pax3 is expressed in the epiblast at 6.5 
dpc and then, in the anterior neural folds [Basch et al., 2006]. 
 
Pax7: 
Pax7 is expressed in the epiblast at 6.5 dpc in the future neurectoderm. Later, it 
is found in the neural folds and, caudal neural folds express Pax7 but not Pax3 [Basch 
et al., 2006]. Pax7 was also found, to have a second expression domain in the 
dermatomyotome, with a role in the development of skeletal muscle tissue [Jostes et 
al., 1990]. Interestingly, Pax7 null mice are born with defects in cephalic neural crest 
derivates, but not in the CNS or skeletal muscle [Mansouri et al., 1996] and Pax7 is 
required for neural crest specification in chick [Basch et al., 2006].  
 
Zic factors: 
Zic genes, the vertebrate homologous of Drosophila odd-paired (opa) gene are 
first expressed at 7.0 dpc in the embryonic mesoderm. At 7.25 dpc Zic1 and Zic2 are 
also expressed in the presumptive dorsal neuroectoderm, with Zic2 expression 
becoming more intense in this structure than in the dorsal mesenchyme. At the time 
of neural tube closure, 9.5 dpc, Zic1, Zic2 and Zic3 were expressed in the dorsal 
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midline [Nagai et al., 1997]. In Xenopus, homologs of Zic1, Zic2, Zic3 and Zic5 are 
all expressed at the neural plate border region and have been found to be important 
for neural crest development [Nakata et al., 1997; Nakata et al 1998; Nakata et al., 
2000]. Mutation of Zic1, Zic2 and Zic3 in mouse induces neural tube development 
defects with a weaker effect on neural crest derivates [Nagai et al., 2000]. However, it 
was later found that Zic5, another member of the Zic family, with an expression 
pattern overlapping the previously describes Zics, induces severe defects, if mutated, 
in facial mesenchyme and facial nerves development [Inoue et al., 2004].  
 
Foxd3: 
Foxd3 is a winged-helix transcription factor which has been reported in chick to 
be expressed in the neural plate at the early primitive streak stage in premigratory 
neural crest progenitors and to be maintained in migratory neural crest cells until they 
reach their destination [Yamagata and Noda, 1998], a finding which has been 
replicated in mouse [Labosky and Kaestner, 1998]. Interestingly, Foxd3 has also been 
reported as a molecular switch between neural crest and neuronal fates, differentiating 
it form other neural crest markers like Msx1/2, Zic1-3, Pax3, Pax7 which are also 
expressed in a subset of neurons. Furthermore, FOXD3 can induce neural crest 
delamination independent of SNAI2 [Dottori et al., 2001].  
 
Snai1: 
Snai1 has been shown to be expressed at 8.5 dpc (7 somite stage) in head and 
trunk migrating neural crest cells. Subsequently, it was expressed in mesenchymal 
derivates from both neural crest and mesoderm, but not in neuronal neural crest 
derivates [Smith et al., 1992].  
 
Snai2: 
Snai2 is detected in migratory, but not pre-migratory neural crest cells and, its 
deletion did not impair formation, migration or differentiation of these cells [Jiang et 
al., 1998].  
 
Sox9 and Sox10 
Sox9 is one of the earliest markers to be expressed in neural crest precursor cells 
in chick and mouse [Sauka-Spengler and Bronner-Fraser, 2008, Lee and Saint-
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Jeanette, 2011] and its expression is followed somewhat later by Sox10 [Haldin and 
LaBonne, 2010]. Sox9 is also required for subsequent neural crest migration [Cheung 
et al., 2005], while Sox9 and Sox10 can both induce formation of ectopic neural crest 
[Cheung et al., 2003; Kelsh, 2006; Haldin and LaBonne, 2010]. 
 
Wnt1 
Wnt1 is expressed only in development and is restricted to CNS, marking the 
prospective midbrain. Around neural tube closure it is detected dorsally, at the 
midline and, its expression preceded delamination of the neural crest cells. It can be 
used as a marker of delaminating neural crest cells although, it is rapidly 
downregulated in these cells [Echelard et al., 1994; Chai et al., 2000].  
 
It is challenging to infer the moment of neural crest induction based on the 
marker analysis. First, none of the markers is neural crest specific, i.e. expressed only 
in neural crest cells. Secondly, neural crest is specified within the neural plate and it 
is unclear what is the sequence of events which turn some of the neural plate cells 
into neural crest. Thirdly, all the presented markers partially overlap spatially and 
temporarily making it difficult to generate a map of prospective neural crest, or even 
neural tube. 
 
A relatively recent study [Puelles et al., 2005] compared the markers reported in 
the literature for neural or non-neural ectoderm with a carefully generated fate map of 
stage 4 chick embryos. They found that no marker corresponds precisely to neural or 
non-neural fates, but rather the “non-neural ectoderm apparently grades over into 




I7.3 Neural Crest Induction Revealed by Fate Mapping 
 
A recent study investigated the fate map of the anterior epiblast and found that it 
can be divided into three regions: proximal, distal and intermediate. The cells from 
the proximal region (most rostral) populate only surface ectoderm. Majority of the 
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proximal cells populate the neuroectoderm, while a minority distributed to ventral 
ectoderm of the anterior prosencephalon, with no contribution to the surface 
ectoderm. Progenitors from the intermediate region generate a wide variety of cells 
[Cajal et al., 2012]. Neural crest cells were found in clones originating from distal and 
intermediate region, but not the proximal one. The most rostral limit of neural crest 
progenitors was found at the level of the prospective forebrain just caudally of the 
optic pit and outside the most anterior limit of Tfap2c (also known as AP2.2) [Cajal et 
al., 2012]. 
 
Corroborating marker analysis with clonal fate maps a clearer picture emerges, 
while the exact steps and signals of neural crest induction still remain to be 
uncovered. It is more likely that rather than being defined by precise marker domains, 
neural crest is determined by the interplay of ectodermal and neural signals and 
represents an area of extended potency, as indeed, it has been named as the fourth 
germ layer [Hall, 2000]. Interestingly, when early chick epiblast explants of stage 3-4 
were cultured on collagen gels, only those from the medial region, prospective 
border, were able to generate migratory cells, which could differentiate into 
melanocytes [Bash et al., 2006]. This indicates that neural crest competence is 
determined before upregulation of any known neural crest marker and before 
induction of the neural plate. 
 
 
I7.4 Signals Inducing Neural Crest Fate 
 
When neural crest induction was investigated in chick, it was found that, 
juxtaposition of non-neural ectoderm and presumptive neural plate induces formation 
of neural crest cells. Moreover, both epidermis and neural plate can contribute to 
neural crest [Selleck and Bronner-Fraser 1995]. Grafting exp in Xenopus showed that 
neural crest can be induced by an interaction between neural plate and epithelium and 
both structures are able to generate neural crest cells [Mancilla and Mayor, 1996]. 
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Regarding signalling molecules which may be involved in neural crest 
specification, BMPs, WNTs and FGFs have been proposed as main palyers [Milet 
and Monsoro-Burq, 2012].  
 
In Xenopus progressively higher levels of BMP induce Neural plate, neural 
crest and non-neural ectoderm respectively [Marchant et al., 1998]. The neural crest 
threshold BMP level, is believed to be determined by interplay of BMP and BMP 
inhibitors and, the authors propose ectoderm as the source of BMP and mesoderm as 
the source of BMP inhibitors [Marchant et al., 1998].  
 
Based on Xenopus work as well, other authors proposed a “Two signal model” 
[La Bonne and Bronner-Fraser, 1998] where low levels of Bmp provide an initial., 
weak specification of neural crest fate, which is then stabilised by a second signal., 
proposed to be either Wnt8a or Fgf4. As a source for this second signal non-neural 
ectoderm and/or underlying mesoderm were considered [La Bonne and Bronner-
Fraser, 1998]. Further workindicated that Fgf4 or Fgf8 are the predominant signals, 
being able, unlike Wnt8a, to induce neural crest even in the absence of Bmp 
inhibition [Monsoro-Burq et al., 2003]. However, more recent work pinpointed 
Wnt8a as the neural crest inducing signal secreted from mesoderm, with Fgf8 acting 
indirectly by activating Wnt8a. Furthermore, the underlying mesoderm secrets Chrd, 
a Bmp antagonist, which works in conjunction with Wnt signalling to specify neural 
crest [Hong et al., 2008; Steventon et al., 2009]. However, these findings have again 
been challenged by further work showing direct FGF signalling requirement in the 
epiblast for correct patterning of the neural plate/neural crest, in chick [Stuhlmiller 
and Garcia-Castro, 2012]. Together, these studies provide strength to the idea of the 
importance of BMP, WNT and FGF signalling in the discussed process, while 
indicating that all these molecules might be acting in a complex manner, at multiple 
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I7.5 Neural Crest Delamination: The First Overt Manifestation 
of an Undercover Cell 
 
After induction neural crest cells delaminate from the neural folds/neural tube 
and migrate to perform their function. This process takes place throughout the length 
of the neural tube with the exception of the rostral most parts [Nichols D.H., 1981; 
Couly and Le Douarin, 1985; Couly and Le Douarin, 1987; Le Douarin et al., 2012]. 
It has also been reported that neural crest migration participates in actual closure of 
the neural tube [Davidson and Keller, 1999].  
 
Interestingly the manner of migration varies along the rostro-caudal axis, as 
well as between different species. In the cranial region, neural crest delaminate in an 
abrupt collective process, while at the trunk level they delaminate individually, over a 
period of time, in a dripping fashion [Erickson and Weston, 1983; Theveneau et al., 
2007]. Moreover, in rostral trunk regions neural crest delaminate just before the 
respective somite formation, while in more caudal regions the delamination is delayed 
in relation to somitogenesis [Clay and Halloran, 2010, Theveneau and Mayor, 2012]. 
Interestingly, neural crest delamination is timed similarly in respect to the neural tube 
closure in all species, at the trunk level, but not at the cranial level. In the former 
delamination takes place after the neural tube has closed in all species examined, 
while in the latter it does so before closure in Xenopus, mouse and human, but not in 
chick [Nichols D.H., 1981; Nichols D.H., 1987, Sadaghiani and Thiebaud, 1987, 
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I8 Dorso-Ventral Neural Tube Patterning 
 
I8.1 Neural Tube Patterning; Ventral Signals 
 
Neural tube is patterned by two streams of opposing signals: BMP and WNT 
from the dorsal and, SHH (sonic hedgehog) from the ventral.  
The ventralmost part of the neural tube is formed by the Floor Plate (FP), which 
can be morphologically recognised as a thin strip of cells and, can be molecularly 
characterized by expression of Foxa2 and Shh. It is thought that signals from the 
notochord induce the FP, as shown by the fact that notochord implants ectopically 
induce FP in the lateral neural tube [van Straaten et al., 1985; Yamada et al., 1991].  
 
I8.1.1 FOXA2 and SHH in Control of The Neural Ventral Patterning 
 
One of the first factors to be expressed in the presumptive notochord is Foxa2 
(also known as HNF3β). It is required for proper formation of the notochord and for 
subsequent expression of Shh in this structure [Echelard et al., 1993; Ang & Rossant, 
1994]. Furthermore, expression of Shh in the notochord induces its own expression in 
the floor plate [Chiang et al., 1996; Dale et al., 1997]. Interestingly, Shh also induces 
Foxa2 in the ventral parts of the neural tube [Echlart el, 1993, Liu et al., 1998] and 
ectopic expression of the Foxa2 can ventralize more dorsal regions [Sasaki & Hogan, 
1994, Liu et al., 1998]. Thus FOXA2 and SHH cooperatively establish the neural tube 
ventral signalling centre. 
 
I8.1.2 Neural Tube Patterning: The Work of Morphogenes 
 
The equivalent of the FP in the dorsal part of the neural tube is the roof plate. In 
between these two plates the neural tube is patterned with progenitors of different 
neuronal types precisely located on the DV axis [Ribes and Briscoe, 2009]. It is 
thought that this patterning is achieved by graded morphogen signals from the two 
sources, ventral and dorsal. For instance, the cleaved form of SHH, which has 
signalling functions, was found to extend through a narrow region in the ventro-
lateral domain, beyond the FP [Marti et al., 1995] and, different concentration of this 
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peptide are required for the induction of floor plate and motor neuron respectively 
[Roelink et al., 1995] 
 
I8.1.3 Hedgehog Signalling: Releasing The Inhibition 
 
SHH is first produced as a pre-protein followed by post-translational 
modifications: first the C-terminal portion is cleaved by autocatalysis [Lee et al., 
1994,], followed by addition of cholesterol at the C-terminus [Porter et al., 1996] and 
palmitoilation at the N-terminus [Pepinsky et al., 1998]. The cholesterol modified Shh 
can be secreted from the cell by the transmembranar protein Dispatched1 (DISP1) 
[Burke et al., 1999]. After reaching the target cell SHH binds its receptor Patched1 
(PTCH1) [Marigo, 1996a; Stone et al., 1996; Fuse et al., 1999] and releases the 
inhibitory action PTCH1 has over Smoothened (SMO) [Martin 2001], which then is 
responsible for all SHH intracellular activity [Frank-Kamenetsky et al., 2002; Chen et 
al., 2002]. In support of this model, deletion of Ptch1 is sufficient to induce hedgehog 
signalling in the absence of hedgehog ligands [Goodrich et al., 1997].  
 
I8.1.4 GLI Factors: The Ultimate Hedgehog Effectors 
 
Activation of SMO induces the dissociation of a microtubule associated 
multiprotein complex, with the release of GLI transcription factors and activation of 
hedgehog target genes [Lum et al., 2003; Ruel et al., 2003; Ogden et al., 2003]. SHH 
performs its actions through GLI proteins (members of the zinc-finger transcription 
factors) and it has been shown that their activation can fully replace SHH in neural 
tube patterning [Stamataki et al., 2005].  
 
In mouse there are three Gli genes [Hui et al., 1994, Hughes et al., 1997], GLI1 
is an activator of SHH pathway target genes, while GLI2 and GLI3 have both 
activator and repressor domains [Dai et al., 1999; Sasaki et al., 1999]. The repressor 
activity of GLI2 and GLI3 is induced by proteolysis of the C-terminal domain and 
this process is blocked by SHH [Sasaki et al., 1999, Wang et al., 2000]. Gli1 
expression is induced by SHH and consequently it is expressed in a ventral to dorsal 
gradient [Lee et al., 1997]. Gli3 expression is induced by WNT and repressed by 
SHH and it is expressed in a dorsal to ventral gradient [Alvarez-Medina et al., 2008; 
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Yu et al., 2008; Marigo et al., 1996b, Bucher et al., 1997]. Gli2 is expressed 
throughout the neural tube independent of SHH activity.  
 
Since Gli2 expression is not dependent on SHH it is thought to be the first GLI 
factor to mediate SHH activity [Bai et al., 2002], its deletion results in the absence of 
floor plate [Ding et al., 1998; Matise et al., 1998]. GLI1 can mimic SHH function, 
including ectopically induction of Foxa2 [Hynes et al., 1997], but its deletion does 
not result in an overt phenotype [Park et al., 2000; Bai et al., 2002]. Together these 
data suggest that GLI2 can compensate for GLI1 but not the other way around.  
 
I8.1.5 Hedgehog Signalling Regulation: Negative Feed-back 
 
The fact that 2 out of 3 GLI factors have repressing functions indicate that the 
negative feed-back is one of the key mechanisms that prevent SHH signalling to be 
induced too far from its source. It is of note that GLI3 is thought to work mainly as a 
hedgehog repressor and its expression is negatively regulated by SHH [Yu et a, 
2008]. Furthermore, in a negative feedback loop SHH transcriptionallly activates 
hedgehog pathway repressor Ptch1 [Tabata and Kornberg, 1994; Marigo and Tabin, 
1996; Goodrich et al., 1996] and all GLI proteins can bind to the Gli binding site in 
the Ptch1 promoter [Agren et al., 2004]. 
 
I8.1.6 Gli Mutants Altered Neuronal Fate on the D-V Axis 
 
In Gli3 mutants intermediate neural tube neurons are expanded dorsally 
[Persson et al., 2002] and neurons with ventral telecephalic identity develop 
ectopically in the dorsal telecephalon [Tole et al., 2000], while Shh-/- Gli3-/- double 
deletion significantly rescues the absence of the ventral neurons from the Shh-/- single 
mutant [Litingtung and Chiang, 2000]. This would suggest that one of the main 
functions of SHH is to suppress GLI3 repressor activity. However, even though in the 
Shh-/- Gli3-/- most of the ventral neurons are rescued, they are not correctly distributed 
in their respective domains, but rather, they are intermingled [Litingtung and Chiang, 
2000]. Interneural mixing has also been observed in Gli3-/- Smo-/- compound mutants 
[Wijgerde et al., 2002] as well as in mutants lacking all Gli genes [Bai et al., 2004, 
Dessaud et al., 2008]. 
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I8.2 Neural Tube Patterning; Dorsal Signals 
 
I8.2.1 Specification by BMP 
 
One of the first signals involved in dorsal patterning is BMP [Liem et al., 1995]. 
As I discussed in the previous chapters, inhibition of BMP signalling is required for 
induction of the neural plate, while a low level of BMP will induce neural border and 
neural crest fates. Using mouse ectodermal epiblast explants it was shown that, in this 
system, BMP can inhibit forebrain fate only until early head-fold stage [Yang and 
Klingensmith, 2006]. Thus, even before the neural tube is closed, the neural fate has 
been stabilized against BMP inhibition and, BMP can assume a role in neural tube 
patterning.  
 
I8.2.2 Evidence for BMP in Neural Tube Patterning: The Chick 
 
The roof plate of chick spinal cord expresses two members of the TGF beta 
family (BMP4 and ACTIVIN B). It was found that explants of roof plate, as well as 
BMP4 and ACTIVIN can induce dorsal neurons, while interplay of BMP and 
ACTIVIN induced different dorsal neurons [Liem et al., 1997]. Further studies 
showed that another member of Bmp family (Gdf7) is involved in generation of a 
specific class of interneurons [Lee et al., 1998] and, that BMP inhibits ventral fates 
[Mekki-Dauriac, et al., 2002]. This latter finding fits well with the report that the 
notochord and adjacent mesoderm secrete BMP inhibitors [Liem et al., 2000].  
 
I8.2.3 Evidence for BMP in Neural Tube Patterning: The Mouse 
 
BMP signals from the roof plate induce expression of the transcription factor 
Lmx1a, which acts by withdrawing progenitors from the cell cycle and preventing 
upregulation of Atoh1 [Chizhikov and Millen, 2004]. Atoh1 is required for generation 
of DI1 progenitors [Gowan et al., 2001]. Interestingly, Lmx1a mutants do not develop 
roof plate [Milloning et al., 2000] and dorsal interneurons fail to form [Milloning et 
al., 2000]. 
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BMP2 and BMP4 contain a N-terminal basic amino-acid core, important for 
heparin sulphate (HS) binding.  If this basic sequence is mutated BMP can act at 
greater distances [Ohkawara et al., 2002]. In mice, an inducible BMP4 transgene with 
a mutation in this region results in a ventral expansion of the dorsal marker Pax7 
compared to control, non-mutated transgene [Hu et al., 2004]. 
Bmpr1a is expressed ubiquitously in the neural precursors and acts to promote 
proliferation and induce a dorsal fate. Bmpr1b is express only in the dorsal part of the 
neural tube after 8.75 dpc downstream BMPR1A and its upregulation is inhibited by 
SHH. BMPR1B induces neuronal terminal differentiation [Panchision et al., 2001].  
In the Bmpr1a and Bmpr1b double knockouts, DI1 neurons are absent, DI2 
neurons domain is significantly reduced and, DI3 and DI4 domains are shifted 
dorsally [Wine-Lee et al., 2004]. 
Deletion of Bmpr1a by Pax3-Cre, induces reduction in the number of 
delaminating neural crest cells, reduction of dorsal marker Atoh1 domain and failure 
of neural tube closure at the level of hindbrain in 40% of the cases. By contrast 
deletion through Wnt1-Cre showed none of these effects, indicating a requirement for 
Bmpr1a before neural tube closure [Stottmann and Klingensmith, 2011]. 
Furthermore, the authors found no influence on Bmpr1b expression, in conflict with 
previous reports [Panchision et al., 2001]. 
 
In summary, this body of evidence indicate that neural progenitors are at all 
times sensitive to BMP influence, as shown by continuous and ubiquitous presence of 
Bmpr1a [Panchision et al., 2001]. Before neural fold stages BMP would negatively 
interfere with the neural fate, but neural progenitors are protected by the BMP 
inhibitors secreted from the notochord, mesoderm, AVE and Node [Sharpe and 
Gurdon, 1990; Ruiz I Altaba A., 1990; Yang and Klingensmith, 2006]. As the neural 
folds rise to approach each other and, the lateral part of the neural plate becomes 
dorsal, this region is less protected by the ventral BMP inhibitors. From this moment 
on BMP participate in induction of the roof plate, dorsal interneurons and neural crest 
cells. Interestingly, roof plate, induced by LMX1A is formed by non-dividing cells. 
However, neither neural crest cells, nor DI1 progenitors are postmitotic at this stage 
and, they can both be found in the roof plate. It is unclear if these cells migrate to the 
floor plate from adjacent regions, or if LMX1A induce only a subset of roof plate 
cells. What is clear is that while LMX1A blocks dorsal interneuron fate, it is 
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permissive for neural crest fates [Chizhikov and Millen, 2004]. Nevertheless, there is 
strong evidence to suggest that BMP is directly involved in neural tube patterning, 
beyond induction of the neural crest. The importance of this pathway was further 
stressed by the fact that Bmp activity in zebrafish was found to regulate D-V 
patterning at all A-P levels, including the most anterior ones which do not form 
neural crest [Barth et al., 1999]. 
 
I8.2.4 Opposing View: BMP Inhibition in The Dorsal Neural Tube 
 
In contrast with these observations recent studies showed that at least in chick 
and at least in the cephalic region, dorsal BMP inhibition rather than activation, 
governs neural tube patterning [Creuzet S.E., 2009]. Thus, cephalic neural crest cells 
(forming the roof plate at this level in chick) express BMP antagonists GREM1 and 
NOG and, ablation of this cell population results in anencephaly, secondary to Fgf8 
downregulation [Creuzet et al., 2006; Creuzet S.E., 2009]. Treatment with dsRNA 
against Grem1 and Nog can replicate the phenotype in intact embryos and treatment 
with NOG of the CNC ablated embryos significantly rescued the phenotype, both 
morphologically and in Fgf8 expression [Creuzet S.E., 2009].  
 
Moreover, an older study showed that, after ablation of the dorsal region of the 
chick neural tube, the correct DV patterning can be re-established in the absence of 
BMP signalling, provided that the neural tube was closed [Buxton et al., 1997]. 
 
In mouse, BMP inhibitor Nog is expressed dorsally in the closing neural folds 
[Anderson et al., 2006]. Its expression is negatively regulated by SHH and in the 
absence of noggin the neural folds fail to bend and thus to generate a close neural 
tube. Zic2 mutants, which develop severe spina bifida fail to express BMP antagonists 
Nog and Chrdl1 in the dorsal neural tube [Ybot-Gonzales et al., 2007].  
 
The evidence supporting a BMP role in dorsal neural tube patterning is too 
strong to be dismissed. On the other hand, Nog expression in the same area with Bmp 
must have a functional role. If NOG would simply be limiting spatially the BMP 
activity its expression would be stronger on the ventral side, which is not the case. It 
has been previously reported that in chick BMP is important for neural crest 
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formation only around neural tube closure, a time point when NOG has an inhibitory 
effect. On the contrary, a few hours earlier neural crest formation can be inhibited by 
SHH, but not by NOG [Selleck et al., 1998]. Furthermore, it was proposed that “a 
coordinated activity of NOG and BMP4 in the dorsal neural tube” is required for 
sequential delamination of the neural crest cells. Thus it was found that NOG 
negatively regulates NC delamination and that its expression in the dorsal neural tube 
is higher in caudal regions, where NCCs will delaminate later [Sela-Donenfeld and 
Kalcheim, 2009]. These studies trigger the hypothesis that waves of BMP and NOG 
signalling in the dorsal neural tube control various processes like neural crest 
specification, floor plate induction, dorsal interneuron specification, neural crest 
delamination.  
 
I8.2.5 Specification by Wnt 
 
In the closing neural tube many Wnt agonists are expressed in a complex 
manner. The pattern is more intricate in the forebrain, indicating a role in regional 
subdivision. Three Wnts: Wnt1, Wnt3 and Wnt3a are restricted to the dorsal neural 
tube both in the forebrain and spinal cord [Parr et al., 1993]. 
 
When WNT signalling was analysed first, it was observed that it has a 
mitogenic activity within the neural tube, which could be ascribed to WNT1 and 
WNT3A, but not to other Wnts and no influence on D-V patterning was reported 
[Dickinson et al., 1994; Megason and McMahon, 2002]. Later is was shown that the 
mitogenic activity of WNT signalling has patterning consequences as it specifically 
expands the neural populations induced by BMP in dorsal neural tube of Leghorn 
spinal cord [Chesnutt et al., 2004]. Subsequently, a more complicate picture emerged 
from mammalian experiments, where it was proposed that in dorsal neural tube BMP 
and WNT antagonize each other; BMP blocking WNT dependent proliferation and 
WNT blocking BMP dependent differentiation [Ille et al., 2007]. 
 
Recently, it was shown that WNT and CTNNB1 signalling is important in D-V 
patterning in chick where it acts in conjunction with BMP. Thus WNT induces DI2 
and DI3 neurons through upregulation of Olig3 cooperatively with BMP signalling 
and if WNT signalling is blocked, Olig3 upregulation is also blocked even under 
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constitutive BMP stimulation [Zechner et al., 2007]. Furthermore, in a zebrafish 
model, Wnt proliferation and differentiation roles in neural tube have been dissected; 
Ctnnb1-b interacting transcription factor Tcf7 being ascribed patterning roles, while 
Tcf7l1 (previously known as Tcf3) was shown to be a major player in Wnt dependent 
proliferation [Bonner et al., 2008]. Furthermore, it was proposed that a key role for 
WNT in DV patterning is the antagonism of SHH pathway, by inducing expression of 
Gli3 and thus, limiting specification of ventral fates in response to SHH [Alvarez-
Medina et al., 2008; Ulloa and Marti, 2010, Fig I4]. 
 
I8.3 Twist1 Role in The Neural Tube Patterning 
 
Twist1 null mice fail to close the neural tube anterior of rhombomere 4 [Chen & 
Behringer, 1995] followed by a lethal phenotype. Mice heterozygous for Twist1 have 
normal CNS development, but display a variable phenotype reminiscent of the human 
SCS syndrome [Bourgeois et al., 1998; el Ghouzzi et al., 1997] including skull 
abnormalities, indicating that high levels of Twist1 are not required for anterior neural 
tube development, but that they are required for correct neural crest migration and 
differentiation. 
 
Twist1 is expressed at high levels in the head mesenchyme prior to neural tube 
closure and onwards but it has not been described in the neural tube [Stoetzel et al., 
1995; Fuchtbauer E.M., 1995].  
 
Twist1 neural phenotype has been explained by the influence on the neural tube 
of the surrounding mesenchyme which leads not only to a failure of closure but also 
to a perturbation of the dorso-ventral patterning [Soo et al., 2002]. However, the 
authors of this study presented no data to support a mechanism of Twist1 expressing 
mesenchyme on neural patterning and, only inferred this phenomenon based on 
previously reported Twist1 expression. Interestingly, a few Twist1 positive cells have 
been observed in the neural tube, but those have been labelled as delaminating neural 
crest [Fuchtbauer E.M., 1995].  
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Thus at present, no hypothesis has been put forward to explain how Twist1 
expressing mesoderm is influencing neural differentiation, nor is it clear why would 
the strongest effect be on the dorsal and not the ventral side of the neural tube, which 
is closest to the mesoderm. Furthermore, it is not known if Twist1 absence from the 
neural tissue signifies an incompatibility between Twist1 transcriptional activity and 
neural development and no attempt has been made to reconcile the absence of Twist1 
from neural progenitors in vivo with the upregulation of Twist1 during neural 

































Figure I4. Dorso-Ventral neural identities are regulated by the 
antagonistic interplay between Shh and Wnt.  
 
SHH from the ventral regions induces expression and activity of GLI activator genes, 
and if this signalling becomes predominant it induces the expansion of ventral neural 
fates dorsally: left arrow. WNT from the dorsal regions induces expression of GLI 
repressors, notably GLI3 and if this signalling branch becomes predominant it 
induces the expansion of dorsal neural fates ventrally: right arrow.  
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I9 Specific Aims of The Thesis 
 
Following the data from the literature presented, I propose the following 
hypothesis: 
 
General hypothesis:  
Twist1 regulates neural differentiation of ES cells and early neural development in 
vivo.  
Specific hypotheses: 
1) Twist1 is expressed in during early stages of neural development in vitro and in 
vivo; 
2) TWIST1 positively regulates neural differentiation; 






1. to investigate Twist1 expression in pluripotent and early differentiating cells; 
2. to determine if presence of Tw-E active dimers is compatible with the neural program 
and can protect it against BMP4 inhibition; 
3.  to revisit Twist1 expression in the mouse development, specifically in the neural 
progenitor compartment; 
4. to investigate what potential roles TWIST1 could have in neural development. 
59 
 
II. MATERIALS AND METHODS 
 
 




M1.1.1 Taq PCR 
 
M1.1.1.1 Taq PCR Materials 
 
Taq DNA polymerase (Qiagen, 2012030) and the reagents provided: 10x PCR 
Buffer, 10x CoralLoad PCR Buffer, 5x Q-Solution, 25 mM MgCl2. 
Other regents: dNTP Mix (Invitrogen, 18427013), Water RNase / DNase free 
(Gibco, 10977). 
 
M1.1.1.2 Taq PCR method 
 
Taq DNA polymerase was the enzyme used when high proofreading activity 
was not essential.  
 
PCR was performed according to manufacturer protocol. For PCR products to 
be revealed immediately on Gel Electrophoresis, 10x CoralLoad PCR Buffer was 
used. If further purification of the PCR product was required, 10x PCR Buffer was 
used. 5x Q-Solution was used at concentrations ranging from 0 to 10 µl per 50 ul 
reaction; usually 5 µl. MgCl2 concentration usually used was 1.5 mM, the 
concentration present in the 10x PCR Buffer. Each primer was used at a final 
concentration of 0.5 uM (2.5 ul of a 10 µM solution in water, per 50 µl reaction). 100 
to 200 ng total Template DNA was usually used. 
 
Thermal cycling was performed using TProfessional Standard Thermocycler 
(Biometra). The annealing temperatures were optimized for each primer pair, usually 




94°C – 5 min 
30 to 35 cycles: 
  94°C –  30 seconds 
  xx°C –  30 seconds 
  72°C –  1 min per kb 
72°C –  5 min 
 
M1.1.2 Pfx PCR 
 
M1.1.2.1 Pfx PCR Materials 
 
Platinum Pfx DNA Polymerase (Invitrogen, 11708) and the reagents provided: 
50 mM Magnesium Sulfate, 10x Pfx amplification Buffer, 10x PCRx Enhancer 
Solution.  
Other regents: dNTP Mix (Invitrogen, 18427013), Water; RNase / DNase free 
(Gibco, 10977). 
 
M1.1.2.1 Pfx PCR Method 
 
Pfx Polymerase was the enzyme used to generate blunt constructs for further 
cloning. 
 
PCR was performed according to manufacturer protocol. PCRx Enhancer 
Solution was used at concentrations ranging from 0 to 10 µl per 50 µl reaction; 
usually 5 µl. Magnesium Sulfate was used at final concentrations varying from 0.75 
mM to 2 mM, usually 1 mM. Each primer was used at a final concentration of 0.3 µM 
(1.5 µl of a 10 µM solution, in water, per 50 µl reaction). 100 to 200 ng total 
Template DNA was usually used. 
 
Thermal cycling was performed using TProfessional Standard Thermocycler 
(Biometra). The annealing temperatures were optimized for each primer pair, usually 




94°C – 5 min 
30 to 35 cycles: 
  94°C –  15 seconds 
  xx°C –  30 seconds 
  68°C –  1 min per kb 
68°C –  5 min 
 
For long primers with annealing temperatures above 68°C the two-step cycling 
was used: 
 
94°C – 5 min 
30 to 35 cycles: 
  94°C –  15 seconds 
  68°C –  1 min per kb 
68°C –  5 min 
 
M1.1.3 PCR Product Validation by Gel-Electrophoresis 
 
M1.1.3.1 PCR Product Validation by Gel-Electrophoresis Materials 
 
Agarose gel: UltraPure Agarose (Invitrogen, 16500), TBE (see below), SYBR 
Safe DNA gel stain (Invitrogen, S33102) 
 
Tris-borate-EDTA buffer (TBE): Tris base (Fisher, BP152-1), orthoboric acid 
(Fisher, 10043-35-3), EDTA 0.5M pH8.0, ultra-pure water. TBE was prepared as a 
10x stock solution comprising Tris base 0.45 M, Orthoboric acid 0.45 M and EDTA 
10 mM in water. Working solution was prepared by diluting the stock solution 1:20 in 
water. 
 
Agarose was melted in TBE buffer, 1% final concentration, in a microwave 
oven. After the mixture was allowed to cool, SYBR Safe DNA gel stain (Invitrogen, 




DNA loading dye: Orange G (Sigma, O3756), glycerol (Fisher, 56-81-5), ultra-
pure water. DNA loading dye was prepared as a 6x solution comprising OrangeG 
0.25% and Glicerol 30% in water. 
 
M1.1.3.2 PCR Product Validation by Gel-Electrophoresis Method 
 
The agarose gel was poured into the mould and allowed to solidify. PCR 
product was mixed 1:6 with DNA loading dye and loaded on the gel, unless the PCR 
had been performed using 10x CoralLoad PCR Buffer, in which case the PCR 
product was loaded directly on the gel. DNA was electrophoresed in 0.5x TBE at 90V 
for 30 to 90 min depending on the expected size of the band and, visualised using UV 
trans-illuminator.  
  
M1.1.4 PCR Product Isolation 
 
When the PCR product was to be used in subsequent cloning isolation of the 
product was performed. For PCR reactions which produced only one band PCR 
purification was used. For PCR reactions which produced more than one band gel 
extraction was used. Another method for DNA isolation is precipitation. This method 
has not been used for PCR products purification, but following other enzymatic 
manipulations, like digestion. However, the method is presented here for coherence. 
 
M1.1.4.1 PCR Product Isolation – PCR Purification 
 
PCR purification was performed using QIAquick PCR Purification Kit (Qiagen, 
28104), according to manufacturer instructions. 
 
M1.1.4.2 PCR Product Isolation – Gel Extraction 
 
DNA was eletrophoresed on an agarose gel as in M1.1.3. For Gel Extraction, 
the gel was casted into the mould using large combs and, the entire PCR reaction (50 
µl) was loaded. After electrophoresis the expected band was cut using a clean scalpel, 
under UV light. The procedure was optimized for the cutting to be performed in 3 sec 
or less, so that the risk of introducing DNA mutations due to UV exposure was 
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minimal. The piece of gel, containing the desired DNA fragment,was placed in a new 
Eppendorf tube. 
 
DNA was then extracted using QIAquick Gel Extraction Kit (Qiagen, 28704), 
according to manufacturer instructions. 
 
M1.1.4.3 DNA Precipitation Following Phenol-Chloroform Extraction 
 
Samples of small volume were scaled to 500 µl by adding water RNase, DNase 
free (Gibco, 10977). Phenol:Chlor:IAA (UltraPure Phenol:Chloroform:Isoamyl 
Alcohol, Invitrogen, 15593-031) 500 ul was added, mixed and centrifuged 14000 g 
for 10 minutes. The top, aqueous layer was moved to a new tube. Chloroform (Fisher, 
C606) 400 µl was added and centrifugation repeated. The top layer was moved to a 
new tube and precipitated with 40 ul NaAc 3M pH5.2. Ethanol 1 ml was added, 
mixed and, incubated on dry ice for 30 min, then the sample centrifuged 14000 g for 
15 min. Supernatant was discarded and the pellet washed with 70% Ethanol and 
centrifuged 14000 g for 5 min. Ethanol wash was repeated, then the tubes were air 
dried and DNA resuspended in Elution Buffer. 
 
M1.1.4.4 Direct DNA Precipitation 
 
Samples of small volume were scaled to 50 µl by adding water RNase, DNase 
free. DNA was directly precipitated by adding 5 µl NaAc 3M pH5.2. 150 µl ethanol 












M1.2 Plasmids manipulation 
 
M1.2.1 Plasmid amplification 
 
M1.2.1.1 Plasmid Amplification Materials 
 
Bacterial growth media: LB medium, SOC medium, LB agar 
 
L-broth Lauria Bertani (LB) medium and LB-agar were prepared by the 
ISCR/CRM Media Service, following standard protocols. LB was made by dissolving 
LB (BD, 244620) 2.5% in water, followed by sterilization through autoclaving. LB-
agar comprised 1.5% bacto-agar (BD, 214010) in LB. 
 
SOC medium was made in a distilled water solution comprising: Bacto 
Tryptone 2% (BD 211705), Bacto Yeast Extract 0.5% (BD, 212750), NaCl 10 mM, 
KCl 2.5 mM, MgCl2 10 mM, MgSO4 10 mM and Glucose 20 mM and, was sterilized 
by filtration. 
 
Antibiotics: Ampicillin (Calbiochem, 171254), Kanamycin (Calbiochem, 
420311), Tetracycline (Sigma, T7660), Chloramphenicol (Sigma, C0378). 
 
All antibiotics were prepared as 1000x stock solutions stored at -20°C. 
 
Ampicillin was prepared as an aqueous solution of 100 mg/ml concentration. 
Kanamycin was prepared as an aqueous solution of 50 mg/ml concentration. 
Tetracycline was prepared as an aqueous solution of 3 mg/ml concentration. 
Chloramphenicol was prepared as an alcoholic solution, in ethanol, of 15 mg/ml 
concentration. 
 
Antibiotic supplemented media was prepared by adding 1 µl stock solution of 
the respective antibiotic for 1 ml of medium. LB agar was first melted by heating in 
the microwave, left to cool down and the antibiotic was added just before the pouring 
of the plates. Agar plates not used immediately were store at 4°C for up to one month. 
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Tetracycline supplemented liquid media or plates were protected from light using 
aluminium foil. 
 
Transfection competent bacterial cells: MAX Efficiency Dh5α Competent 
Cells (Invitrogen, 18258012), One Shot Top10 Chemically Competent E. Coli 
(Invitrogen, C404003) 
 
M1.2.1.2 Plasmid Amplification Methods 
 
Plasmidic DNA which either resulted from a ligation reaction (see DNA 
ligation), or had been previously extracted (see DNA extraction) was incubated on ice 
for 30 min with the competent cells. For difficult constructs, like TwTw which 
contained large homology regions, Top10 cell were used.  
 
After incubation, cells were heat shocked for 45 seconds at 42°C, in water bath, 
and cooled down on ice. Immediately, antibiotic free medium was added and bacteria 
cells were incubated for 1h at 37°C. In the case of Dh5α 1ml of LB medium was 
added, in the case of Top10 250 ul of SOC medium was added. Then, 100 µl of 
bacterial culture was inoculated on one agar plate supplemented with the relevant 
antibiotic and incubated over-night at 37°C. In the case of plasmids for which the 
desired ligation was considered a rare event, multiple plates were inoculated. 
 
Next day, individual colonies were picked and inoculated on 5 ml LB 
supplemented with the same antibiotics and incubated again over-night at 37°C. 
 
M1.2.2 Bacterial DNA Extraction 
 
M1.2.2.1 Bacterial DNA Extraction – Plasmids 
 
Plasmids were extracted from overnight liquid cultures, using Qiagen Plasmid 
Mini Kit (Qiagen, 12123), according to manufacturer instructions. For low copy 
plasmids, or large plamids, amplification procedure was modified in the sense that the 
5 ml culture was used as starter culture. Subsequently, 250 µl of the starter culture 
were inoculated into 500 ml medium with the appropriate antibiotics and incubated 
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overnighta and, plasmidic DNA extracted using Qiagen Plasmid Maxi Kit (Qiagen, 
12763), according to manufacturer instructions. 
 
M1.2.2.2 Bacterial DNA Extraction – Artificial Chromosomes 
 
Materials: 
Reagents: Tris base (Fisher, BP152-1), HCl (Fisher, H/1200/PB17), EDTA 
(Fisher, D0450/53), RNase A (Roche, 10109142001 NaOH (Fisher, S/4920/53), SDS 
(Sigma, 75746), NaAc (Sigma, S2889), Acetic acid (VWR, 20104), Ethanol (VWR, 
20821330)), Water RNase / DNase free (Gibco, 10977). 
 
Buffer P1: 15 mM Tris pH8, 10 mM EDTA, 100 µg/ml Rnase A. 
Buffer P2: 0.2 M NaOH, 1% SDS. 
Buffer P3: 3 M NaAc pH5.2. 
Elution Buffer: 10 mM Tris pH8.5 
 




A 5 ml LB culture was centrifuged 6000 g, for 10 min. The pellet was 
resuspended in 300 µl buffer P1. Buffer P2 (300 µl) was added, gently mixed and, 
incubated at room temperature for 5 min. Buffer P3 (300 µl) was added gently mixed 
and the lysate was incubated on ice for 5 min. The mixture was centrifuged for 10 
min at 14000 g 4°C. The supernatant was carefully moved to a new tube and 
centrifugation repeated. The supernatant was carefully moved to a new tube, 800 µl 
ice-cold isopropanol added and incubated on ice for 15 min. The mixture was 
centrifuged at 14000 g for 15 min. Supernatant was discarded and the pellet washed 
with 70% Ethanol and centrifuged 14000 g for 5 min. Ethanol wash was repeated, 







M1.2.3 Plasmid digestion 
 
After extraction, plasmids were digested using relevant enzymes in the buffers 
provided by the manufacturer, using the recommended conditions. For validation of 
the presence of the expected cutting sites in the plasmid at the appropriate position 
typically 100 to 200 ng of DNA were digested in a 10 µl reaction. For further cloning 
1 to 5 µg of DNA were digested in a 50 µl reaction. The amount of enzyme used 
varied between 1x and 10x recommended amount based on predicted activity. 
Digestion time was typically 1 to 3 hours, except for NEB time saver enzymes for 
which digestion time was reduced at 10 to 20 minutes. For enzymes with high star 
activity digestion time was reduced below 1 hour and 1x amount of enzyme was used. 
In the case of plasmids used for transfection by electroporation 100 µg of plasmid 
was digested in a 1 ml reaction, incubated overnight. 
 
Plasmid digested fragments which were used in further cloning were isolated 
using gel extraction method (see M1.1.4.2). 
 
Plasmids linearized for transfection in Eukaryotic cells were purified by direct 
DNA precipitation (see M1.1.4.4).  
 
M1.2.4 Plasmid Generation 
 
M1.2.4.1 Plasmid Generation from PCR Constructs 
 
Blunt end PCR products generated by Pfx PCR (see M1.1.2) were purified and 
then isolated by PCR purification (see M1.1.4.1). A plasmid was generated using 
Zero Blunt TOPO PCR Cloning Kit (Invitrogen, 450245), according to manufacturer 
instructions. 
 
Following amplification and extraction the construct was usually digested using 






M1.2.4.2 Plasmid Generation by Fragment Ligation 
 
Fragments with compatible ends, generated by enzymatic digestion (see 
M1.2.3) and isolated by gel extraction (see M1.1.4.2) were ligated using T4 DNA 
Ligase (NEB, M0202), according to manufacturer instructions. 
 
The DNA fragments concentration was calculated so that a ratio vector: insert 
of 1:3 was achieved. The vector was considered to be the DNA fragment containing 
the origin of replication and the selective gene and, thus, able to form a viable 
plasmid if self ligated. The reaction was usually performed at room temperature for 2 
hours, or at 4°C overnight. 
 
The resulting plasmid was amplified by transfection to competent cells (see 
M1.2.1)  
 
M1.2.4.3 Plasmid Generation from Bacterial Artificial Chromosomes by 
Recombineering 
 
Generation of Recombineering Competent Cells. 
Bacterial cells containing the relevant Bacterial Artificial Chromosome (BAC) 
were electroporated with the pSC101-BAD plasmid as described below. All DNA 
used for electroporation of bacterial cells was resuspended in water as opposed to 
Elution buffer, which was the usual procedure. 
 
BAC containg cells were cultured expanded in Chloramphenicol supplemented 
medium (as in M1.2.1). 30 µl of an overnight culture were inoculated in 1 ml LB 
selective medium and incubated at 37°C for a few hours, until turbidity reached OD 
0.6. Then, the culture was put on ice, transferred to the cold room, and washed 3 
times with water, using centrifugation 14000 g for 1 min. Cells are resuspended in 
100 µl water, moved to a 0.1 cm electroporation cuvette and pulsed at 1.8kV. 





Agar plates supplemented with Chloramphenicol and Tetracycline were 
inoculated as in M1.2.1.2. and incubated at 30°C overnight in dark. 
Inserting a Modification into The BAC by Recombineering. 
Recombineering competent bacterial cells produced as described above were 
cultured in medium supplemented with Chloramphenicol and Tetracycline. The 
electroporation procedure was repeated, with the plasmid of interest, containing 60 bp 
homology sequence flanking the region with the desired modification of the wild type 
chromosome and a Kanamycin resistance cassette [Fig M1]. 
 
After electroporation bacterial cells were inoculated on agar plates 
supplemented with Chloramphenicol and Kanamycin and, incubated at 37°C 
overnight. 
 
Producing a Final Plasmid by Recombineering.  
Using the modified BAC cells the above two steps were repeated using in the 
second step a low copy plasmid containing an Ampicillin resistance cassette flanked 
by reverse 60 bp homology sequence which corresponds in the BAC with 60 bp 
sequencing flanking the entire region desired to be retrieved [Fig M2]. The 60 bp 
sequence were introduced by PCR as in M1.1.2. 
 
After the first electroporation bacteria cells are plated on medium supplemented 
with Chloramphenicol, Kanamycin and Tetracycline, or just Kanamycin and 
Tetracycline and, incubated at 30°C in dark. After the second electroporation bacteria 
cells are inoculated on medium supplemented with Ampicillin and incubated at 37°C. 



















Figure M1. Genetic modification of the BAC 
 
Schematic representation of the strategy for introducing a modification in a gene of 






























































Figure M2. Plasmid containing a genetic modified locus generation  
 
Schematic representation of the strategy to retrieve the modified locus in a low copy 
plasmid. Homology arms typically represent a genetic region of a few kb flanking the 
gene of interest which will direct homologous recombination in the eukaryotic cell. 
Solid blue lines represent schematic stretch of the DNA to allow visualisation of the 
















































M1.2.5 Sequencing The Newly Generated Plasmids 
 
Newly generated plasmids were sequenced by BigDye reaction using 
appropriate primers. For plasmids generated by digestion – ligation method 
sequencing focused around the restriction sites. For plasmids generated from 
construct resulting from PCR reactions the sequencing covered the PCRed fragment. 
 
Sequencing was set as a 6 µl reaction in water, containing 200 to 500 ng 
plasmidic DNA with 0.3 ul of 10 µM primer. The analysis was performed by the 
GenePool Sequencing Service at the University of Edinburgh. 
 
M1.2.6 Plasmid Sequence Analysis 
 
All plasmid sequence analysis for identifying useful cutting sites, primer design, 
and plasmid map generation were performed using: ApE- A plasmid Editor v2.0.36, 
copyright © 2003-2009 M. Wayne Davies. Optimal primer sequence was designed 
using: Primer3, Release 2.2.3, SourceForge; http://primer3.sourceforge.net/. The final 
oligonucleotide properties were confirmed using the online source: Oligo Calc: 
Oligonucleotide Properties Calculator; http://www.basic.northwestern.edu/biotools/ 
oligocalc.html. 
 
M1.3 Generation of Specific Constructs and Plasmids 
 
M1.3.1 FKBP Inducible System 
 
All bHLH constructs used had been previously cloned by Owen Davies in the 
lab of Dr. Sally Lowell in plasmids containg a SV40 origin of replication with the 
construct expressed under pCAG promoter. The FKBP plasmid [Banaszynski at al, 
2006] was obtained from the lab of Dr. Keisuke Kaji. It contained multiple unique 
restriction sites after the modified FKBP sequence. However, none of these restriction 
sites were compatible with the restriction sites flanking the bHLH contructs in the 
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bHLH SV40 pCAG plasmids. For this reason convenient restriction sites were 
introduced by PCR as in M1.1.2.1. 
 
The forward primer was identical for all constructs containing the EcoRV 
restriction site a 21 nucleotide spacer, meant to introduce a flexible linker between the 
FKBP and the bHLH factor, and a Flag sequence, which was thus introduced before 
the bHLH factor. The reverse primer was unique for each bHLH factor containing the 
last 24 nucleotides of respective gene, a second TGA end and, a Not1 restriction site, 
all reverse complemeted; see Table M4. Note: EcoRV and NotI sites exist in the 
TOPO plasmid after the locus for blunt fragment insertion, but these extra cutting 
sites would produce an extra small fragment easily separated by electrophoresis. This 
cloning strategy, as well as the primers involved, were designed by Owen Davies. 
 
M1.3.2 Tetracycline Inducible System 
 
For this approach the constructs cloned in the SV40-pCAG plasmids described 
in M1.3.1 were used. The constructs were cloned in a plasmid where the gene of 
interest was transcribed downstream a TetO promoter with the Puromycin selection 
cassette under the influence of Pgk promoter. The strategy used was restriction digest 
on convenient sites, followed by ligation (M1.2.4.2), without any PCR required. The 
bHLH fragment was digested using XhoI – NotI digestion. The TetO containing 
plasmid was digested using PspXI – NotI digestion. The PspXI and XhoI digestion 
produce compatible ends which, upon ligation, generate a new XhoI, but not PmsXI 
site [Fig M4]. In this manner plasmids for the following bHLH constructs were 
produced: Twist1, Twist1-E and Twist1-Twist1. 
 
The resulting construct was subcloned into a TOPO vestor as in M1.2.4.1, 
sequenced as in M1.2.5, digested using EcoRV – Not1 sites and ligated into the 
FKBP plasmid as in M1.2.4.2. In this manner plasmids for the following bHLH 
constructs were produced: Twist1, Twist1-E, Twist1-Twist1, Tcf15, Tcf15-E, 













Figure M3. Inducible FKBP TwE plasmid 
 





























































Figure M4. Strategy for generating TetO bHLH plasmids 
 
The original plasmid could not be usefully XhoI digested, due to multiple XhoI sites 
in the TetO promoter. For this reason a PspXI site located after the TetO promoter 
was used. Agter ligation with a XhoI generated end a XhoI site is produced, position 














































M1.3.3 Twist1 RNA probe for In Situ Hybridization 
 
BAC was extracted from clone bMQ-350m18 (Geneservice), as described 
(M1.2.2.2). PCR primers were designed to amplify a 0.8 kb fragment in the 3’ UTR 
region of Twist1 gene [Fig M5]. The fragment was amplified as in M1.1.2.1, 
subcloned into TOPO as in M 1.2.4.1, sequenced using the M13 primers as in M1.2.5. 
Sequencing revealed that clone WOTO2 contained a correct insert which could 
produce a RNA probe complementary to Twist1 mRNA using the T7 promoter site in 
the TOPO vector. Clone WOTO1 was in the opposite orientation and required the use 
of SP6 promoter, situated on the other side of the construct [Fig M6]. In the following 
procedures WOTO2 was used. 
 
To produce the RNA probe, first WOTO2 was linearized at the BamH1 site [Fig 
M6] as in M1.2.3. 10 µg of Plasmid were digested with 30 units of BamH1 (NEB, 
R0136S) using buffer 3 and BSA provided; reaction was incubated overnight at 37°C.  
 
The complete linearization was checked by electrophoresis on agarose gel, as in 
M1.1.3.2 and DNA was extracted by using Phenol – Chloroform as in M 1.1.4.3. 
 
The linearized and purified DNA was used as template for T7 RNA polymerase 
(Roche, 10881767001) and the reagents provided: 10x transcription buffer, dNTPs 
(DIG-UTP) and RNase inhibitor, according to manufacturer protocol. 1 µg of DNA 
was used in a 20 µl reaction incubated at 37°C for 2 hours. 
 
The template DNA was removed by DNA digestion using DNaseI (Promega, 
M6101) and the reagents provided: reaction buffer and STOP solution, according to 
manufacturer protocol. 
 
A small aliquot (1 µl) of the reaction solution, before and, after DNase step was 
checked by electrophoresis on agarose gel, as in M1.1.3.2 to confirm the presence of 











Figure M5. Twist1 RNA probes 
 
Schematic representation of the RNA probe for in situ hybridization. Presented are 
the probe from Wolf et al, 1991 and WOTO2 used in the present work. The WOTO2 
probe spans over the corresponding genomic sequence between 188 and 1062 bp after 




























































Figure M6. Plasmid for generation of Twist1 RNA probe 
 
BamHI cutting site is shown, where, after linearization of the plasmid, the RNA 





















































The RNA was purified using RNeasy Mini Kit (Qiagen, 74106). The reaction 
was resuspended in 400 µl lysis buffer (provided) and from this point the extraction 
was performed according to manufacturer protocol. The labelled RNA was aliquoted 
in RNase free PCR tubes containing 1.5 µg RNA each and stored at -80°C. 
 
M1.3.4 Twist1-Venus Plasmid for Generation of Reporter Cell Lines 
 
M1.3.4.1 Twist1-Venus Plasmid – General Strategy 
 
A strategy was devised to generate Twist1 reporter ES cell lines. In this strategy 
[Fig M1 and M2] the Twist1 coding sequence was modified by inserting the coding 
sequence for Venus, followed by a double selection cassette, which was flanked by 
Frt sites [Fig M7].  
 
Venus construct is driven under the Twist1 promoter, its translation being 
directed by a Synthetic IRES augmented by 10 repeats of the Gtx gene IRES, which 
have been shown to amplify gene expression [Chappell et al, 2000] and to be useful 
in reporter cell lines [Tanaka et al, 2008]. 
 
The selection cassette consists of Neomycin resistance gene under the Pgk 
promoter and the Thymidine kinase gene under the MC1 promoter. After clonal cell 
lines are selected under Neomycin resistance, the selection cassette can be removed 
by transient transfection with a Flipase expressing plasmid and cells which failed to 
undergo the recombination event can be eliminated by treatment with Ganciclovir, 
which is transformed in the toxic compound Gaciclovir triphosphate by Thymidine 
















Figure M7. Plasmid for generation of Twist1 reporter cell lines 
 
Retrieved plasmid from modified BAC; in between the wild type homology arms, 
Flag, Twist1 coding sequence, Venus and the selection cassette were introduced. Frt 
sites for removal of the selection cassette are shown. For electroporation this plasmid 



















































M1.3.4.2 Twist1-Venus Plasmid for BAC Modification 
 
To generate the Twist1-Venus construct I started from a NEB193 plasmid which 
contained the Venus construct downstream an IRES modified as described above. 
This plasmid had been produced in the lab of Prof. Joshua Brickman by Dr. Maurice 
Canham. To subclone Twist1 coding sequence into this plasmid, convenient sites 
were introduced by PCR starting from SV40 pCAG Twist1 plasmid similar to M1.3.1. 
For this purpose primers were designed in the following manner: forward primer 
contained PacI restriction site, followed by Flag and the first 21 bases of Twist1; 
reverse primer contained AgeI restriction site followed by the last 24 bases of Twist1; 
see Table M4. The new plasmid was generating following the procedures described in 
M1.2.4.1, M1.2.3 and M1.2.4.2 [Fig M8]. 
 
Furthermore, the selection cassette was digested from another plasmid provided 
by Maurice Canham, in order to be subcloned into NEB193_Twist1-Venus using the 
BamH1 restriction site [Fig M9]. The digested fragments were isolated as in 
M1.1.4.2. 
 
Since this digestion used the same restriction sites at both ends of the constructs 
the vector containing the origin of replication (NEB193_Twist1-Venus) was 
dephosphorilated using Rapid Alkaline Phosphatase (Roche, 04898133001) and the 
buffer provided according to manufacturer protocol. The DNA was purified as in 


















Figure M8. Generation of Twist1-Nkx6-2_IRES-Venus construct 
 
Flag-Twist1 coding sequence was introduced into the NEB193 plasmid, following 
addition of convenient cutting sites PacI and AgeI, shown. BamHI is the site where 





















































Since the presented method involved ligation of two fragments with identical 
ends at both sides any orientation was possible. To test for this I made use of a second 
Age1 restriction site present in the selection cassette. As can be observed from the 
map in Fig M9, if the selection cassette had been inserted in the forward orientation, 
AgeI digestion would have produced a fragment of approximately 1.5 kb and another 
fragment close to 7 kb in size. However, if the selection cassette had been inserted in 
the opposite orientation, the AgeI digestion would have produced two fragments 
closer in size of 3.5 and 4.5 kb respectively. Five clones were checked by this method 
and clones 1 and 3 had the insert in the forward orientation. In the following 
experiments clone 1 was used. 
 
M1.3.4.3 Inserting Twist1-Venus Plasmid into BAC 
 
To generate the construct for BAC modification PCR primers were designed 
containing 60 bases of genomic Twist1 sequence immediately before and after the 
coding sequence followed by 21 bases homologous to the limits of the region to be 
recombined, containing the first 21 nucleotides of Flag and the last 21 nucleotides 
ending with the second Frt site; see Table M4. In this manner a 5.5 kb fragment was 
PCR amplified as described in M1.1.2 using the two step cycling. 
 
The PCR fragment was isolated using the gel extraction procedure (M1.1.4.2), 
and resuspending the DNA in water followed by DPN1 digestion (NEB, R0176S) 
using NEBuffer 4, according to manufacturer protocol. The DPN1 only cuts DAM 
methylated DNA, not affecting the PCR product, but removing eventual traces of 
plasmid template, which could induce bacterial cell survival in the absence of desired 
















Figure M9. Plasmid for BAC modification at the Twist1 locus 
 
The plasmid contains Flag-Twist1, followed by Nkx6-2_IRES-Venus and the 
selection cassette flanked by Frt sites. BamH1 sites were the selection cassette was 




















































The construct was elctroporated into BAC clone bMQ-350m18 (Geneservice) as 
in M1.2.4.3.1 and M1.2.4.3.2. The recombination event was checked by colony PCR 
for 5 clones following the procedure in M1.1.1 with the exception that one isolated 
bacterial colony, for each clone, from agar plate, supplemented with Chloramphenicol 
and Kanamycin was used instead of purified DNA. The PCR primers used were 
designed to be complementary to the BAC just outside the expected recombination 
event and, within Twist1 and selection cassette respectively. Clones 1 and 3 produced 
bands of the expected size. 
 
To further confirm the recombination event, the above described PCR products 
were subcloned as described in M1.2.4.1, except that in this case TOPO TA Cloning 
Kit was used (Invitrogen, 450641). The resulting plasmids were sequenced as in 
M1.2.5 using M13 primers. 
 
M1.3.4.4 Generation of Twist1-Venus Plasmid for Homologous Recombination 
 
To retrieve the modified fragment a low copy plasmid, pACYC177 generated 
by Dr. Andrew Smith was used. Using this plasmid as template, a DNA fragment was 
PCR amplified as in M1.3.4.3. Forward primer contained 60 bases at the 5’ end of 
Twist1 homology arm followed by XhoI site and 20 bases upstream BamHI site in the 
pACYC177 plasmid. The reverse primer contained 60 bases at the 3’ end of Twist1 
homology arm followed by 22 bases positioned 55 bases downstream plasmid origin 
of replication. In order for the homology regions to be aligned with the BAC the 
forward primer was designed forward in respect to the pACYC177 sequence, but was 
reverse complemented in respect to the genomic region. On the other hand the reverse 
primer was reverse complemented in respect to the pACYC177 sequence but 
contained a forward sequence in respect to genomic DNA. The 60 bases regions were 
designed as to encompass the homology arms used for targeting Twist1 locus used by 












Figure M10. Twist1-Venus for homologous recombination 
 
Strategy for retrieving the modified Twist1 locus from the BAC and generation of the 
final targeting vector. 5’ homology arm represent 6 kb upstream Twist1 coding 
sequence. 3’ homology arm represent 1.2 kb downstream Twist1 coding sequence. 
Twist1-Venus represent the insertion of Gtx-IRES-Venus downstream Twist1 coding 
region. Neo represents Pgk-Neomycin resistance. TK represents MC1-Thymidine 
















































The final construct presented in Fig M7 was linearized using the unique 
restriction site Xho1 as in M1.2.3 digestion for electroporation. 
 
However, at this point careful sequencing of the original NEB193 plasmid 
containing the Venus, carried by my colleague Mattias Malaguti, revealed a fatal 
point mutation which generated a BamH1 restriction site between the end of Venus 
and the beginning of the polyadenilation signal which was designed to terminate the 
Twist1-Venus mRNA. Thus the polyadenilation signal sequence had been lost in the 
first BamH1 restriction digest, of the original plasmid. 
 
If the vector produced in this manner had been used for gene targeting a single 
mRNA would have been generated for Twist1-Venus and Neomycin resistance gene 
in a polycistronic sequence. However, after the elimination of the selection cassette at 
Frt sites the elongation would have terminated at the Twist1 polyadenilation site at the 
end of the second non-coding exon. Regrettably, the introduction of Venus before the 
end of the first exon could influence the splicing site and generate unpredictable 
splicing events [Fig M11].   
 
For the reasons presented, generation of Twist1 targeted cell lines was not 
pursued any further with the above construct. Nevertheless, the work done here 
showed that the strategy used to introduce a modification into the BAC locus was 
feasible and that starting from a corrected plasmid the same strategy could produce a 


















Figure M11. Twist1-Venus unpredictable splicing event  
 
Schematic representation of Twist1 locus and its modification to introduce a 























































M2. Cell culture 
 
M2.1 Materials, solutions and cell lines 
 
All routine culture procedures and experiments were performed in tissue culture 
flask/plates (Iwaki or Corning), unless otherwise stated. All flasks, plates, tubes as 
well as solutions were maintained sterile at all times. Wherever the solutions were 
made by CRM Cell Culture Service, they are noted as CRM-CCS. For all solution 




Dulbecco’s Phosphate Buffer Saline (DPBS), 1x sterile solution, suitable for 
cell culture (Sigma, D8537) 
Gelatine, powder, Type A, for electrophoresis, suitable for cell culture (Sigma, 
G1890) 
Trypsin 2.5%, 10x, without Phenol Red (Gibco, 15090) 
Accutase, suitable for cell culture (Sigma, A6964) 
Chick serum (Sigma, C5405) 
GMEM (Sigma, G5154) 
DMEM/F12 (Gibco, 11320) 
Neurobasal (Gibco, 21103) 
L-Glutamine, 200 mM (Gibco, 25030) 
Sodium pyruvate, 100 mM (Gibco, 11360) 
MEM Non-essential amino acids, formulated to contain 100x the non-essential 
amino acids found in the standard Minimum Essential Medium (MEM) (Gibco, 
11140) 
2-Mercaptoethanol (VWR, 44143-3A) 
Foetal Calf Serum (Gibco, 10270, Batch 40F0240K) 
Puromycin dihydrochloride, powder, suitable for cell culture (Sigma, P8833) 
Hygromycin B, 50 mg/ml (Roche, 843555) 
G418 sulphate (PAA, P27-011) 
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BMP-4, recombinant human (R&D, 314-BP) 
Activin, recombinant human, 100% homology with mouse and other mammals 
for the mature protein (R&D, 338-AC) 
FGF2, recombinant human FGF basic (R&D, 233-FB) 
PD0325901 (Axon, 1408) 
Chiron99021 (Axon, 1386) 
LDN193189 (Axon, 1509) 
Poly-L-ornithine, 0.01%, mol wt 30,000 to 70,000, suitable for cell culture 
(Sigma, P4957) 
Laminin, 1 mg/ml, from Engelbreth-Holm-Swarm murine sarcoma basement 
membrane, suitable for cell culture (Sigma, L2020) 





Gelatine: (CRM-CCS) was prepared as 1% solution in water. 
 
Laminin: was diluted in PBS to a final conc of 5 µg/ml. 
 
Fibronectin: was dissolved in warm PBS to a final conc of 7.5 µg/ml. 
 
Trypsin: (CRM-CCS) was prepared as 0.25% Trypsin, 1.3.mM EDTA, 1% 
Chick Serum in PBS. 
 
Glutamine / pyruvate: (CRM-CCS) as a mixture 1:1 per volume of L-
Glutamine and Sodium pyruvate resulting a solution of 100 mM Glut and 50 mM Pyr. 
 
2-Mercaptoethanol: (CRM-CCS) was prepared as a 0.1M solution in water. 
 
LIF: (CRM-CCS) was prepared in house as conditioned medium of Cos7 cells, 
transiently transfected with a plasmid encoding the human LIF. Medium was 
collected and LIF activity assayed using CP1 indicator cells. Then, the medium was 




Puromycin: (CRM-CCS) was prepared as 5 mg/ml solution in PBS. 
 
Hygromycin B: (CRM-CCS) bought as 50 mg/ml and was simply aliquoted. 
 
G418: (CRM-CCS) was prepared as 200 mg/ml active molecule in water, 
considering the batch activity. 
 
N2 supplement 100x: was prepared as solution in DMEM-F12 containing 
Insulin (Sigma I-1882) 2.5mg/ml, Apo-transferrin (Sigma T-1147) 10mg/ml, BSA 
(Gibco 15260-037) 7.5mg/ml, Progesterone (Sigma P8783) 0.002 mg/ml, Putrescine 
(Sigma P5780) 1.6mg/ml, Na Selenite (Sigma S5261) 3µM. 
 
Standard ES cell medium: was prepared by mixing 500 ml GMEM, 51 ml 
FCS (final conc 10%), 11 ml Glutamine / pyruvate (100 mM Glut and 50 mM Pyr, 
final conc 2 mM Glut and 1 mM Pyr), 5.5 ml MEM Non-essential amino acids 
(100x), 550 µl LIF (100,000 units/ml, final conc 100 units/ml) and 550 µl 2-
Mercaptoethanol (0.1 M, final conc 0.1 mM). 
 
N2B27: was prepared by mixing DMEM-F12 with Neurobasal medium 1:1 per 
volume and supplementing with N2 1:200, B27 1:100 (50x, serum free supplement, 
Gibco, 17504-044) 1:1000, Glutamine (200 mM, final conc 0.2 mM) and 2-
Mercaptoethanol 1:1000 (0.1 M, final conc 0.1 mM). 
 
2i medium: was prepared as N2B27 except Glutamine was increased to 1:200 
(1 mM final conc). The medium was supplemented with PD0325901 1µM final conc 
and Chiron99021 3uM final conc. 
 
Lif + BMP medium: was prepared as N2B27 except Glutamine was increased 
to 1:200 (2 mM final conc). The medium was supplemented with 1:200 MEM Non-
essential amino acids (100x, final conc 0.5x), 1:1000 LIF (final conc 100 units/ml) 




EpiSC medium: was prepared as N2B27 except Glutamine was increased to 
1:100 (4 mM final conc) and B27 was increased to 1:50 (final conc 1x). The medium 
was supplemented with 1:100 MEM Non-essential amino acids (100x, final conc 1x), 
Activin (final conc 20 ng/ml) and FGF2 (final conc 10 ng/ml). 
 
M2.1.2 Cell lines 
 
E14Tg2a: ES cell line derived from 129/Ola mice. 
 
E14ju: rederived ES cell line from blastocyst of E14Tg2a chimeric mice. 
 
Oct4GIP: Derived from parental line CGR8. Green fluorescent protein (GFP) 
and Puromycin resistance gene are expressed under the control of the Oct4 promoter 
[Ying et al, 2002]. 
 
46c: E14Tg2A cell line where GFP and Puromycin resistance gene were 
knocked in the Sox1 locus [Ying et al, 2003b]. 
 
Rosa26 rtTA: E14Tg2A_AW2 cell line was generated by Andrew JH Smith 
and Anna Waterhouse. It contains the coding sequence for the reverse tetracycline-
controlled transactivator (rtTA) integrated into the Rosa 26 and expressed from the 
R26 promoter. The E14tg2A_AW2 cell line will be described in more detail 
elsewhere [AW, AJHS, S. Lowell in preparation]. 
 
M2.2 Cell Culture Procedures 
 
All cell lines were maintained and differentiation experiments performed at 
37°C in 7% CO2 humidified atmosphere.  
 
M2.2.1 ES Cell Culture and Maintenance 
 
ES cells were routinely cultured on tissue culture flasks or plates, coated with 
Gelatine 1% for 30 minutes. Cells were maintained in Standard ES medium and 
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passaged every two days. To passage, cells were briefly washed with DPBS, and 
incubated with Trypsin solution at 37°C for 2 to 5 min. The Trypsin was stopped by 
adding Standard ES medium 10:1 ratio to Trypsin solution, per volume and, 
centrifuging at 1300 rpm for 3 min. Cells were resuspended in Standard ES media, 
counted and plated usually at 20,000 cells per cm2, or at the stated density for each 
individual procedure. 
 
M2.2.2 Freezing ES Cells 
 
20 million ES cells were detached as in M2.2.1 and resuspended in 5 ml of 
Freezing Medium, containing 10% dimethyl-sulphoxide (DMSO) and 90% FCS. The 
cell suspension was aliquoted as 1 ml per cryovial. Vials were placed immediately at 
-80°C and subsequently transferred to liquid nitrogen after at least 24 hours in the 
freezer. To thaw, one vial of cells in Freezing medium was quickly thawed at 37°C 
and cells transferred as soon as possible in Standard ES medium. Then, they were 
centrifuged at 1300 rpm for 3 min. Cells were resuspended in Standard ES media and 
plated without counting in one T25 flask. 
 
M2.2.3 2i ES Cell Culture 
 
Tissue culture plates were coated subsequently with Poly-ornithine and Laminin 
2h each, at room temperature (RT). Alternatively, second coating was done overnight 
at 4°C. Cells were maintained in 2i medium and passaged every three days. To 
passage, cells were briefly washed with PBS and detached using Accutase. 
Furthermore, a procedure similar to the standard ES cell technique was employed, 
except serum free medium was used at all times.  
 
M2.2.4 ES Cell Culture in LIF + BMP Medium 
 
Cells were plated on plates coated with Gelatine for 30 min, in Lif + BMP 
medium and passaged every two days. To passage, the same technique was employed 







M2.2.5 EpiSC Culture 
 
Tissue culture plates were coated with Fibronectin for 1h at RT. Cells were 
initially plated at a density of 200,000 cells per well in a 6 well plate, maintained in 
EpiSC medium and passaged every two days 1:4. To passage, cells were briefly 
washed with DPBS and detached using Accutase. EpiSC were pipetted very gently in 
order to maintain the cells in small clumps rather than dispersing them into single 
cells, and cells were not counted. 
 
M2.2.6 Neural Differentiation 
 
Tissue culture plates were coated with Gelatine for 1h at RT. Cells were grown 
in Standard ES medium so that they would reach approximately 70% confluency at 
the time of passaging. Cells were detached as described in M2.2.1 except that before 
counting they were washed twice in serum free medium. Then, were plated at a 
density between 150,000 and 200,000 per well, in a 6 well plate in N2B27. Media 
was changed every 2 days. 
 
M2.2.7 Induction of Doxycyclin Dependent Transgene 
 
For Doxycyclin dependent transgene induction medium was supplemented with 
Dox at the time the cells were plated as described above either in Neural 
Differentiation conditions or in pluripotent conditions of LIF + BMP. The 
concentration of Dox was either 800 ng/ml or the concentration stated for a particular 
experiment. 
 
For short induction, 150,000 cells were plated per well in a 6 well plate in LIF + 
BMP medium and the next day the medium was changed either with LIF + BMP 
supplemented with Dox, or with N2B27 supplemented with Dox. 9 hours later cells 






M2.3 Generation of Transgenic Cell Lines 
 
M2.3.1 Lipofection Method 
 
ES cells were plated as in M2.2.1 at a density of 200,000 cells per well in a 6 
well plate, in 2 ml Standard ES medium and, allowed to attach for a few hours. 
Plasmids containing the desired transgene were linearized as in M1.2.3. For transient 
transfection non-linearized plasmids were used. 1 µg of DNA was diluted in 250 µl 
GMEM. In a separate tube, 1 µl Lipofectamine 2000 (Invitrogen, 11668) was diluted 
in 250 µl GMEM and incubated at RT for 5 min. The DNA and Lipofectamine 
solutions were mixed and, incubated at RT for 20 min to form the transfection 
complexes. The reaction was then added to the previously plated cells, 500 µl 
reaction for each well to be transfected. The plate was gently rocked and placed back 
in the incubator. 
 
M2.3.2 Isolation of Clonal Lines 
 
The next day, cells were passaged without counting using a serial dilution form 
1:10 to 1:1000 cells per plating surface. Medium was changed to Standard ES 
medium supplemented with the relevant antibiotic. The following final concentrations 
were used: Hygromicin 200 ug/ml, Puromycin 2 µg/ml, G418 200 µg/ml. Medium 
was changed every two days for the next 1 to 2 weeks, checking microscopically the 
formation and growth of antibiotic resistant colonies. When colonies grew to be 
macroscopically visible: 2 to 4 mm diameter, they were transferred to a 96 well plate, 
one colony per well, using the following procedure. 
 
The position of each macroscopically visible colony was labelled on the plate 
using a marker. Each marked colony was checked microscopically to confirm that it 
did not touch or, closely neighboured another colony, in which case its position was 
crossed with the marker. The remaining colonies were physically removed from the 
plate in a film of DPBS using a p200 sterile tip. The colony was aspirated into the tip 
and moved to a round bottom well, of a non-adherent plate, where cells were 
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dissociated by trypsinization, and then plated in Standard ES medium. Considering 
that this was a stressful procedure, for the cells, the antibiotic was omitted for the first 
24 hours, but added after that time point. 
 
M2.3.3 Electroporation Method 
 
A large number of cells were dissociated as in M2.2.1, washed twice in un-
supplemented GMEM, counted and resuspended to a density of 10 million cells per 
800 µl DPBS.  
 
100 µg of plasmidic DNA containing the desired transgene was linearized as in 
M1.2.3. and resuspended in 100 µl water. 
 
100 ul DNA and 800 ul cell suspension were mixed as quickly as possible in a 4 
mm gap electroporation cuvette and incubated at RT for 3 min. Cells were 
electroporated at 3 uF and 0.8 kV, and the time constant was 0.1 or 0.2. 
 
Electroporated cells were plated on 10 cm diameter tissue culture dishes, in 
Standard ES medium, at densities ranging form 50,000 cells per dish to 1,000,000 
cells per dish and incubated at 37°C. The next day medium was changed to Standard 
ES medium supplemented with the relevant antibiotic. From this moment on the 
procedure was continued as in M2.3.2. 
 
 
M3 Preparation of Biological Material for Analysis 
 
M3.1 Cell Fixation for Immunofluorescence 
 
Cells were cultured or differentiated as described in M2. Cells growing on tissue 
culture plates had the medium removed and fixed using a solution of 4% 
Paraformaldehyde (PFA, Signma, 158127) in PBS, for 20 min at RT. Cells were 






M3.2 Fluorescence Activated Cell Sorting (FACS) 
 
Differentiated cells were detached using Cell Dissociation Buffer, enzyme free 
in PBS (Gibco, 13151-014). Briefly, cells were washed once with PBS and once with 
dissociation buffer. Then, dissociation buffer was added (3 ml for one T75 flask) and 
cells incubated at 37°C for 5 min. 10 ml FACS buffer (3% FCS in DPBS) was added 
and cells detached by gentle pipetting, centrifuged at 1300 rpm for 3 min. Cells were 
resuspended in 1 to 2 ml FACS buffer and filtered through the Cell-Strainer Cap of a 
5 ml Polystyrene Round-Bottom Tube (BD Falcon, 352235) to remove any cell 
clumps. DAPI was added, to a final concentration of 100 ng/ml, for visualization of 
non-viable cells. 
 
Sox1 GFP cells and Tomato labelled cells were sorted using FACS Aria II 
apparatus. Cell fragments, dead cells and duplets were excluded from analysis. Wild 
type cells were used to set the negative gates. Positive versus negative or high versus 
low cells were collected in the in separate tubes in FACS medium. Sort quality was 
assessed by reanalysing sorted populations by FACS and the accuracy exceeded 95% 
in every instance. Cells were moved as soon as possible on ice and RNA extracted 
immediately as in M3.3.1 Trizol method, followed by cDNA synthesis. 
 
M3.3 RNA Extraction and cDNA Synthesis 
 
M3.3.1 RNA Extraction 
 
RNA was extracted for cells cultured or differentiated as described in M2, using 
Total RNA Isolation Mini Kit (Agilent Technologies, 5185-6000) according to 
manufacturer protocol. 
 
For cells isolated by Flowcytometry Activated Cell Sorting (FACS) RNA was 
extracted manually using Trizol reagent (Invitrogen, 10296) according to 
manufacturer protocol. Briefly, 100,000 to 1,000,000 cells isolated by FACS were 
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centrifuged at 1500 rpm for 5 min and resuspended in 1 ml Trizol. Cells were 
dissociated and nuclear complexes disrupted by passing 5 times through a seringe 
fitted with a 26G needle. The suspension was incubated at RT for 5 min. 250 µl 
Chloroform was added, sample mixed an incubated at RT for 5 min. The sample was 
centrifuged at 12,000g for 15 min at 4°C. The aqueous phase was moved to a new 
tube and 650 µl Isopropanol were added and homogenized. The mixture was 
incubated at RT for 10 min and then, centrifuged at 12,000g for 10 min at 4°C. 
Supernatant was discarded and the pellet washed with ethanol as in M1.1.4.3 and the 
RNA resuspended in water. 
 
M3.3.2 cDNA Synthesis 
 
RNA concentration in all samples of one experiment was measured using 
Nanodrop spectrophotometer. Ideally 1 µg of RNA was diluted in water to a final 
volume of 10 µl, for each sample. If some samples had a RNA concentration which 
was lower than 0.1 µg/µl, the final concentration in all samples was scaled 
accordingly. Samples with RNA concentration lower that 0.01 µg/µl were not 
included. 
 
cDNA synthesis was performed using M-MLV Reverse Transcriptase 
(Invitrogen, 28025) according to manufacturer protocol. Included reagents: 5x First-
Strand Buffer, 0.1M DTT. Reagents not included: Random Primers (Invitrogen, 
48190), 50 ng per reaction, dNTP Mix (Invitrogen, 18427013) 1 µl of 10 mM per 
reaction, 0.5 mM each dNTP final concentration, RiboLock RNase Inhibitor (Thermo 
Scientific, E00382), 20 units per reaction.  
 
No-RT control was performed for each sample by not adding the Reverse 
Transcriptase to the reaction. The absence of significant levels of genomic DNA was 
confirmed by performing qPCR (see M4.2) using a non-intron spanning pair of 
primers (Twist1 coding). The samples were only used if the transcript levels were at 






M3.4 Cell Lysis for Western Blot 
 
RIPA buffer: was prepared as an aqueous solution containing: Tris-HCl pH 7.4 
50 mM, NP-40 1%, Na-deoxycholate 0.25%, NaCl 150 mM, EDTA 1 mM. and was 
kept a 4°C.  
 
Pefablock: irreversible serine protease inhibitor (Sigma, 76307), was diluted in 
water at a concentration of 500 mM (833 µl of water for 1 vial of 100 mg) and kept at 
4°C. 
 
Protease inhibitors: cOmplete ULTRA tablets, EDTA free, (Roche, 
05892953001). One tablet was diluted in 2 ml water (25x), aliquoted in 50 µl vials 
and kept at kept a -20°C. 
 
RIPA working buffer was prepared shortly before use by adding to 1 ml of 
RIPA buffer of: 1 µl Pefabloc 500 mM (final conc 0.5 mM), 1 µl DTT 1M, (final 
conc 1mM) and, 40 µl 25x Protease inhibitors. 
 
10 million cells were trypsinised as in M2.2.1. and resuspended in 500 µl RIPA 
working buffer. Cells were rocked at 4°C for 30 min for complete lyses, then 1µl (250 
U) Benzonase Nuclease (Sigma, E1014) was added and incubated at RT for 10 min. 
At this point samples were either stored at -80°C or directly used for Western Blot. 
 
M3.5 Preparation of Embryos for In Situ Hybridization  
 
MF1 wild type mice were housed and mated at the Animal Unit Facility of the 
ISCR and CRM, in accordance with the provisions of the Animals Scientific 
Procedures Act (1986). At the stated time points, after mating, pregnant mice were 
sacrificed by cervical dislocation. Immediately, the mouse was dissected and the 
uterus containing the embryos was moved to a dish containing sterile M2 medium, 
with HEPES, suitable for mouse embryos (Sigma, M7167). The embryos were further 
dissected, using fine forceps, by removing them from the uterine wall. The decidua 
was removed as well as the Reichert’s membranes and, for older embryos, at somitic 
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stages, the yolk sack and the amnion. After dissection, embryos were moved with a 
pipette from the M2 medium to a 4% fresh PFA solution, where they were kept 
overnight. The pipette size was adjusted to the embryo age. Fresh PFA means: stored 
for maximum one moth at -20°C and thawed the day it was used. For very small 
embryos: E 6.5 and earlier fixation was shortened at 30 min to 1 hour. 
 
The next day embryos were dehydrated by subsequent incubation in the 
following solutions at RT: PBT (PBS with 0.1% Tween) twice for 5 min, 25% 
Methanol in PBT for 5 min, 50% Methanol in PBT for 5 min, 75% Methanol in PBT 
for 5 min, 100% Methanol twice for 5 min. The embryos were stored in 100% 
Methanol at -20°C for up to one month. 
 
M3.6 siRNA procedure 
 
RNA silencing was performed using GeneSolution siRNA for Twist1 (Qiagen 
GS22160) which comprised of the following siRNA constructs: Mm_Twist1_1 – 
SI00202356, Mm_Twist1_2 – SI00202363, Mm_Twist1_3 – SI00202370, 
Mm_Twist1_5 – SI02714460. As a negative control AllStars Negative Control 
siRNA conjugated with Alexa-488 (Qiagen, 1027292) was used. This RNA has no 
homology with any known mammalian gene and had been validated against non-
specific effects on gene expression. siRNA was transfected using HiPerfect 
Transfection Reagent (Qiagen, 301705) according to manufacturer instructions. 
Briefly, lyophilized siRNA was resuspended in water to a stock concentration of 10 
µM. On the first day of the experiment 200,000 cells (for each condition) were plated 
in a well of a 6 well plate, coated with gelatine, in N2B27 (serum free). An aliquot of 
each 10 µM stock solution siRNA was diluted to 2 µM working solution. This 
included the 4 siRNA Twist1 constructs and the control siRNA. 6 ul of the 2 µM 
siRNA were mixed with 91 ul N2B27 and 3 ul HiPerfect reagent. Two more control 
conditions were set: no transfection, and no siRNA were 91 µl of N2B27 were mixed 
with 3 µl of HiPerfect only. The siRNA transfection reagent mixture was incubated at 
RT for 5 min and then added dropwise to the culture, followed by a gentle swirl. The 
final siRNA concentration in the culture medium was 5 nM. Cells were lysed at 24, 




The optimal siRNA / HiPerfect ratio was determined for the presented culture 
conditions by incubating various amounts of control siRNA (3 to 12 µl) and HiPerfect 










Detection of protein expression in adherent culture was performed using 
specific antibodies. Cells fixed as in M3.1 were blocked and permeabilised using the 
Block/Perm buffer while rocking for 1 hour at RT. Block/Perm buffer contained 3% 
serum and 0.1% Triton in PBS. Depending on the secondary antibody Goat or 
Donkey serum was used. 
 
Perm/Block buffer was removed and replaced directly with the relevant primary 
antibody, at the appropriate, concentration diluted in Perm/Block buffer 
supplemented with Sodium azide 2 mM. See Table M1 for a list of primary 
antibodies used. Cells were incubated with the primary antibody for 1 hour at RT 
while rocking. 
 
Next the primary antibody was removed, cells were washed trice for 10 min at 
RT in PBS, while rocking. Antibody labelling was repeated with the secondary 
antibody, diluted usually 1:1000 in Perm/Block buffer; 1 hour at RT while rocking. 
See Table M2 for a list of secondary antibodies used. 
 
The secondary antibody was removed and cells washed twice in PBS for 10 min 
at RT while rocking. Nuclei were counterstained using a solution of DAPI 100 ng/ml 
in PBS for 5 min at RT while rocking. Cells were subject to two final washes with 
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PBS. For cells differentiated to neurons, where long neurites, loosely attached to the 
dish were present rocking was very gentle, close to the lowest speed of the machine. 
 
For double marker staining the above procedure was simply repeated. Primary 
or secondary antibodies were never mixed. The final PBS solution was supplemented 
with Sodium azide 2 mM and samples were stored at 4°C. 
 
Imaging was performed using an Olympus IX51 inverted microscope with 
fluorescence and images captured with a Retiga 2000R (QImaging) camera guided by 
Volocity software version 4.2.0 (Improvision). 
 
M4.1.2 Quantification of Neuron Formation 
 
To quantify neuronal formation pictures of the same field were taken in the blue 
channel for nuclei stained with DAPI and, in the green channel for neural bodies and 
processes labelled for TUBB3. To ensure unbiased field selection, fields were chosen 
in the blue channel based on presence of significant cell numbers. 
 
The total cell numbers in a certain field was assessed automatically following 
nuclear segmentation using FARSIGHT Nucleus Editing Tool 0.4.4 (Rensselear 
Polytechnic Institute, http://www.farsight-toolkit.org). The number of cells assessed 
in each field was between 300 and 1200. TUBBIII positive neurons were counted 
manually and neurite length was assessed using ImageJ measuring tool (ImageJ 
1.47d, Wayne Rasband, National Institute of Health, USA, http://imagej.nih.gov/ij). 
To assess formation of neurons with “long” neurites 10 random nuclei diameters were 
measured and the results averaged. An arbitrary threshold of 7 nuclear diameters was 
set. Neurites shorter than this length were considered as “short” and neurites of this 
length or exceeding it were deemed “long”. For neurons with more than one neural 
process the longest process was measured and multiple process lengths were not 















Figure M12. Quantification of neuron formation  
 
Nuclear segmentation is shown in (a); each identified nucleus being contoured with a 
light green line. Neuron counting shown in (b); yellow arrows point towards the 
cellular bodies of neurons with short neurited, red arrows point towards cellular 




















































For statistical analysis “R: A language and environment for statistical 
computing” was used (R Foundation for Statistical Computing, Vienna, Austria. 
ISBN 3-900051-07-0, URL http://www.R-project.org/). The statistical significance 
was determined using One-way ANOVA followed by Tukey HSD post hoc test. For 
analysis the data from two clones was pulled. Error bars represent standard deviation 
of six microscopic fields for each condition. The data from each clone was not 
averaged and, each data set was considered an individual sample. 
 
M4.2 Quantitative PCR 
 
Quantitative PCR was performed using cDNA samples produced as in M3.3. 
LightCycler480 System (Roche) was used with Universal Probe Library (UPL). 
Briefly UPL is based on 165 short hydrolysis probes which detect 8- or 9-mer motifs 
that are very prevalent in the transcriptomes. The probes are labelled at the 5' end 
with fluorescein (FAM) and at the 3' end with a dark quencher dye allowing for 
fluorescence only upon dissociation of the synthetic nucleotide by polymerase 
exonuclease activity. 
 
The quantitative PCR was carried in a LightCycler480II apparatus (Roche). The 
reaction was set in a 384 well plate, in 10 µl reactions, using LightCycler480 Probes 
Master (Roche, 04887301001) and individual UPL probes (used at 100 nM final 
conc), purchased from Roche. Amplification primers (used at 200 nM final conc) 
were designed using Roche online software: http://www.roche-applied-
science.com/sis/rtpcr/upl/. A list of primers used and their corresponding probes is 
presented in Table M3. 
 
Each primer pair was tested against formation of non-specific amplification 
products in a Taq PCR reaction revealed on a gel. As a template, cDNA from samples 
where the gene of interest was expected to be expressed was used. The testing for the 
majority of the primers used in our lab was performed by XinZhi Zhou. New primers 
were designed in the case of primer pairs which produced more than one band. 
Furthermore, the single band was subcloned into pGEM-T Easy (Promega, A1360), 
and six decimal serial dilutions of the resulting plasmid were used to generate a 
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standard curve for each gene. For all genes the highest standard concentration was of 
400 ng/ml. Correction for DNA copy number based on insert size was not performed, 
given that the insert would not exceed 150 bp, less than 5% of the total plasmid size. 
R2 for all standard curves used was of at least 0.9. 
 
The Cp value for each reaction was automatically calculated using the Roche 
Light Cycler 480 algorithms. Concentration values were also obtained automatically 
from the Roche Light Cycler 480 software by reporting the Cp values of the samples 
to the standard curve. 
 
The following cycle conditions were used: 
 
95°C – 5 min 
45 cycles: 
  95°C –  5 seconds 
  61°C –  10 seconds 
  72°C –  1 second 
40°C –  10 seconds 
 
Acquisition was performed during elongation at 72°C. 
 
Each gene expression was normalized to TBP. For each sample duplicate 
reactions were performed and the assay repeated if technical replicates showed 
significant inconsistency. Error bars represent range value between two samples. 
 
Statistical analysis was performed across multiple experiments. For this, the 
average expression value for each gene in each experiment was arbitrarily set to 1. 
Error bars represent standard deviation of the mean of the samples from all 
experiments taken into consideration. Significance was calculated using a paired T-
test and p values below 0.05 were considered significant. For this analysis samples 






M4.3 Western Blot 
 
M4.3.1 Measuring Sample Protein Concentration 
 
Concentration of total protein from cell lysate obtained as in M3.4 was 
measured using the Bio-Rad protein assay, based on Bradford method, using a 202.5 
ul reaction in transparent 96 well plates (Corning, CLS3085) assessed in Glomax 
Multi Detection System (Promega). 
 
Briefly, Protein Assay Dye Reagent Concentrate (Bio-Rad, 500-0006) was 
diluted 1:5 in water. Each protein sample was diluted 1:10 in water. In each well, 200 
ul diluted assay reagent were mixed with 2.5 µl diluted sample. Samples were 
incubated at RT for 20 min and absorbance was measured at 595 nm. Protein 
concentration was determined against a BSA standard curve. BSA stock solution of 
50 µg/µl was serially diluted in water to the following concentrations: 0, 0.75, 1, 5, 
7.5, 10 ug/µl. These BSA solutions were treated in the same way as the samples, 
except that 2.5 ul of RIPA working buffer diluted 1:10 in water was also added, to 
compensate for sample buffer absorption. An example of standard curve is presented 
in Fig M13. 
 
M4.3.2 Protein Separation by Weight in Gel Electrophoresis 
 
Based on assayed protein concentration samples were diluted in water to the 
lowest concentration of the particular batch. 50 µl of diluted samples were mixed 
with 25 µl 4x NuPAGE LDS Sample Buffer (Novex, NP0008) and 25 µl DTT 1M. 
Samples were heated at 95°C for 10 min. 
 
10 µl of heat denaturated samples were loaded on a NuPAGE 4-12% Bis-Tris 
Gel 1 mm 10 wells (Novex, NP0321). In each gel one lane was loaded with 10 µl 
SeeBlue Pre-Stained Standard (Life Technologies, LC5625). Electrophoresis was 
performed in a Novex MultiCell gel tank using NuPAGE MOPS SDS running buffer 
(Novex, NP0001) at 200 V, and not exceeding 120 mA. The samples were run until 
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the standard ladder was well displayed and the blue dye reached the bottom of the gel, 
usually 1 to 1.5 hours. 
 
The gel was then removed from its precast case and equilibrated for 15 min in 
transfer buffer. Transfer buffer was made as an aqueous solution containing 1x 
NuPAGE Transfer buffer (Novex, NP0006) and 10% Methanol. Amersham Hybond 
ECL blotting membrane (VWR, RPN203D) was equilibrated in transfer buffer for at 
least 5 min. The proteins were transferred on the membrane in a Novex MultiCell gel 
tank at 25 V for 1 hour in transfer buffer. 
 
M4.3.3 Resolving The Protein of Interest on Western Blot 
 
Presence of proteins was checked by briefly staining the membranes with 
Ponceau S solution, 0.1% in 5% Acetic acid (Sigma, P7170). The Ponceau S was 
gradually washed with water, until the bands could be clearly seen and, finally, 
completely removed by adding a few drops of 0.2 M NaOH in water. NaOH was 
removed by a couple more water washes and the membrane was transferred to 
blocking solution for 1 hour at RT while rocking. Blocking solutions contained 10% 
skimmed milk and 0.1% Tween in PBS. 
 
Next the primary antibody was diluted in blocking solution and the membrane 
was transferred in this solution for 1 hour at RT while rocking. See Table M1 for 
antibodies and concentrations used. Subsequently, the membrane was washed for at 
least 1 hour at RT, changing the solution at least three times. Washing buffer 
contained 1% skimmed milk and 0.1% Tween in PBS.  
 
The procedure was repeated for the secondary antibody; see Table M2. 
 
Finally the membrane was washed twice in PBS and 1 ml of SyuperSignal West 
Pico Chemiluminescent Substrate (Thermo Scientific, 34077) was incubated on the 
active site of the membrane, for a few min. Images were captured on Amersham 
Hyperfilm ECL (VWR, 28906837), which were developed depending on the strength 








Figure M13. Standard curve for protein concentration assay  
 























































For loading control analysis the membrane was reblotted with anti-alpha-
Tubulin (see table M1). The membrane was striped using acidic stripping buffer, 
which was made as an aqueous solution containing: 1.5% Glycine, 0.1% SDS, 1% 
Tween, and pH was adjusted to 2.2 with HCl. Membranes for stripping were 
incubated at RT for 10 min in this buffer while rocking, followed by two washes in 
PBS 10 min each and 2 washes in PBS-Tween 0.1% 10 min each. The labelling 
procedure was then repeated starting from blocking. 
 
 




Anti Digoxigenin-AP (Roche, 11093274910) 
Citric acid, anhydrous, cell culture tested (Sigma, C2404) 
DEPC (Sigma, 472565) 
DIG RNA Labeling Mix (Roche, 11277073910)  
DNase I (Promega M6101) 
Formamide 37% (Sigma, F1635) 
Formamide 99.5 GC (Sigma, F9037)   
Glutaraldehide (Sigma, G5882) 
Glycine (Sigma, G8898) 
Heparin (Sigma, H3393) 
Hering sperm DNA (Promega, D1811) 
Hydrogen peroxide, 30% (Sigma S216763)  
Hydrochloric acid, 36.5-38% (HCl, Sigma, H1758) 
Hydrogen peroxide (Sigma, S216763)  
Magnesium chloride, anhydrous (MgCl2, Sigma, M8266) 
Methanol (VWR, 20846) 
Sodium acetate, 3M (NaAc, Sigma 71196) 
Paraformaldehyde (PFA, Sigma, 158127) 
PBS 10x, cell culture tested (Sigma, P5493) 
Potassium chloride (KCl, Sigma, P9333) 
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Proteinase K (Sigma, P2308) 
RNase A (Roche, 10109142001)  
RNase free water (Invitrogen, 10977-049) 
RNase Inhibitor (Roche 03335399001) 
Sheep serum (Sigma, S2263)  
SigmaFast BCIP/NBT, tablets (Sigma, B5655) 
Sodium chloride (NaCl, Sigma, S7653) 
Sodium citrate dihydrate (Sigma, W302600) 
Sodium dodecyl sulphate (SDS, Sigma, L3771) 
T7 RNA polymerase (Roche 10881767001) 
Tween (Promega, H5151) 
Yeast RNA, Ribonucleic acid from torula yeast (Sigma, R6625) 
 
M4.4.2 Stock Solutions 
 
PBS: prepared by diluting PBS 10x in RNase free water 
PBT: prepared by adding 0.1% Tween to PBS 
PFA 4%: prepared by diluting PFA in PBS warmed to 70°C aliquoted, stored at 
-20°C. 
Methanol 25% to 75%: prepared by mixing the appropriate volume of 
Metahnol with PBT. 
Proteinase K: 500x prepared as a solution of 5 mg/ml in PBT. Aliquoted as 
50ul containing tubes and stored at -20°C. 
SSC: was prepared as an aqueous solution of NaCl 3M, NaCitrate 350 mM and 
pH was adjusted to 4.5 with Citric acid. DEPC was added, 1:1000, mixed, the 
solution was left with the cap unscrewed in the fume hood overnight and autoclaved 
the next day. 
Heparin: was prepared as an aqueous solution of 10%, aliquoted as 50 µl 
containing tubes and stored at -20°C. 
SDS solution: was prepared as an aqueous solution of 10% SDS. 
NaCl solution: was prepared as an aqueous solution of 5M NaCl. 
Tris pH 7.5: was prepared as an aqueous solution of 1M Tris-HCl. pH was 
adjusted with HCl. 
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Tris pH 9.5: was prepared as an aqueous solution of 1M Tris-HCl. pH was 
adjusted with HCl. 
TBS: was prepared as an aqueous solution containing NaCl 1.38 M, KCl 27 
mM, and Tris pH 7.5 125 mM (1:8 form 1 M solution). Solution was autoclaved.  
RNase stock solution: was prepared as an aqueous solution of 1%, aliquoted in 
125 µl containing tubes and stored at -20°C. 
Sheep serum: was inactivated by heating at 55°C for 30 min. Then it was 
aliquoted as 1 ml containing tubes and stored at -20°C. 
MgCl2: was prepared as an aqueous solution containing 1 M MgCl2. Solution 
was autoclaved. 
PBT pH 5.5: was prepared by adjusting the pH of PBS solution with HCl. Then 
0.1% Tween was added. 
 
M4.4.3 Short Term Solutions 
 
Hydrogen peroxide working solution: was prepared by diluting Hydrogen 
peroxide 30% 1:5 in PBT. 
Proteinase K working solution: was prepared by diluting Proteinase K stock 
solution 1:500 in PBT. 
Glycine: was prepared as a solution containing 0.2% Glycine in PBT. 
Refix solution: was prepared by adding 0.2% Glutaraldehide to a 4% PFA 
solution. 
Refix labelled embryos solution: was prepared by adding 0.1% Glutaraldehide 
to a 4% PFA solution. 
Long term storage solution: was prepared by diluting 4% PFA to a 
concentration of 0.1% PFA in PBT 
Prehybridization solution: was prepared by diluting SSC 1:4 in a 50% 
Formamide aqueous solution. Tween was added to 0.1% and Heparin to a final 
concentration of 0.005%. 
Yeast RNA: was prepared as an aqueous solution of 10% RNA. 
Hybridization solution: was prepared by adding to the prehybridization 
solution Yeast RNA 1:100 and Hering sperm DNA 1:100. The probe was denatured 
for 10 min at 80°C. 1 µg of probe was added to 1 ml hybridization solution 
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Wash Solution I: was prepared by diluting SSC 1:5 in a 50% Formamide 
aqueous solution. SDS was added to a final conc of 1%. 
Wash Solution II: was prepared as an aqueous solution containing NaCl 500 
mM, Tris pH 7.5 10 mM and Tween 0.1% 
Wash Solution III: was prepared by diluting SSC 1:10 in a 50% Formamide 
aqueous solution. 
RNase working solution: was prepared by diluting RNase stock solution 1:100 
in Wash Solution II (final conc 0.01%) 
TBST: was prepared by diluting TBS 1:10 in water and adding Tween to a final 
conc of 0.1%. 
Blocking solution: was prepared by diluting sheep serum 1:10 in TBST. 
DIG Label: was prepared by diluting Blocking solution 1:10 in TBST and 
adding DIG-AP 1:2000. 
NTMT: was prepared as an aqueous solution containing NaCl 100 mM, Tris pH 
9.5 100 mM, MgCl2 50 mM and Tween 0.1%. 
BCIP/NBT: was prepared as an aqueous solution containing 100 mM NaCl, 45 
mM MgCl2 and Tween 0.1%. To 10 ml of this solution one BCIP/NBT tablet was 
added, dissolved in the dark and filtered using a syringe fitted with a 0.45 µm filter. 
Note: the salts in the solution were calculated so that with the salts in the BCIP/NBT 
tablet the final desired concentrations would be achieved, namely: Tris pH 9.5 100 
mM, NaCl 100 mM and MgCl2 50 mM. 
 
M4.4.4 In Situ Hybridization Procedure 
 
For the following experiments Twist1 probe generate as described (M1.3.3) was 
used. As control, previously validated probes for Pou5f1 and Tcf15 were used. 
 
Prehybridization procedures 
Embryos dissected, fixed and dehydrated, as in M3.5 were rehydrated by 5 min 
sequential washes in 75%, 50% and 25% Methanol solution respectively, followed by 
two washes in PBT 5 min each. 
 
Next embryos were bleached in Hydrogen peroxide working solution for 1 hour 
at RT, followed by three 5 min washes in PBT. Proteolysis was performed by placing 
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embryos in Proteinase K working solution at RT for times optimized for embryo age. 
For the embryos used in the experiments presented here proteolysis lasted between 5 
and 12 min. Proteolysis was stopped by placing embryos in Glicine solution for 5 min 
at RT. Glicine was washed in PBT at RT, twice, 5 min each. 
 
Next embryos were refixed by placing them in Refix solution for 20 min. Refix 
was washed in PBT at RT, twice, 5 min each. Embryos were then placed in 
Prehybridization solution overnight at 65°C.  
 
RNA probe hybridization 
Next day embryos were briefly washed with prewarmed Hybridization solution 
not containing probe. They were then placed in Hybridization solution with probe, 
overnight at 65°C. 
 
Next day the embryos were washed twice in Wash Solution I for 30 min at 65°C 
and once in a 1:1 mixture of Wash Solution I and Wash Solution II for 10 min at 
65°C. Then they were washed three times in Wash Solution II at RT for 5 min each 
and placed in RNase working solution at 37°C for 15 min. RNase step was repeated. 
Then the embryos were washed at RT for 5 min once in Wash Solution II and once in 




Next embryos were equilibrated in TBST, three washes at RT, 5 min each. Then 
they were placed in Blocking solution for 5 to 8 hours at RT. Then, embryos were 
placed in DIG Label overnight at 4°C. 
 
Next day, embryos were washed all day in TBST at RT. First three brief 5 min 
washes were performed, than multiple 1 or 2 hour washes. Finally, embryos were 
placed in TBST at 4°C overnight. 
 
Alkaline phosphatase reaction 
Next day embryos were equilibrated in NTMT for 3 washes at RT, 10 min each. 
Then they were placed in BCIP/NBT solution and rocked in dark. Staining 
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development was checked microscopically at increasingly longer intervals 15 min, 30 
min, 1 hour, 2 hours etc, up to 48. When staining was considered sufficient, embryos 
were removed from the staining solution and washed, still in dark, twice with NTMT 
for 10 min each and twice with PBT for 10 min each. Then, embryos were placed in 
the stop solution: PBT pH 5.5 at 4°C overnight. 
 
Next day they were fixed in Refix labelled embryos solution for 1 ht at RT and 
then placed in Long term storage solution at 4°C. 
 
Whole embryos were imaged using a Nikon AZ100 microscope and images 
captured with NIS Elements Imaging Software version 4.0 (Nikon Instruments Inc.). 
For sectioning embryos were embedded in paraffin, after dehydration is ethanol 
sequential solutions (40%, 70%, 90%, 95% and twice 100%) and cleared in Xylene. 
Next day, embryos were sectioned at 7 µm thickness in a microtome (Anglia 
Scientific). Sections were washed twice with Xylene to remove the wax and mounted 
underneath coverslips in DPX (Agar Scientific). Sectioning procedure was performed 
by Ronald Wilkie. Sections were imaged using an Olympus BX61 microscope and 




Table M1 primary antibodies: 
Antibody 
name 










































1:200 Santa Cruz 
Biotech 
Immunostain 
























































Table M2 secondary antibodies: 
Specificity Conjugate Specie Dilution Source Technique 
































Mouse IgG HRP Goat 1:25000 Promega 
V4021 
Western Blot 









Table M3 qPCR primers: 
Gene Forward primer Reverse primer Probe # 
Cadherin1 ATCCTCGCCCTGCTGATT ACCACCGTTCTCCTCCGTA 18 
Cadherin2 GCCATCATCGCTATCCTTCT CCGTTTCATCCATACCACAAA 18 
Eomes ACCGGCACCAAACTGAGA AAGCTCAAGAAAGGAAACATG 9 
Esrrb CGATTCATGAAATGCCTCAA CCTCCTCGAACTCGGTCA 89 
Fgf5 AAAACCTGGTGCACCCTAGA CATCACATTCCCGAATTAAGC 29 














Klf4 CGGGAAGGGAGAAGACACT GAGTTCCTCACGCCAACG 62 




Msx1 CAGAGTCCCCGCTTCTCC GTCTTGTGCTTGCGTAGGG 20 
Ncam1 GATTTCCAGAGCCCACCAT CGGAGCTGTCACTCACTGAA 69 
Nanog CCTCCAGCAGATGCAAGAA GCTTGCACTTCATCCTTTGG 25 
Pou5f1 GTTGGAGAAGGTGGAACCAA CTCCTTCTGCAGGGCTTTC 95 
Pax3 AAAAGGCTAAACACAGCATCG CAATATCGGAGCCTTCATCTG 110 






Sox1 GTGACATCTGCCCCCATC GAGGCCAGTCTGGTGTCAG 60 
Sox9 GAAGCTGGCAGACCAGTACC GGTCTCTTCTCGCTCTCGTTC 75 
T ACTGGTCTAGCCTCGGAGTG TTGCTCACAGACCAGAGACTG 27 
TBP GGGGAGCTGTGATGTGAAGT CCAGGAAATAATTCTGGCTCA 97 
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Tcf15 GTGTAAGGACCGGAGGACAA GATGGCTAGATGGGTCCTTG 104 
Twist1 GAGCAACAGCGAGGAGGA CGACTGCTGCGTCTCTTG 66 
Wnt1 TACTGGCACTGACCGCTCT CTTGGAATCCGTCAACAGGT 25 
Zeb1 GCCAGCAGTCATGATGAAAA TATCACAATACGGGCAGGTG 48 
Zeb2 CAAGAGGCGCAAACAAGC TGCGTCCACTACGTTGTCAT 79 




Table M4 cloning primers: 




FKBP common forward primer. 







E47 reverse primer for FKBP Twist1-
E  and FKPB Tcf15-E plasmids. In 
bold NotI sequence and the 2 stop 







Twist1 reverse primer for FKBP 
Twist1 plasmid. In bold NotI 








Tcf15 reverse primer for FKBP Tcf15 
plasmid. In bold NotI sequence and 







Neurod1 reverse primer for FKBP 
Neurod1 and FKBP Neurod1-
Neurod1 plasmids. In bold NotI 
sequence and the 2 stop codons, 
reverse complemented 
PP015-ISHf CCCTGGCAAGCAGTTCAGTCC Forward primer for Twist1 In Situ 
Hybridization probe, in the 3’ UTR 
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PP016-ISHr ACCATACTTCCTCTGAAGGAA Reverse primer for Twist1 In Situ 







Forward primer for generation of a 
Twist1 coding amplicon containing a 
PacI site for subcloning into NEB193 
plasmid. In bold Pac1 site and the 





Reverse primer for generation of a 
Twist1 coding amplicon containing a 
AgeI site for subcloning into NEB193 
plasmid. In bolt the AgeI site and the 







Forward primer to generate BAC 
modification, containing 60 nt of 
Twist1 genomic locus. In bold the 








Reverse primer to generate BAC 
modification, containing 60 nt of 
Twist1 genomic locus. In bold the last 
21 nt of the NEB-Twist construct 




GGGAAGCTGGCGGGCTAGGGC Forward primer for modified BAC 
colony PCR recognizing the Twist1 
locus up to 6 nt before the start of the 
60 nt flanking sequence in the primer 
SL22_recTw1F. 
SeqTw r CTAGTGGGACGCGGACATGGA Reverse primer for modified BAC 
colony PCR recognizing the end of 






Reverse primer for modified BAC 
colony PCR recognizing the Twist1 
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locus up to 9 nt after the end of the 60 
nt flanking sequence in the primer 
SL224_recTw1R, reverse 
complemented 
A2RF TGCTAACCCCACATCCTTCT Recognizes a region close to the end 








Forward primer for generation of a 
retrieval construct from pACYC177 
plasmid. In bold is the Xho1 site; 
underscored is the homology 
sequence with the pACYC177. See 








Reverse primer for generation of a 
retrieval construct from pACYC177 
plasmid. Underscored is the 
homology sequence with the 




III. RESULTS 1 






Inhibition of BMP signalling is the key requirement for the progression towards 
neural differentiation both in vivo and in vitro [Munoz-Sanjuan and Brivanlou, 2002; 
Ying et al, 2003a]. Furthermore, BMP downstream target, ID1 is able to replace BMP 
in blocking neural differentiation in vitro [Ying et al, 2003a]. However, our 
understanding of neural fate regulation by BMP/ID has yet not progressed any 
further.  
 
Dr Sally Lowell has been interested in finding out what are the signalling 
pathways affected by IDs in blocking neural differentiation. To this end, Dr Owen 
Davies, in her lab, performed a Yeast-2-Hybrid assay on a mouse ES cell cDNA 
library. He found that at the highest stringency level ID1 interacts only with E12 and 
E47, the two splice variants of Tcf3 gene [previously known as E2A]. When he then 
asked, which are the binding partners of these two latter proteins, besides IDs, he 
found only 3 other proteins TWIST1, TCF15 and NEUROD1; all bHLH factors. 
 
Microarray data, as well as our lab unpublished data showed that Twist1 is 
expressed at low levels in ES cells and its expression increases during neural 
differentiation [Aiba et al., 2009; Lowell lab unpublished data]. Tcf15 is expressed at 
higher levels in ES cells, but its expression is downregulated in early stages of 
differentiation [Aiba et al., 2009; Lowell lab unpublished data]. Neurod1 is a known 
neural bHLH factor. However, its action has been reported on later stages, being 
downstream of Neurogenin1 [Ma et al, 1996; Talikka et al, 2002]. Taking into 
consideration these reasons, I inferred that Twist1 is the candidate gene with the 




In this chapter I present evidence for Twist1 expression in pluripotent and 
differentiating cell compartments. Furthermore, I test the influence of an ID resistant 
TWIST1 active form on neural differentiation. Finally, I investigate the requirement 
for Twist1 in the process of neural differentiation 
 
 
R1.2 Twist1 Marks The Primed Pluripotent Cell Compartment. 
 
Before testing the role of TWIST1 on differentiation I asked the question of its 
expression in the pluripotent compartment. As stated previously, Twist1 is 
upregulated during the transition from ES cells maintained in LIF and Serum, towards 
neural differentiation. However, Twist1 expression in the pluripotent compartment 
was less studied. 
 
To address this point I used the Oct4-GIP cell line produced in the lab of Prof. 
Austin Smith [Ying et al, 2002]. In this cell line GFP-Ires-Puro is expressed 
downstream of the Pou5f1 promoter in a randomly integrated construct. Culturing this 
cell line, under Puromycin selection, eliminates differentiated cells and, thus removes 
the confounding issue represented by high expression of differentiation markers in a 
small number of cells within an ES cell population. For this experiment I compared 
ES cells, established in 2i conditions, cultured in LIF and Serum or established in 
EpiSC condition (this cell line has been established in EpiSC conditions by Rodrigo 
Osorno).  Twist1 expression was compared with the expression of Fgf5, a known 
epiblast stem cell marker. I found that for both Twist1 and Fgf5 expression increases 
from 2I to LIF-Serum to EpiSC conditions [Fig R1.1]. However, while for Fgf5 the 
most dramatic increase was found between LIF-Serum and EpiSC, over 100 fold [Fig 
R1.1b and c], for Twist1 the major increase was between 2I to LIF-Serum almost 50 
fold, with a minor further increase to EpiSC [Fig R1.1a]. Thus it appears that Twist1 











Figure R1.1. Twist1 marks the primed ES cell population.  
 
qPCR for Twist1 (a) and Fgf5 (b and c) for pluripotent cells maintained in 2i 
conditions, ES standard conditions (LIF + Serum) and EpiSC conditions. Expression 
in 2i has been arbitrarily set to 1. One experiment performed in duplicates is shown. 














































R1.3 Twist1 Is Associated With The Neural Differentiating 
Population. 
 
Although Twist1 is upregulated during in vitro neural differentiation, it was not 
thought to be associated in vivo with early neural progenitors, but rather it was 
considered a mesenchymal marker [Soo et al., 2002]. Since neural differentiation in 
vitro is never a perfectly controlled process there is a possibility that Twist1 
upregulation follows its expression in non-neural differentiating cells which are 
usually present in the culture.  
 
To test for this possibility a Sox1-GFP reporter cell line, called 46c [Ying et al, 
2003b] was used. 46c cells were differentiated for 4 days in the monolayer protocol, 
sorted based on GFP and gene expression assessed by qPCR. (Differentiation, sorting 
and RNA extraction, for this experiment, were performed by Ms. XinZhi Zhou.) 
 
Zfp521 is a transcription factor shown to be upstream of Sox1 in neural 
differentiation [Kamiya et al, 2011] and, is used here along Sox9, an early neural and 
neural crest marker [Cheung and Briscoe, 2003], as control of the neural 
differentiation. On the other hand, Gata6 a marker of endoderm and some 
mesodermal cells [Molkentin J.D., 2000; Fletcher et al, 2006] should not be 
upregulated during neural differentiation.  As expected Zfp521 and Sox9 are 
upregulated in the Sox1-high population, compared to Sox1-low population, while 
Gata6 was expressed at similar levels in both populations indicating that endoderm is 
not a major route taken by cells which differentiate towards non-neural fates. 
Furthermore for Twist1 a small but significant upregulation in the Sox1-high 
population was observed. This result shows that Twist1 is not preferentially 
upregulated by non-neural differentiating cells and, supports the idea that Twist1 
could have a role in neural differentiation. Gata6 was expressed at similar levels in 
both populations indicating that endoderm is not a major route taken by cells which 














Figure R1.2. Twist1 is associated with Sox1 high population. 
 
qPCR for Zfp521 (a), Sox9 (b), Gata6 (c) and Twist1 (d) in 46c cells differentiated in 
N2B27 for 4 days and GFP sorted (XinZhi Zhou). Twist1 is upregulated in Sox1 high 
population along other neural associated markers: Zfp521 and Sox9. On the other 
hand the primitive endoderm marker Gata6 is not differentially regulated between 
samples, indicating that non-neural cells do not progress via an endoderm route. 
Expression in Sox1 low samples has been arbitrarily set to 1. For Zfp521, Sox9 and 
Gata6 one experiment performed in duplicates is shown. Error bars represent value 
range. For Twist1 triplicate experiment performed in duplicates is shown. Error bars 
represent standard deviation of the mean; p = 0.03. Two qPCR analyses were 




































R1.4 Generating TWIST1 Inducible Cell Lines 
 
As it has been previously reported ID proteins bind E proteins and sequester the 
latter from forming binding partners with other bHLH factors [Jen et al, 1992; 
Kurabayashi et al, 1994; Peverali et al, 1994]. In the case of TWIST1 the 
unavailability of E proteins shifts dimer choice probability towards formation of 
TWIST1-TWIST1 homodimers [Connerney et al, 2006]. Thus TWIST1-E dimers 
activity would mimic a molecular status of low ID while TWIST1-TWIST1 dimers 
would mimic a status of high ID activity. A theoretical model of TWIST1 dimer 
formation in the process of neural and non-neural differentiation is presented in Fig 
R1.3. 
 
In order to investigate the role of TWIST1 and its dimer choice on cell 
differentiation I set out to generate cell lines with inducible tethered dimers by means 
of a flexible linker, which have a low sensitivity for competing interactors 
[Connerney et al, 2006]. Fig R1.4 explains schematically the strategy of using 
inducible TWIST1 constructs to dissect the effects of dimmer choice. When TWIST1 
monomer is induced it forms dimers with E proteins if they are available. However, if 
IDs are present at significant levels they sequester the E proteins and TWIST1 forms 
homodimers. The formation of either dimer results in the activation of its specific 
target genes [Fig R1.4a]. By contrast, if TWIST1 forced homodimer (TwTw) is 
induced it activates its target genes even if E proteins are available [Fig R1.4b]. 
Moreover, if TWIST1-E forced dimer (TwE) is induced it activates its target genes 
even in the presence of ID proteins [Fig R1.4c]. Thus, TW-E is the active dimer to be 
considered in regard to the blocking activity of BMP/ID.  
 
The first attempt of producing inducible TwE cell lines involved the FKBP 
system, where the protein of interest is fused to a form of FKBP1A containing a 
destabilizing mutation. Thus the entire transgenic construct is effectively targeted for 
degradation. Protein expression is achieved by treating the cells with the small 








Figure R1.3. ID1 sequester E proteins from forming active dimers. 
 
Theoretical model on how ID1 acting downstream of BMP can influence bHLH 























































Figure R1.4. Schematics of TWIST1 inducible constructs transcriptional 
activity 
 
Formation of TW-E or TW-TW active dimers results in transcriptional regulation of 
their respective genes. Induction of TwE or TwTw forced dimers is resistant to dimer 































Figure R1.5. Strategy for conditional control of protein stability  
 
DD = destabilizing domain, here FKBP1A-L106P, POI = protein of interest, here 
TwE, ligand = small molecule with affinity for DD, here Shield (adapted from 
Banaszynski at al, 2006) (a). Flag staining of cells transfected with FKBP constructs 
and induced with Shield for 24 hours. Positive cells could be obtained in transient 
transfections for TWIST1 monomer and TwE but not for TWIST1 stably transfected 
cells. However, other constructs, like HES1, can generate inducible cells stably 




































However, using this strategy no clones expressing the protein of interest could 
be isolated. Expression could be elicited in transient transfection experiments 
indicating that the construct was functional [Fig R1.5b]. I considered that the most 
likely explanation was that the transgene was detrimental for cell proliferation in self 
renewal conditions, while the degradation mechanism was probably not efficient 
enough to remove the active protein before exerting its effects.  
 
To address this problem I employed a different strategy, where the construct of 
interest was expressed under the CMV-TetO promoter and transfected into ES cells 
where the rtTA2S-M2 construct [Urlinger et al, 2000] had been targeted to the Rosa-
26 locus. Diagram of the strategy is presented in Fig R1.6. rtTA targeted ES cells 
were a kind gift of Dr. Andrew Smith. 
 
Using this strategy it was possible to isolate clones capable of inducing the TwE 
transgene, though some of them retained the Puromycin selection cassette while 
losing TwE. Furthermore, the expression was heterogeneous for all the clones 
isolated. Fig R1.7 shows induction at the RNA level [Fig R1.7a], Flag 
immunofluorescence [Fig R1.7b] and western blot [Fig R1.7c]. 
 
 
R1.5 TwE Accelerates In Vitro Neural Differentiation. 
 
When TwE was induced during neural differentiation a striking effect could be 
observed in the form of premature formation of post-mitotic neurons. Thus, at day3 of 
differentiation, when TUBB3 just begins to be expressed, by a few cells in the control 
conditions, it can be observed in a high proportion of the cells in TwE induced 
sample, taking the shape of long interconnecting neurites [Fig R1.8]. 
 
While early formation of post-mitotic neurons was striking and unexpected, it 
could not be considered as an indication that TwE favours neural induction. One 







Figure R1.6. Schematics of Doxycyclin inducible system  
 
Model of the system: Rosa26 = genomic locus constitutively active. rTetR-VP16 = 
reverse Tet Repressor fused with viral VP16 activator domain. Tet Repressor element 
is revered in the sense that it was mutated so that its product binds to the TetO 
sequence only in the presence of Doxycyclin. rtTA = reverse tetracycline controled 
Trans Activator, the product of rTetR-VP16 element [Urlinger et al, 2000] (a). 










































Figure R1.7. Characterization of TwE inducible cell lines 
 
qPCR showing expression of Twist1 after  48 hours of induction compared to 
uniduced samples or control non-transfected cells. Expression in parental cell line has 
been arbitrarily set to 1. One experiment performed in duplicates is shown. Error bars 
represent value range (a). Immunofluorescence for Flag staining after 48 hours of 
induction showing typical heterogeneous expression; scale bars represent 50 µm (b). 



















































Figure R1.8. TwE induces rapid formation of mature neurons 
 
After three days of monolayer neural  differentiation in N2B27 TUBB3 positive cell 
just began to be observed in control –Dox, while being well represented in TwE 
induced +Dox. Upper panels: phase contrast, lower panels: TUBB3 staining. Scale 












































Two markers: Sox1 and Sox2 could provide useful insights regarding this issue. 
Sox1 marks neural progenitor cells both in vivo and in vitro [Wood & Episkopou, 
1999; Ying et al., 2003b]. Sox2 is expressed throughout the epiblast before 
gastrulation, but then, is restricted to anterior ectoderm. At the start of somitogenesis, 
just like Sox1, Sox2 specifically marks the neural progenitors [Wood & Episkopou, 
1999]. During in vitro differentiation, at day 4, SOX2 was still strongly expressed by 
control cells, while in TwE induced it was downregulated already at day 3 and was 
almost undetectable at day 4 [Fig R1.9]. 
 
Next, Sox1 was assessed at the mRNA level. Similar to SOX2, Sox1 is 
downregulated prematurely in response to TwE. Interestingly, Sox1 is also 
upregulated earlier in TwE induced samples, indicating a possible facilitation of 
neural induction [Fig R1.10c]. However, the upregulation at day 2 is not statistically 
significant across three experiments, while downregulation at days 4 and 5 is. 
Increasing the n of repeat experiments could provide statistical significance at day 2 
as well, but the present data may indicate that the later downregulation is a more 
robust phenomenon. Zfp521 is an early neural transcription factor, reported to act 
upstream of Sox1. There is a trend for its upregulation at all time points in response to 
TwE, but the differences are not statistically significant [Fig R1.10b]. Furthermore 
the pluripotency marker Pou5f1 is abruptly downregulated in the presence of TwE, 
although for this marker more repeat experiments are required in order to assert 
statistical significance [Fig R1.10a].  
 
Nestin is another neural progenitor marker. In the control population it begins to 
be upregulated at day 4 and, at day 5 produces a strong signal by 
immunofluorescence. In the TwE induced cells it was slightly upregulated in a few 
cells at day 3 [Fig R1.11a yellow arrows], however the later upregulation on days 4 
and 5 is curbed in this condition [Fig R1.11b and c]. 
 
In summary, the data presented here supports the idea that TwE accelerates 
neural differentiation and forces cellular exit from the neural progenitor state. There 
is also some indication that TwE facilitates entry in the process of neural 










Figure R1.9. TwE induction leads to premature downregulation of 
pluripotent and neural progenitor cell marker SOX2.  
 
Four days of monolayer neural differentiation in N2B27; no Dox induction Day 3 (a) 
and Day 4 (c), Dox induction Day3 (b), Day 4 (d). From left to right panels represent: 




















































Figure R1.10. TwE accelerates progenitor dynamics during neural 
differentiation.  
 
qPCR of cells after 4 days of monolayer differentiation in N2B27; Pou5f1 (a), Zfp521 
(b) and Sox1 (c). Expression in ES cells has been arbitrarily set to 1. For Pou5f1 one 
experiment performed in duplicates is shown. Error bars represent value range. For 
Zfp521 and Sox1 triplicate experiments performed in duplicates are shown. Error bars 

















































Figure R1.11. TwE induction negatively influences the upregulation of 
NESTIN.  
 
Five days of monolayer differentiation in N2B27; no Dox induction left panels, Dox 
induction right panels, DAPI and NESTIN staining. Day3 (a), Day4 (b) and Day 5 














































R1.6 TwE Acts Early on Neural Differentiation. 
 
In the previous sections I showed that TwE influences neural differentiation. 
However, the evidence to support the notion of TwE acting at the initial stages of 
neural differentiation is less compelling. To clarify this point an experiment was 
designed concentrating at the early events of differentiation. Thus, control cells are 
plated in N2B27 at what is considered to be Day 0 of neural differentiation, similar 
with previous experiments. To test TwE early roles the transgene was induced with 
Dox 24 hours prior to differentiation (Day -1), while cells were maintained in ES cell 
conditions, LIF and Serum. Thus, at Day 0 when differentiation began cells were 
already expressing the transgene. Dox was maintained for the first 24 hours of 
differentiation (Day 1) after which it was removed. This condition is compared to 
Dox stimulation throughout the experiment Day 0 to Day 5 and –Dox control [Fig 
R1.12a]. 
 
First, it was tested that the upregulation and downregulation dynamics of the 
transgene corresponds to the desired features of the experiment. Thus, 24 hours after 
removal of Dox there was no expression of the transgene either at the RNA [Fig 
R1.12b] or protein level [Fig R1.12c]. Furthermore, upregulation dynamics shows 
that the protein reaches maximum level after 24 hours of induction [Fig R1.12c], the 
time when differentiation began. 
 
Sox1 was upregulated at the highest levels at Day 2 by the early Dox 
stimulation, while, in these conditions, subsequent downregulation was mitigated, the 
expression reverting to control levels by day 5. In contrast, Dox stimulation 
throughout differentiation produced a more modest upregulation of Sox1 at Day 2 
followed by a marked downregulation at later time points [Fig R1.13a]. Thus, it 
appears that TwE action is biphasic: first it facilitates entry to neural differentiation 
and upregulation of Sox1 and subsequently, hastens the exit from neural progenitor 
state, a phenomenon which correlates with Sox1 downregulation. 
 
Zfp521 was maximally upregulated at Day 2 in early Dox condition as well. 
However, at later time points it reverted to control level, in the case of early 
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treatment, while being upregulated by continuous Dox induction [Fig R1.13b]. This 
would indicate that Zfp521 expression above the control levels is dependent on the 
transgene at all time points. 
 
Pax3 is expressed in vivo in a subset of dorsal neural progenitors and future 
neural crest cells [Goulding et al, 1991]. In the present in vitro experiment it started to 
be upregulated at Day 3 of neural differentiation. Interestingly, TwE induction 
stimulated an early upregulation at Day 2, followed by block of high level 
upregulation at the later time points. Moreover, at Day2, Pax3 was maximally 
upregulated by early Dox treatment. The upregulation at later time points was further 
augmented by this early treatment [Fig R1.13c]. Pax3 data confirms the biphasic 
action of TwE, as well as indicating that the transgene has opposing actions on 
specific markers depending on the cellular context. 
 
Atoh1 is a more mature neural marker marginally induced in the first 5 days of 
monolayer neural differentiation, but highly upregulated in response to TwE. 
However, early Dox treatment had no positive influence on this marker upregulation, 
further stressing the two phase hypothesis [Fig R1.13d]. 
 
The experiment presented in this section complements the previous 
experiments, indicating that TwE is able to influence neural differentiation most 
notably at early time points. Furthermore, it is suggested that only certain neural 
features can be generated by transiently activating TwE. However, in order to assess 















Figure R1.12. TwE early induction during neural differentiation 
experiment 
 
The diagram presents the three conditions used. ES cells were usually cultured in LIF 
+ Serum and transferred to N2B27 when neural differentiation began: Day 0 (green 
and blue bars).  For transgene induction Dox is added when cells were transferred to 
N2B27 (orange bar). For early induction Dox was added 24 before the start of 
differentiation and maintained for the first 24 hours of differentiation (pink bar), after 
which the cells continued to differentiate in N2B27 alone (a). qPCR for Twist1 for 
cells during 5 days of monolayer differentiation in N2B27 not induced (-Dox), 
induced (+Dox) or induced early (+Dox early) as described. Expression in ES cells 
has been arbitrarily set to 1. One experiment performed in duplicates is shown. Error 
bars represent value range (b). Western blot for Flag, showing induction and 
clearance of the protein after Dox removal at the stated time points (c). For this 








































Figure R1.13. TwE accelerates entry to and exit from neural progenitor 
stage.  
 
qPCR for early or continuous induction of TwE during neural differentiation showing 
early upregulation of Sox1 (a), Zfp521 (b) and Pax3 (c), followed by later 
downregulation of Sox1 (a), Pax3 (b) and upregulation of Atoh1 (d). Expression in ES 
cells has been arbitrarily set to 1. One experiment performed in duplicates is shown. 












































R1.7 TwE and EMT during Neural Differentiation 
 
When neural folds form, prospective neural progenitors undergo a particular 
form of EMT, during which CDH1 (E-cadherin) is downregulated but, the 
morphological epithelial characteristics are maintained. This type of EMT is 
dependent on Zeb2 (also known as Sip1) and, this factor is required for neural 
differentiation [Sheng et al, 2003; Chnq et al, 2010].  
 
On the other hand, TWIST1 is a known EMT effector, being involved in CDH1 
downregulation in physiological and pathological processes [Hay E.D., 1995; Yang et 
al, 2004]. Furthermore, Ncam1 is an adhesion molecule with a role in neural cell 
communication [Rutishauser et al, 1988] and neural crest migration [Breau et al., 
2006] 
 
During monolayer neural differentiation, Zeb1, Zeb2 and Ncam1 were 
upregulated. Upon TwE induction there was a trend of enhanced upregualtion for 
Zeb1, but this was not statistically significant. Furthemore, Zeb2 upregulation was 
also enhanced, and this was statistically significant across three experiments for days 
3 and 4. Ncam upregulation was also enhanced but more repeat experiments are 
required for this marker in order to assess statistical significance [Fig R1.14]. In 
conclusion, TwE stimulates EMT in a fashion consistent with that observed in neural 
differentiation and, could act upstream of Zeb2. 
 
 
R1.8 TwE Opposes BMP4 During Monolayer Differentiation. 
 
In the work presented so far, I showed that TwE influences neural 
differentiation, that it may act both on very early stages of entry to the neural 
progenitor stage, as well as on later stages and that it stimulates EMT in the process. 
However, my central hypothesis stipulated that BMP signalling block on TW-E dimer 
formation is part of the process of neural inhibition. I will now investigate whether 









Figure R1.14. TwE upregulates EMT markers during neural 
differentiation.  
 
qPCR of cells during 5 days of monolayer differentiation in N2B27; Zeb1 (a), Zeb2 
(b) and Ncam1 (c). Expression in ES cells has been arbitrarily set to 1. For Zeb1 and 
Zeb2 triplicate experiments performed in duplicates are shown. Error bars represent 
standard deviation of the mean. For Zeb2 at day 3 p = 0.02 and at day 4 p = 0.01. For 

















































Figure R1.15. TwE overcomes BMP4 block on neurite formation.  
 
Cells differentiated for 3 days in N2B27+BMP4 (1ng/ml). Neuron formation as 
assessed by TUBB3 staining is blocked by BMP4 and rescued by induction of TwE 















































To test this hypothesis, 1 ng/ml BMP4 was added to the medium of cells 
differentiating in the monolayer protocol, in N2B27. This dose was sufficient to block 
the neurite formation. However, if TwE is induced, by Day 3, long interconnecting 
neurites, staining positive for TUBB3, could be readily observed [Fig R1.15]. 
 
R1.9 TwE Partially Overcomes BMP4 Block on Neural 
Differentiation. 
 
The experiments presented above indicated that TwE has the ability to 
overcome BMP4 block on neural differentiation as assessed by formation of TUBB3 
neurons. However, when BMP4 dose was increased to 5 ng/ml, TUBB3 positive 
neurons were no longer apparent in response to TwE induction (data not shown). I 
asked whether at this dose of BMP4, TwE could rescue neural differentiation as 
assessed by mRNA markers level. An experiment was designed where ES cells were 
differentiated for 5 day in N2B27 as a control of neural differentiation. In sister wells 
neural differentiation was blocked by addition of 5 ng/ml BMP4 while, in the third 
condition, this inhibition was rescued by activation of TwE.  
 
FigR1.16 shows upregulation of mRNA levels for a number of neural markers, 
in the course of 5 day of differentiation, as well as the block in upregulation affected 
by BMP4: Sox1 (a), Zfp521 (b), Pax3 (c), Sox9 (d) and Ascl1 (e). Furthermore, Cdh2 
is upregulated during neural differentiation and this is mitigated, albeit not completely 
blocked by BMP4 [Fig R1.16f]. TwE is able to rescue the expression of all the 
mentioned markers, with the exception of Sox1 and Ascl1, at similar or higher levels 
compared to those in the control differentiation. It should be mentioned that for Pax3 
expression, the rescue to controls levels is only observed until day 3. After this time 
point, the levels continue to increase in the control, but plateau in the TwE rescue 
condition. This is consistent with previous data showing that TwE has a positive 
influence on Pax3 only early in differentiation. However, in order to assess statistical 









Figure R1.16. TwE partially overcomes BMP4 block on neural 
differentiation.  
 
Cells differentiated for 5 days in N2B27 with or without BMP4 (5ng/ml) and Dox. 
qPCR analysis shows that BMP4 blocks upregulation of neural markers and this is 
rescued for most of them by TwE: Sox1 (a), Zfp521 (b), Pax3 (c), Sox9 (d), Cdh2 (f) 
Tcf15 (g). Expression in ES cells has been arbitrarily set to 1. One experiment 

































The most serious failure in neural rescue by TwE was the lack of Sox1 
upregulation against high BMP levels. The data presented in the previous sections 
indicated that TwE is able upregulate as well as to downregulate Sox1, although the 
data supporting downregulation was more consistent. In the context of BMP4 
inhibition of neural differentiation it indicates that targets other than TwE are stopped 
from enacting the neural program. The absence of Sox1 correlates with the TwE 
failure to upregulate Ascl1 or to produce overt morphologically recognizable neurons. 
Interestingly, in vivo Sox1 is not required for neural differentiation [Malas et al, 
2003]. Hence, the lack of neuron formation, is most likely, not a consequence of Sox1 
absence, but rather Sox1 is a marker of the failure of proper neural differentiation. 
 
However, there is a possibility that Zfp521, Pax3 and Sox9 do not mark a neural 
population in this context. Zfp521 is restricted to the neural compartment in the 
gastrulating embryo [Kamiya et al, 2011], but has been reported as having a role in 
mesenchymal cells at later stages [Hesse et al, 2010]. Pax3, Sox9 and Twist1 are all 
expressed in the neural crest and somitic compartment [Goulding et al, 1991; Ng et al, 
1997; Stoetzel et al, 1995; Fuchtbauer E.M., 1995]. I therefore asked if the cells 
induced by TwE against BMP could have a profile consistent with somitic like cells. 
To answer this question I made use of the somitic specific marker Tcf15 [Burgess et 
al, 1995]. This marker was expressed at lower levels that in ES cells in all conditions 
tested, and the lowest levels, at all time points, were found in TwE induced samples 
[Fig R1.16g]. Consequently, the most likely explanation is that TwE induces 
formation of a cell type expressing a subset of neural and neural crest markers. 
 
To clarify the role TwE has in rescuing neural differentiation, another 
experiment was set up, where cells were differentiated with or without Dox induction, 
in the absence of BMP4, 1 ng/ml BMP4 and 5 ng/ml BMP4 respectively. The same 
markers were tested as in the previous experiment at day 4 of differentiation with the 











Figure R1.17. TwE rescue of neural differentiation depends on BMP4 
levels.  
 
Cells differentiated for 4 days in N2B27 with 0, 1 or 5 ng/ml BMP4. qPCR analysis 
shows that 1 ng/ml BMP4 does not block completely Sox1 upregulation (a) while 
having a significant negative effect on all neural markers (a-f). In this conditions TwE 
can fully rescue the expression of all neural markers except Sox1; Sox1 (a), Zfp521 
(b), Pax3 (c), Sox9 (d), Ascl1 (e) and Cdh2 (f). Expression in ES cells has been 
arbitrarily set to 1. For Sox1, Zfp521, Pax3, Sox9 and Ascl1 two repeat experiments 
performed in duplicates are shown. Error bars represent standard deviation of the 
mean. For Sox1 with no BMP4 p = 0.02, for Pax3 no BMP4 p = 0.005, for Pax3 with 
5 ng/ml BMP4 p = 0.003, for Sox9 with 1 ng/ml BMP4 p = 0.01 and for Sox9 with 5 
ng/ml BMP4 p = 003. For Cdh2 one experiment performed in duplicates is shown. 
































In 1 ng/ml condition Sox1 was permitted, albeit at lower levels compared to no 
BMP4 and induction of TwE did not seem to have a notable influence on Sox1 
expression. In these conditions, of 1 ng/ml BMP4, the expression of all the other 
tested neural markers was rescued by TwE, including that of Ascl1 [Fig R1.17]. 
When statistical significance was assessed, it was observed that Sox1 is significantly 
downregulated by TwE in the absence of BMP4, while Zfp521 upregulation was not 
statistically significant. Pax3 was significantly downregulated at day 4 in the absence 
of BMP4 and significantly upregulated at 5 ng/ml BMP4 dose only. Sox9 was 
significantly upregulated in the presence of BMP4 (1 and 5 ng/ml), while Ascl1 
upregulation was not significant in any condition. 
 
In conclusion, it can be noted that TwE ability to rescue neural differentiation 
against BMP block is dependent on Sox1 expression. As long as Sox1 is expressed 
TwE can rescue neural differentiation, while TwE cannot rescue Sox1. On the other 
hand, in the presence of high BMP4 and no Sox1 TwE only the expression of some 
markers common for neural and neural crest progenitors and thus, drives cells 
towards a phenotype that resembles neural crest. 
 
 
R1.10 Mesenchymal-like Cells under TwE and BMP4 Influence 
 
R1.10.1 TwE Blocks Primitive Streak fate. 
 
In the previous section I showed that TwE and BMP4 have opposing effects on 
neural differentiation. On the other hand, BMP4 is one of the key signalling 
molecules involved in PS formation and essential for T (Brachyury) upregulation 
[Winnier et al, 1995].  
 
When PS markers Eomes and T were analysed during monolayer neural 
differentiation it was observed that they undergo only a minor upregulation in control 
conditions, but this is significantly enhanced by BMP4. This enhancement is blocked 
by TwE induction, indicating that cells induced in the presence of both BMP and 
TwE do not turn on the PS program [Fig R1.18]. 
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R1.10.2 Not BMP4 but TwE Induces EMT. 
 
In vivo PS formation is accompanied by overt EMT as the epiblast cells begin 
their migration to form the mesodermal and enodermal germ layers [Arnold and 
Robertson, 2009]. Interestingly, an EMT event could not be observed in response to 5 
ng/ml BMP4 during monolayer differentiation in spite of PS marker upregulation. On 
the contrary, when cell morphology was analysed, it was observed that until Day3, 
BMP4 induces formation of tight colonies, more or less indistinguishable from those 
formed during neural differentiation. Starting on Day 4, the clusters of compact cells 
begin to be surrounded by large epithelial cells with a polygonal morphology [Fig 
R1.19b, yellow arrows]. On the other hand, in TwE induced samples an early 
formation of mesenchymal like cells with reduced cellular contacts can be observed 
[Fig R1.19a and b, orange arrows]. By Day 4, these cells cover almost the entire 
surface of the well. Depending on the experiment, the epithelial polygonal cells in the 
+Dox condition are either completely absent or greatly reduced.  
 
Previously Twist1 had been reported to drive loss of CDH1 [Yang et al., 2004]. 
I was not able to test this feature for TwE during neural differentiation since in this 
context CDH1 is normally replaced by CDH2. Here CDH1 is maintained by BMP 
and, TwE influence could be investigated. For this purpose, cells were stained for 
CDH1 on day 4 of differentiation. In the absence of Dox, polygonal cells stained 
brightly, CDH1 marking the membrane and, making the points of cellular adhesion 
readily observable. By contrast, in Dox treated samples CDH1 signal was very weak, 
it did not localize at the membrane and cellular contacts could not be visualised [Fig 
R1.19c]. 
 
These data indicates that in the context of in vitro monolayer differentiation 
BMP induces markers of PS but fails to generate overt mesodermal cells with 
mesenchymal characteristics. On the other hand, TwE blocks upregulation of PS 
markers, but induces formation of morphologically recognizable mesenchymal cells. 
Furthermore, marker analysis has indicated that these cells had a neural crest like 









Figure R1.18. TwE blocks BMP4 induced primitive streak fate.  
 
Cells differentiated for 5 days in N2B27 with or without BMP4 (5ng/ml) and Dox. 
qPCR analysis shows that BMP4 induces upregulation primitive streak markers 
Eomes (a) and Brachyury (b) and that this event is negatively influenced by TwE. 
Expression in ES cells has been arbitrarily set to 1, except for Brachyury which was 
unfetectable in ES cells. For this marker Day2 condition (-)BMP (-)Dox which was 
the lowest detectable condition and was set to 1. One experiment performed in 






















































Figure R1.19. TwE blocks formation of epithelial cells induced by BMP4.  
 
Cells differentiated in N2B27+BMP4 (5ng/ml) for 3 days (a) or 4 days (b and c). At 
day 4 BMP4 induces formation of epithelial cells (yellow arrows), but this is blocked 
by TwE which induces instead formation of mesenchymal like cells starting at day 3 
(orange arrows). CDH1 is lost from cell surface in samples where TwE was induced 






























R1.11 Twist1 Is Not Required for Early Neural Progression. 
 
After showing that TwE facilitates progression through neural differentiation 
and can partially rescue this type of differentiation against BMP inhibition, the next 
question to ask was if Twist1 is required for neural induction. 
 
For this purpose I employed the method of siRNA directed against Twist1. Four 
siRNA constructs were tested and the two with the best knockdown were 
subsequently used. Cells were transfected with the siRNA according to manufacturer 
protocol at the beginning of neural differentiation; siRNA used: Twist1 construct1, 
Twist1 construct4 and Control a siRNA which does not target any known gene. RNA 
knockdown was good after the first 24 hours, close to 90% and, was gradually lost, 
cells reverting to levels of Twist1 close to physiological ones, by day 3 [Fig R1.20a]. 
When early neural markers were tested: Sox1, Zfp521 and Zeb2 [Fig R1.20b to d], it 
was found that they all progressed through neural differentiation with a dynamic 
similar to control. 
 
A negative result in a siRNA experiment is hard to interpret, due to the 
difficulties in estimating what is the knockdown level which should produce 
phenotypical consequences and, for how long should the knockdown be maintained. 
On the other hand it is conceivable that BMP blocks multiple targets when inhibiting 
neural differentiation and the data presented in this chapter supports the notion that if 


















Figure R1.20. High levels of Twist1 RNA are not required for neural 
differentiation.  
 
ES were differentiated for 3 day in the neural monolayer protocol and treated either 
with control siRNA or with siRNA constructs directed against Twist1. qPCR for 
Twist1 (a), Sox1 (b), Zfp521 (c) and Zeb2 (d). Expression for each gene in day1 
control conditions has been arbitrarily set to 1. One experiment performed in 













































In the present chapter I started from the observations that Twist1 is expressed in 
ES cells, that it is upregulated during neural differentiation and that, as a partner of E 
proteins is a putative target for BMP/ID pathway. I complemented these observations 
with the notion that within the pluripotent cell compartment it is upregulated at the 
exit from the ground state and that, later on, it is associated with neural differentiating 
cells. 
 
By using an ID resistant and inducible active form of TwE I made the striking 
observation that neural differentiation is accelerated both at the point of entry and exit 
from neural progenitor state, that TwE enhances an EMT process specific to neural 
differentiation and that TwE can partially rescue the BMP imposed block on neural 
differentiation, although this was most striking at low doses of BMP. An important 
point is that Zfp521 expression can be fully rescued with no positive influence on 
Sox1 [Fig R1.16a and b]. It has been previously reported that when overexpressed 
Zfp521 rescues Sox1 expression from BMP inhibition [Kamiya et al, 2011]. It can be 
inferred that either Zfp521 requires very high, non-physiological levels to induce 
Sox1, or that TwE induces other phenotypic changes which makes Sox1 not 
responsive to Zfp521 induction  
 
Another interesting observation was the fact that in the presence of BMP, TwE 
induces the formation of a mesenchymal like cell type which is not generated through 
a PS intermediate state. Furthermore, to this cell type the choice seems to be open 
whether to adopt a neural fate or to remain mesenchymal. In recent years a neural-
mesenchymal progenitor has been described, residing at the node/streak border, 
namely, at the edge of BMP signalling [Tzouanacou et al, 2009]. On the other hand it 
should be noted that neural crest cells are also at a crossroad between neural and 
mesenchymal fates, that they require BMP signalling and that, TwE induces the 
upregulation of a number of neural crest markers, both in the presence and in the 
absence of BMP.  
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Regarding the initial hypothesis, according to which Tw-E dimer function as a 
neural inducer, it can be considered that the data presented here serves more to refute 
than to support it.  
First, the fact that TwE accelerates neural differentiation could label TwE as a 
neural facilitator. However, in vivo, acceleration of neural differentiation has 
disastrous consequences, usually resulting in smaller brains, improperly patterned 
[Kageyama et al, 2005]. Thus, it is reasonable to infer that neural induction relies on 
transcription factors which do not risk accelerating the neural differentiation, and 
above all, not accelerating the exit from neural progenitor state.  
Second, moderately high levels of BMP are able to block neural differentiation 
in the presence of TwE, at least in certain key aspects. 
Third, early neural differentiation can progress unhindered, in the presence of 
Twist1 siRNA. 
 
Taking into account the above considerations, it becomes essential to ask 
whether Twist1 has a physiological role in neural differentiation in vivo; and what 























Figure R1.21. Schematic Conclusions 
 
TwE might facilitate pluripotent cells entry to the neural program, while strong 
evidence support the idea that it accelerates the exit from neural progenitor state, 
towards postmitotic neurons. TwE partially blocks BMP4 activity on neural 
































IV. RESULTS 2 





As discussed in the previous chapter, BMP and ID inhibit neural differentiation 
and, one of their putative targets in the process is the TWIST1-E dimer. A 
constitutively active form of TwE can accelerate neural differentiation and partially 
rescue neural induction after blockade by BMP. However, it is not easy to infer from 
the in vitro work presented how TwE normally integrates in the general process of 
neural induction and development.  
 
Interestingly, knockout studies showed that the absence of Twist1 leads to 
failure in anterior neural tube closure, followed by severe malformation of the 
developing brain [Chen and Behringer, 1995]. However, expression studies showed 
that while Twist1 is strongly expressed in the head mesenchyme it is absent from the 
neural tissue [Stoetzel et al., 1995; Füchtbauer E.M., 1995].  
 
A detailed analysis of neural tube development in Twist1 mutant mice revealed 
defects of dorso-ventral patterning at the level of anterior neural tube. The study 
concluded that these defects, which consist mainly of a dorsal expansion of ventral 
marker domains, at the anterior level, are due to non-autonomous influences from 
surrounding mesenchyme [Soo et al, 2002]. However, a mechanism for such an 
influence has not been proposed. Moreover, the ventral neural tissue, which is closest 
to the mesoderm, develops relatively normally, while the pernicious effects of Twist1 
absence are cast on the dorsal neural tissue. Currently, no explanation has been 
provided for this phenomenon. 
 
In this chapter I investigate potential Twist1 roles on dorso-ventral patterning of 
the neural tube. I investigate Twist1 expression in the gastrulating embryos, with an 
emphasis on neural tube and compare the results with the already published data on 
this issue. Finally, based on in vitro mixing differentiation experiments, I propose a 
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R2.2. TwE Biases Neural Differentiation Towards Dorsal. 
 
I presented, in the previous chapter, data showing that TwE enhances the 
expression of neural markers both in the absence and in the presence of exogenous 
BMP. Furthermore, when these markers were analysed based on their dorso-ventral 
positioning it was observed that only dorsal markers were upregulated, while the 
ventral ones were downregulated. 
 
Fig R2.1 presents a synopsis of these markers at day 4 of differentiation in the 
absence of BMP: Sox9 (a), Ascl1 (b), Atoh1 (c), Pax3 (d), Pax6 (e) and Shh (f). 
Dorsal markers like Sox9, Ascl1, Atoh1 are upregulated while, Pax6 which has its 
domain immediately ventral to the Ascl1/Atoh1 markers is downregulated. The 
ventral morphogen Shh is downregulated, as well. Pax3, which is a dorsal marker, is 
downregulated, by this has already been explained as a biphasic action of TwE on this 
marker. Across three repeat experiments only Atoh1 upregulation and Pax3 
downregulaton was statistically significant. More repeat experiments are probably 
required to assert statistical significance for the other markers. A diagram of dorso-
ventral distribution of these markers from Liu and Niswander, 2005 is presented [Fig 
R2.1g]. 
 
While it is possible that all the actions reported for the TwE dimer represent 
artificial phenomenons, with no physiological significance, it is quite a coincidence 
that dorsal markers should be upregulated, connecting TwE activity with reported 
patterning and neural tube closure defects. Therefore a physiological role for Twist1 
becomes more likely and I set out to investigate its expression and mechanism of 







R2.3. Twist1 Begins to Be Expressed in The Embryo around 
Gastrulation. 
 
As stated earlier, Twist1 is expressed in ES and neural differentiating cells. 
Aliaxandra Radzisheuskaya, in Lowell lab, compared Twist1 levels of expression in 
ES cells to those in the whole embryo at different stages and found, that until 
gastrulation, expression in the embryo is lower than in ES cells, that it reaches the ES 
cells level between 6.5 and 7.5 dpc and then, continues to increase sharply until 9.5 
dpc when it reaches the maximum [Fig R2.2]. 
 
These data is consistent with the previously reported expression pattern, which 
showed that Twist1 expression begins at gastrulation [Stoetzel et al., 1995; 
Füchtbauer, 1995]. However, it is harder to explain why expression in ES cells should 
be higher than in peri-implantation blastocyst: 10 fold higher than at 5.5 dpc while, at 
4.5 dpc is virtually undetectable. The most obvious explanation would be that some 
element in the artificial environment of ES cells brings about this expression of 
Twist1. On the other hand, it should be noted that the expression in the blastocyst is 
more similar with that in 2i conditions, although 2i also represents an artificial 
context, where pluripotency is maintained by small molecule inhibitors. 
 
 
R2.4 Twist1 Is first Expressed at Streak Stages. 
 
To clarify any potential points of controversy, I wanted to confirm Twist1 
expression in early embryos by whole mount in situ hybridization, an analysis which 
has already been performed in the past [Wolf et al, 1990; Ang and Rossant, 1994; 
Stoetzel et al., 1995; Füchtbauer, 1995]. An overview of the finding in these studies is 









Figure R2.1. TwE induces a dorsal phenotype during neural 
differentiation. 
 
qPCR showing expression of Sox9 (a), Ascl1 (b), Atoh1 (c), Pax3 (d), Pax6 (e) and 
Shh (f) in ES cells and cells at day 4 of neural differentiation in monolayer protocol. 
Cells were either not induced: (-)Dox, or induced throughout differentiation: (+)Dox. 
For each gene the expression in ES cells has been arbitrarily set to 1. For Sox9, Ascl1, 
Atoh1, Pax3 and Pax6 triplicate experiments performed in duplicates are shown. 
Error bars represent standard deviation of the mean. For Atoh1 p = 0.005, for Pax3 p 
= 0.01. For Shh one experiment performed in duplicates is shown. Error bars 
represent value range. Schematics of antero-posteriom neural marker distribution in 
the mouse spinal cord, adapted from Liu & Niswander, 2005. Red circle represents 




































Figure R2.2 Twist1 is expressed in ES cells at low levels.  
 
qPCR for Twist1 for ES cells, whole embryos from 4.5 dpc to 10 dpc and decidua. 
(Aliaxandra Radzisheuskaya). The expression in ES cells has been arbitrarily set to 1. 











































To this end I generated a Twist1 RNA complementary probe as described in 
Material and Methods (M1.3.3). The probe, of approximately 870bp in length, was 
design to target the 3’UTR to avoid any conserved regions homologous with other 
bHLH factors and, encompasses the sequence of the shorter probe described in Wolf 
et al, 1990. 
 
At 6.5 dpc, pre-streak/early-streak stages the embryo lacks any signal even after 
being developed for 48 hours [Fig R2.3a]. A signal was first observed around 7.5 dpc 
in mid-streak embryos as weak and diffuse staining, probably of mesodermal cells 
which migrated through the primitive streak. The signal becomes stronger and more 
condensed as the embryo progresses towards late streak and early bud stages [Fig 
R2.3b]. As the signal becomes stronger it is apparent, that at these stages, it is 
restricted to mesoderm of the embryo proper and the allantois [Fig R2.3e and f]. 
 
As the embryo progresses towards the late bud stage (8.0 dpc), the signal 
becomes suddenly quite strong. Twist1 expressing cells accumulate mainly in the 
anterior mesoderm and allantois [Fig R2.4a]. Slightly later (early 8.5 dpc), at the 
head fold stage, the signal in the prospective head mesenchyme is very strong. In the 
same time, distal and posterior mesoderm becomes clear. The epiblast, which on the 
anterior side has now transformed to neural folds, is also clear of any discernable 
staining [Fig R2.4b, c and d]. The black arrow, in Fig R2.4b, indicates the 
proximal/distal limit of the signal. The few positive cells which seem to be posterior 
and proximal [Fig R2.4b, yellow arrow] are an artefact resulted from superimposition 
of cells from the anterior mesenchyme of an embryo which could not be perfectly 
aligned for viewing from the lateral perspective. This can be observed better in Fig 
R2.4d which presents the posterior view. Here it is clear that the whole posterior 
region is devoided of signal. The only other positive region besides anterior 
mesenchyme and allantois is represented by a bilateral string of extra-embryonic 












Figure R2.3. Twist1 is expressed in the mesoderm starting at mid streak 
stages.  
 
Whole mount in situ hybridization for Twist1 of post implantation embryos. Pre-
streak embryos (a), group of embryos arranges from left to right mid streak to early 
bud (b) and individual embryos: late streak (c) early bud (d, e and f). Last to pictures 
present the same embryo: anterior view (e) and lateral view (f). Blue arrows indicate 
allantois, yellow arrows indicate a patch of positive cells in the mesoderm lateral of 

















































Figure R2.4. Head mesenchyme the first embryonic domain of high 
Twist1 expression.  
 
Whole mount in situ hybridization for Twist1 of embryos around head fold stage. Late 
bud stage (a), head fold stage (b, c and d). Head fold stage same embryo lateral view 
(b), anterior view (c) and posterior view (d). Black arrow marks the anterior distal 
limit of the Twist1 signal. Yellow arrow points to lateral mesoderm cells which seem 
to stretch to the PS. Red arrow shows in posterior view that the only cells which 
stretch towards posterior underline the extraembryonic amnion. Blue arrow indicates 





































The data presented in this section correlates well with the previous in situ data, 
as well as with the results from whole embryo RNA expression. Initiation of 
expression, which has been previously placed at the rather loose time point of 7.5 dpc 
[Stoetzel et al., 1995; Füchtbauer, 1995] has now been narrowed to the mid to late 
streak-stage. I was able not only to confirm the strong expression in the anterior, 
prospective head, mesenchyme, but also to show downregulation, at the head fold 
stage, of Twist1 from the posterior mesoderm. 
 
R2.5 Twist1 Expression in The Primitive Streak Controversy 
 
While Twist1 expression in the mesoderm is undisputed, the moment when 
Twist1 begins to be expressed in a mesoderm cell enjoys less consensus. Füchtbauer, 
1995 reported that only cells “at a distance from PS” express Twist1, while Stoetzel et 
al., 1995 reported Twist1 expression in the PS, see Appendix 2. 
 
When studying Twist1 expression in embryos of all relevant stages, I could find 
no evidence that this marker is present in the PS.  
 
First, Twist1 is upregulated very weakly, after PS formation and, at this point, 
the staining is not confined or even apparent in PS. Thus, it is clear that at least for the 
early cells migrating from the PS, Twist1 upregulation is a subsequent event, which 
probably correlates with the differentiation of these cells. 
 
Second, at the bud stage, when staining becomes more convincing it is possible 
to tilt the embryo so that mesodermal signal would appear as located in the epiblast. 
Yellow arrow in Fig R2.3e points to a group of positive cells, which in the frontal 
view, can be easily identified as mesoderm cells. However, if the embryo is rotated to 
lateral view, the usual way of imaging embryos, the same signal seems to come from 
the epiblast [Fig 2.3f].  
Fig R2.4a shows a late bud stage embryo with what appears to be strong 
staining in the posterior epiblast. This image is similar with images in the literature on 
which Twist1 PS expression claim is based. However, this again, is just 
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superimposition of lateral planes, as all embryos appear clear when viewed from 
posterior [Fig R2.4d]. Furthermore, if one wants to recognize that signal as real 
epiblast signal, one would have to consider the fact that immediately adjacent 
mesoderm cells are negative and hence, infer that mesoderm cells downregulate 
Twist1 when migrating from the epiblast. Thus, according to such a theory, Twist1, an 
EMT inducer, would be expressed in the epithelial epiblast and downregulated as 
soon as mesodermal cells begin their migration. 
 
Third, Füchtbauer, 1995 showed the absence of Twist1 on transverse sections, 
while no such sections have been published by the proponents of Twist1 expression in 
PS. 
 
Moreover, even in cephalochordate, the evolutionary precursor of vertebrates, 
twist homologue is not expressed “during initial mesoderm formation … unlike in 
Drosophila” [Yasui et al., 1998]. This suggests that Twist1 expression later in 
mesoderm differentiation is a feature conserved in the chordate branch of evolution. 
 
However, since the question of Twist1 expression in PS is not central to my 
project, I did not pursue this matter any further, as deciding beyond any doubt would 
require careful sectioning of all stages from streak to head fold. It is regrettable, 
though, that most authors, considering Twist1 as a mesoderm marker accept its 
expression in PS on insufficient evidence. 
 
 
R2.6 Twist1 Expression during Somitogenesis 
 
As somitogenesis begins and the embryo starts to turn, the main difference in 
Twist1 expression is represented by the new signal domain which now comes from 
the somites and the mesoderm cells condensing to form a new somite [Fig R2.5]. The 
distal limit of Twist1 expression domain, has now transformed into a posterior limit 
[Fig R2.5, black arrow; see also Fig R2.6b]. The positive extraembrionic mesoderm 
is connected by two strings of lateral mesoderm, the only portion of the embryo 







Figure R2.5. New Twist1 domains: somites and lateral mesenchyme.  
 
Whole mount in situ hybridization for Twist1 of embryos at early somitic stages. 3 
somite stage (a), 6 somite stage (b and c). C presents lateral view of the embryo in b. 
Black arrow indicated the caudal limit of Twist1 domain, which corresponds to the 
point to which somitogenesis has progressed. Red arrow points to the head 
mesenchyme. Yellow arrow points to neural folds. Blue arrow shows the base of the 














































Head mesenchyme continues to express strongly especially under the neural 
folds [Fig R2.5a and b]. The ectoderm remains negative, including the neural 
ectoderm. 
 
As the first branchial arch is formed it represents a new domain of Twist1 
expression, where at this stage, the signal is stronger than in any other structure. The 
ectoderm of the branchial arch is negative and, can be seen as a translucid hallo 
surrounding the arch [Fig R2.6 red arrows]. 
 
Since the purpose of this experiment was to identify any signal in the neural 
tissue, which was assumed to be very weak, if at all, or else it would have already 
been reported, embryos were developed for 48 hours, a time at which most strongly 
positive structures were saturated. Fig R2.6b and c shows two embryos of close age. 
The embryo in (c) has only been developed for 4 hours. Here the difference in 
intensity between the fist branchial arch and the rest of the positive structures can be 
seen more clearly. 
Interestingly, all previously reported expression domains can also be 
distinguished with this shorter developing time. Furthermore, a subset of heart 
mesenchyme, which is positive for Twist1 can observed. 
 
At 9.5 dpc [Fig R2.6d] the signal continues to be strong without any major 
changes in the domains of expression. 
 
The body of data presented in this section, largely confirms the previously 
published information on Twist1 expression in mouse development. Some 
clarifications have been produced on small points while, no indication could be 













Figure R2.6. Twist1 expression remains constant for later stages.  
 
Whole mount in situ hybridization for Twist1 of embryos at mid and late somitic 
stages. 8.5 dpc turning embryos (a, b and c). 9.0 dpc embryo (d). C presents an 
embryo developed for shorter time. Black arrow indicated the caudal limit of Twist1 
domain, which corresponds to the point to which somitogenesis has progressed. Red 
arrow indicates the clear ectoderm surrounding the cells which express Twist1 at very 
high levels in the brachial arch. Yellow arrow indicates the Twist1 positive cells in 






























R2.7 Twist1 Is Weakly Expressed in Dorsal Neural Folds. 
 
Since Twist1 appeared to be not expressed in the neural tube, even by 
employing the method of extending in situ developing time, transverse embryo 
sections were imaged to confirm or rule out any possible Twist1 signal in neural cells. 
Embryo sectioning was performed by Ronald Wilkie.  
 
One possible problem with whole embryos imaging could have been the fact 
that the strong mesoderm signal might obscure an eventual weaker signal in the 
neural tube. This would be overcome as well by imaging sections. 
 
At the bud stage, section imaging revealed Twist1 expression in the expected 
domains: extraembryonic mesoderm, and embryonic mesoderm lateral of PS [Fig 
R2.7a to g]. 
 
At the somitic stage, expression in the mesodermal compartment is obvious. 
However, now a second weaker domain can be seen in the neural folds. In more 
posterior regions [Fig R2.8a to d], the signal is so weak it can barely be observed, 
appearing more like a shadow on the dorsal side. However, at careful examination, 
this shadow can be clearly distinguished from ventral side which is completely 
staining free. 
As the sectioning plan moves more anteriorly, towards the hindbrain, the signal 
becomes restricted to the dorsal tip of the folds [Fig R2.8e to g]. At this level the 
signal is more evident and individual positive cells can be distinguished: see Fig 
R2.8h presenting a magnification of the tip of the fold in (g). 
 
A few hours later, after the embryo has turned, the neural folds at the spinal 
cord level become clear, devoided of any signal [Fig R2.9a]. On the other hand, at 
the brain level, the signal is now limited to the very edge of the neural fold [Fig R2.9 
b to d and h]. The more posterior regions of the forebrain are the first to close, before 
the more anterior ones. Fig R2.9e to g shows this region as the neural folds are just 







Figure R2.7. Twist1 an early mesoderm marker.  
 
Transverse sections of whole mount in situ hybridization for Twist1 of early bud 
embryo. Sections are arranged from proximal to distal: a to g. Posterior side of the 
embryo is marked with an asterisk. Ectoderm (red arrow), endoderm (yellow arrow). 














































Figure R2.8. Twist1 is weakly expressed in the dorsal neural tube.  
 
Whole mount in situ hybridization for Twist1 of an 8.5 dpc embryo sectioned from 
posterior to anterior (a to g) as shown in (i). Magnification of the box in (g) focussing 
on dorsal neural tube (h). Neural fold (nf, red arrow), somite (so, yellow arrow), head 
















































Figure R2.9. Twist1 signal localizes to the dorsal edges of the neural folds before 
closure.  
 
Whole mount in situ hybridization for Twist1 of an 9.0 dpc embryo sectioned from 
posterior to anterior (a, b and e) as shown in (i). (b) shows a section through hindbrain 
and frontbrain presented at a higher magnification in (c and d) respectively. 
Magnification of the box  in (g) focussing on dorsal neural tube (h). Magnification of 
box showing dorsal neural fold in the hindbrain (h). Consecutive section after (e) 
restricted to the neural folds (f and g). Forebrain (fb, red arrow), hindbrain (hf, yellow 



































Here Twist1 signal is slightly stronger, but restricted to just one or two cell in each 
plane and fold; the cells which most likely are going to be involved in the fusion 
process. 
 
R2.8 TWIST1 Non Autonomous Roles Tested In Vitro 
 
In the previous section I provided evidence for the existence in the neural folds 
of cells which express Twist1 at low levels and which are restricted to the dorsal 
regions. These data make the previously suggested non-autonomous mechanism of 
action no longer obligatory, while raising new possibilities. 
 
However, a non-autonomous role is still possible: that of the influence of neural 
cells expressing Twist1 over neighbouring neural cells, which lack this marker. To 
test this hypothesis an experiment was designed where a mixture of cells inducible for 
the active dimer TwE and non-inducible cells were differentiated together. 
 
First, a TwE inducible cell line was labelled with Tomato fluorescent protein 
localized to the nucleus. For this purpose a plasmid, produced by Frederick Wong in 
the lab of Prof Ian Chambers, containing a CAG-H2B-td Tomaoto-Ires-Puromycin 
construct was used. Since the cells I intended to label, the doTE77 line, already 
contained a Puromycin resistance gene, I replaced the Puromycin selection cassette, 
with Hygromicin, in the mentioned plasmid, as described in Material and Methods; 
resulting plasmid is presented in Fig R2.10a. 
 
Using this plasmid to transfect TwE inducible cells resulted in generation of 
double resistant cell lines containing pCAG-Puro-TetO-TwE and pCAG-H2B-
Tomato-IRES-Hygro. A cell line, called doTE77T2 which expressed Tomato in every 
cell was used [Fig R2.10b]. This cell line had a similar response to Dox induction 












Figure R2.10. Tomato labelling of TwE inducible cells 
 
Schematic representation of the plasmid used for labelling TwE inducible cells (a). 
Subclone T2 of clone doTE77 expresses Tomato in all cells. Fluorescence: left 
















































Figure R2.11. Diagram of cell mixing experiments strategy.  
 
TwE inducible ES cells labelled with Tomato, clone doTE77T2 were mixed  1:1 with 
Sox1-GFP reporter cells, 46c. The mixture of cells was put through neural 
differentiation in the monolayer protocol for 4 day, a time point at which the majority 
of 46c cells were expressing GFP. The two population were separated by FACS and, 














































Fig R2.11 shows the experimental design for cell mixing differentiation. 
Briefly, TwE inducible, Tomato labelled cells were mixed with Sox1-GFP, 46c cell 
line [Ying et al, 2003b], in a ratio of 1:1 in N2B27 with or without Dox. After 4 days 
of differentiation, the majority of 46c cells express GFP, indicating that they 
underwent neural differentiation. The two cell lines were once again separated by 
FACS, based on red fluorescence and, RNA extracted from each cell population. 
 
 
R2.9 TwE Does Not Accelerate Neural Differentiation Non-
Autonomously. 
 
At the first analytic step of the experiment: cell separation based on flow 
cytometry after 4 days of differentiation, it was observed that the presence of TwE 
cells did not generally alter the process of neural differentiation in the neighbouring, 
non-inducible cells. Sox1, as reported by GFP was upregulated in 46c cell line in a 
similar percentage of cells and at the same level, regardless whether the neighbouring 
cells were induced or not for TwE [Fig R2.12]. 
 
However, a subtle but interesting phenomenon was observed at the level of the 
cells which upregulated Sox1 at very low levels or did not upregulate it at all. When 
TwE was induced, there was a clearer separation between GFP+ and GFP- cells in the 
46c line [Fig R2.12b and c black arrows]. This could indicate that TwE expressing 
cells “help” other differentiating cells to make a decision between neural and non-
neural and, is consistent with Twist1 being expressed in cells close to neural/surface-
ectoderm border. 
 
Next, neural induction/differentiation markers in the two populations were 
analysed by qPCR. For TwE inducible cells, the expected pattern for tested markers, 
as reported in the previous chapter, was observed. On the other hand, no difference 
for any of the markers was seen for 46c cell line when cultured either with TwE 
induced or not-induced cells [Fig R2.13: Twist1 (a), Sox1 (b), Zfp521 (c), Atoh1 (d), 






Figure R2.12. TwE induction does not facilitate non-autonomously 
neural induction.  
 
Flow cytometry of ES cells differentiated for 4 day in the neural monolayer protocol. 
Mixed culture of TwE inducible cells labelled with H2B td-Tomato and 46c-Sox1-
GFP cells. Pseudocolour blot of uniduced samples (a) and induced samples (b). 
Ellipses for (a) and (b) indicate populations which were sorted as Tomato positive 
(green arrows) and Tomato negative (red arrows). Vertical bars in the lower ellipses 
indicate the GFP 15% lowest and highest population respectively. In induced samples 
the GFP negative and positive population are better separated (black arrow), but the 
overall GFP positive population is not shifted. Histogram of the non-red population 
only (c). Vertical bars indicate gating for the GFP negative, low and high populations 
respectively. Percentage of GFP neg and GFP low cells in uninduced and induced 
samples respectively from the histogram (c) are presented in (d). Error bars represent 












































Figure R2.13. TwE does not influence neural differentiation non-autonomously.  
 
qPCR for Twist1 (a), Sox1 (b), Zfp521 (c), Atoh1 (d), Pax3 (e) and Sox9 (f) for sorted 
TwE inducible and Sox1-GFP reporter cells after 4 days of coculture in neural 
differentiation conditions. For each gene, expression in Sox1-GFP reporter cells in 
the Dox not-treated condition has been arbitrarily set to 1. One experiment performed 







































Figure R2.14. TwE does not recapitulate non-autonomously its 
autonomous influence on neural differentiation.  
 
qPCR for Sox1 (a), Zfp521 (c), Sox9 (c) and Pax3 (d) for sorted TwE inducible and 
Sox1-GFP high and low cells after 4 days of coculture in neural differentiation 
conditions. For each gene, expression in TwE inducible cells in the Dox not-treated 
condition has been arbitrarily set to 1. Error bars represent standard deviation of the 
mean for two biological replicates. One experiment performed in duplicates is shown. 











































The data indicate that there is no modification in neural progenitor dynamics 
(Sox1 and Zfp521), no early entry to mature cell phenotype (Sox1, Atoh1), and no 
dorso-ventral bias (Atoh1, Pax3 and Sox9) induced by TwE on Sox1-GFP cells. 
 
There was a possibility that the absence in marker expression change was due to 
an upregulation, for instance, in the GFP high population, masked by a 
downregulation in the GFP low population. To test for this hypothesis a similar 
experiment was designed, where the Tomato negative cells were sorted based on the 
15% highest and lowest GFP expression. In this case, clear differences could be seen 
between GFP high and low population but not between non-inducible cells 
differentiated in the presence or absence of Dox [Fig R2.14].  
 
This experiment confirms that the presence of TwE expressing cells does not 
alter in vitro neural differentiation in the neighbouring cells. 
 
 
R2.10 TwE Non-Autonomously Influences Fate-Choice 
Decisions 
 
Analysis of Sox1GFP expression which indicated that there might be a bias in 
fate decision [Fig R2.12] was somewhat contradicted by qPCR analysis of 
differentiation markers in sorted populations, which showed no difference in 
expression of neural marker brought about by non-autonomous expression of Twist1 
[Fig R2.13]. There was a possibility that the effect noticed by flow cytometry as a 
population shift was too small to have any phenotypic significance. However, taking 
into consideration the Twist1 expression at the dorsal edge of the neural fold, there 
was a possibility that, from that position it might influence the fate choice between 
neural crest and surface ectoderm, and not neural differentiation per se. I therefore, 










Figure R2.15. TwE non-autonomously stimulates the neural 
differentiating population to adopt a neural crest fate.  
 
qPCR for Wnt1 (a and c) and Gata2 (b and d) for sorted TwE inducible and Sox1-
GFP high and low cells after 4 days of coculture in neural differentiation conditions. 
For each gene, expression in TwE inducible cells in the Dox not-treated condition has 
been arbitrarily set to 1. Error bars represent standard deviation of the mean for two 
biological replicates. For each graph one experiment performed in duplicates is 











































Upregulation of Wnt1 is one of the most specific markers of neural crest cells 
which are preparing to delaminate from the neural tube [Echelard et al., 1994; Chai et 
al., 2000], while Gata2 is a marker of surface ectoderm [Sheng & Stern, 1999; Basch 
et al., 2006].  
 
When Wnt1 was tested I found it to be markedly upregulated in 46c cells 
differentiated in the presence of TwE expressing cells. On the other hand, Gata2 was 
downregulated in 46c line under TwE expressing cells influence [Fig R2.15a and b]. 
 
Furthermore, when tested against populations separated based on GFP 
expression, Wnt1 was found to be specifically upregulated in the neural 
differentiating cells, but downregulated in cells which failed to turn on Sox1. On the 
other hand Gata2 was downregulated only in Sox1 high cells but permitted in Sox1 
low cells [Fig R2.15c and d]. 
 
Together, these data reveal that TwE expressing cells could have a fate choice 
influence, consistent with their potential location at the border between neural 
ectoderm and surface ectoderm. Thus, TWIST1 can non-autonomously upregulate 
Wnt1 and suppress Gata2 in neighbouring neural cells. On the other hand, surface 
ectoderm cells, which are present close by, have their fate safeguarded by Wnt1 
suppression and Gata2 expression. 
 
However, upregulation of Wnt1, a neural crest marker and, dorsal morphogen, 
did not induce upregulation of other neural crest markers like Sox9 or Pax3. One 
explanation is that in the course of the in vitro differentiation there was not enough 
time for Wnt1 to influence cell fates. However, another explanation could be that 
Pax3 and Sox9 being expressed before Wnt1 are not downstream the latter gene, or 
that WNT1 requires other partners, like BMP, absent from the artificial cell culture 









In this chapter I started from the observation that TwE induction has a 
dorsalizing effect on neural differentiation as assessed by marker expression level. 
 
Then, I challenged the idea that Twist1 is absent from the neural tissue and, 
showed that it is expressed at low levels in a time and domain restricted manner. It 
starts by being expressed in the dorsal parts of the neural folds both in the brain and 
in the spinal cord; expression in the spinal cord being weaker and more diffuse. As 
the neural folds prepare for the fusion process, Twist1 expression is lost from the 
spinal cord and is gradually restricted more dorsally in the prospective brain until 
only the cells in the fusing margins still express this marker. I showed that this weak 
and restricted expression cannot be observed in whole embryos and that on sections 
was only detected due to being purposefully looked for and, by using a staining 
saturating technique. This may explain why this expression domain has not been 
reported previously in the literature 
 
Finally, based on in vitro differentiation experiments I proposed a role for 
Twist1 expressing cells, concerning cell fate decisions at the border between neural 
and surface ectoderm. I also showed that although TwE has a dramatic and, one might 
even call it devastating, effect on neural differentiation in the cells in which it is 
expressed, it does not seem to have a readily observable effect on neural 
differentiation in neighbouring cells, at least not for markers tested here. 
 
Twist1 is a well known neural crest marker and in my experiments it mildly 
increased Wnt1 expression autonomously and, markedly non-autonomously. A 
question here rises if Wnt1 in neural crest cells might be downstream of Twist1; in 
which case Twist1 should be expressed in neural crest cells before their delamination 
from the neural tube. The large number of neural crest cell leaving the neural tube 
stand in stark contrast with the very few cells expressing Twist1. On the other hand, it 
is possible that neural crest cells upregulate Twist1 at, or around the time of 
delamination from the neural tube. Since this is a sudden process in the brain I would 
have missed it in my analysis. A much more detailed investigation of the stages from 
 235 
neural fold to mid somitogenesis stages would have been required. It should also be 
noted that Twist1 can be observed as soon as the neural crest domain forms outside 
the neural tube, indicating that this marker is either upregulated at the time of 
delamination or, immediately after. 
 
I propose a mechanism, in which a subset of dorsal neural cells upregulate 
Twist1 before anterior neural tube closure, around the time of neural crest 
delamination. They stabilize the neural program in the neighbouring cells by 
downregulating Gata2, strengthen the dorsal identity by inducing Wnt1 while 
autonomously upregulating dorsal markers like Pax3 and Sox9. The later neural crest 
marker Sox10 is not upregulated as these cells are not necessarily fated to become 
neural crest. Then, the cells which are to remain in the neural tube, downregulate 
Twist1, before Pax3 and Sox1 would be negatively influenced and, the exit from 
neural progenitor state risked. 
 
The data presented in this chapter highlights an important question: “why is 
Twist1 expressed at much lower levels in neural versus mesoderm tissue?” I will 


















Figure R2.16. Schematic Conclusions  
 
Twist1 is expressed in the developing neural tissue in very restricted manner in time 
and space. Its expression can only be detected after the head fold stage and is lost as 
soon as the anterior neural folds fuse (a). It is of note that before the fusion of the 
anterior neural folds, Twist1 can be observed at the trunk level as well, but the 
expression in this domain ceases even before the expression in the anterior. In vitro 
data suggest that active TWIST1 favours neural dorsal fate on the expense of both 





























V. RESULTS 3 





Pluripotency is a cellular state which can be maintained indefinitely in vitro, but 
exists only briefly in vivo. Both in vivo and in vitro transcriptional mechanisms exist 
which allow a cell to follow its developmental program through differentiation 
[Chambers et al., 2003; Ying et al., 2008]. Such transcriptional effectors should be 
able to induce differentiation, but are kept inactive in pluripotent cells. In Results_1 I 
analyzed the possibility that the transcriptionally active TwE functions in the 
induction of neural differentiation from pluripotent cells. The work had been based on 
Twist1 expression in ES and differentiating cells as well as on the notion that in the 
absence of BMP signalling, TWIST1 partner choice would be biased towards 
formation of TW-E dimers. Using a cell line in which TwE could be induced at levels 
comparable with observed Twist1 upregulation during in vitro neural differentiation I 
noticed an acceleration of neural differentiation in response to TwE. A partial rescue 
of neural differentiation against BMP4 was also effected by TwE. 
 
Expression analysis in the mouse embryo, as described in Results_2, indicated 
that Twist1 is not expressed in pluripotent epiblast cells. One possibility would be that 
Twist1 expression in ES cells is simply a cell culture artefact and is not informative in 
respect to any physiological process. However, there is still a possibility that while 
not usually involved in early differentiation events, Twist1 could be recruited to such 
an end, in special circumstances, as might be the case of in vitro differentiation. 
Either way, Twist1 presence in ES cells indicates that, at least at certain levels, it can 
be tolerated without compromising the pluripotency. 
 
Furthermore, at somitogenesis Twist1 is massively upregulated, over 100 fold 
compared to ES cells, by whole embryo mRNA levels. When in situ data is taken into 
consideration it has to be concluded that this upregulation is generated mainly by the 
mesenchyme. On the other hand, high levels of Twist1 have not been observed either 
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in vivo or in vitro in pluripotent or neural differentiating cells. High Twist1 levels 
could simply be a molecular mark of the mesenchyme. An alternative hypothesis 
would be that pluripotency cannot be maintained if Twist1 is expressed beyond a 
certain threshold. Moreover, the neural differentiation program might be incompatible 
with high levels of Twist1. 
 
Following the above considerations I asked the questions whether:  
 
1. High, but still physiological levels of active Twist1 are capable of forcing the 
exit from pluripotency? 
2. Twist1 high levels of activity could bias differentiation away from the neural 
program towards mesenchyme? 
 
By physiological levels of Twist1 I understand levels of expression not 
exceeding expression observed in certain cell types, like the mesenchyme.  
 
In this chapter, I analyse the effects of TwE induction at levels, comparable with 
Twist1 levels in the mesenchyme, in pluripotent cell differentiation. I show that high 
expression of TwE is not compatible with maintenance of pluripotency in mouse ES 
cells and, that neural differentiation is blocked. Finally, taking into consideration the 
idea that BMP activity could influence TWIST1 dimer choice I analyse the effects of 
TWIST1-TWIST1 forced dimer (TwTw) in the context of neural differentiation. 
 
 
R3.2 TwE Forces Differentiation of ES Cells. 
 
R3.2.1 Generation and Characterization of ES Cell Lines Expressing 
TwE at Relatively High Levels 
 
Expression analysis indicated that during in vitro differentiation Twist1 mRNA 
levels is upregulated up to 30 fold [Aiba et al., 2009; Lowell lab unpublished data], 
while in whole embryos, at a time when the mesenchyme form an important part of 
the embryo, it is upregulated over 100 fold compared with its expression in ES cells 
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[Fig R2.2a]. In order to test the effects of higher TwE levels it was necessary to 
obtain clones which could be induced to express the transgene at higher levels, which 
would reflect more closely the expression levels in the mesenchyme. I inferred that 
the reason behind the difficulty of obtaining TwE high level inducible clones was the 
potential leakiness of a pluripotency detrimental factor. In order to mitigate this 
phenomenon, I isolated new clones, supplementing the standard ES cell media with 
PD0325901, a MAP2K inhibitor. Using this method, I was able to isolate clones 
which stained brightly, albeit still heterogeneously, when screened for Flag 
immunofluorescence, with some of them expressing TwE RNA at higher levels than 
the clone doTE77, used previously [Fig R3.1]. 
 
R3.2.2 TwE Induced Cells Lose ES Cells Morphological Characteristics 
 
In order to test self renewal in defined conditions, cells were established in 
N2B27 supplemented with LIF and BMP4, by being cultured in these conditions for 
two weeks. The cells were passaged every two days. The passage at which Dox was 
first added was considered passage 1. After 48 hours cells were imaged, trypsinized 
and, replated in the same conditions. This was considered passage 2. The procedure 
was continued in the same manner up to passage 4. Details of cell culture procedure 
are presented in M2.2.1 and M2.2.4. 
 
From the first passage it was observed that cells differentiated in response to 
TwE induction. After the first 48 hours of treatment two morphologically 
distinguishable cell populations segregated [Fig R3.2]. These populations consisted 
of cells in tight colonies which resembled pluripotent cells (red arrows), surrounded 
by small mesenchymal like cells which covered the remainder of the available culture 
surface (yellow arrows). This feature was initially similar among multiple clones. 
However, as the cells were passaged, clone doTE155 maintained a relatively stable 
pool of pluripotent cells forming tight colonies. On the contrary, in the case of clone 
doTE171 the pluripotent colonies grew smaller and smaller, and died out by passage 
4. Other clones displayed a phenotype which was in between these two clones, in the 
sense that they were able to maintain some tight colonies, but not as efficiently as 







Figure R3.1. Screening of Twist-E cell lines selected for high induction  
 
Immunofluorescence for two clones: doTE 155 and doTE 171, after 24 hours of 
induction showing heterogeneous expression, including brightly stained cells; red 
staining: Flag, blue: DAPI. Scale bars represent 50 µm (a). qPCR showing expression 
of Twist1 after  24 hours of induction compared to uniduced samples  Expression in 
uninduced cell of clone doTE77 has been arbitrarily set to 1. For each clone one 
experiment performed in duplicates is shown. Error bars represent value range (b). 















































Figure R3.2. Maintenance of TwE inducible clones is dependent on 
transgene silencing.  
 
Phase-contrast pictures of cells passaged in self renewal conditions, N2B27 with LIF 
and BMP4, under continuous Dox induction. Red arrows: colonies of cells with 
pluripotent morphology, Yellow arrows: young differentiated cells, probably 
generated from the pluripotent colonies, Green arrows: old differentiated cells, 
probably generated from parent differentiated cells from the previous passages. 
Passage 1 +Dox (a), passage 2 +Dox (b), passage 3 +Dox (c), passage 4 +Dox (d), 
























Careful observation of what seemed to be differentiating cells indicated that 
they lost their proliferating capacity fairly quickly, as by passage 4 their number was 
greatly reduced in the case of both clones. Furthermore, these cells suffered a 
progressive change in morphology: they became larger and more elongated at later 
passages [Fig R3.2 green arrows]. The observation that even for clone doTE155 
which maintains pluripotent colonies at later passages, the differentiated cells become 
larger and, small mesenchymal like cells could no longer be seen, indicates that these 
cells do not differentiate continuously from the pluripotent pool, but that the 
pluripotent cells adapted and were no longer sensitive to TwE influence. 
 
R3.2.3 TwE Induced Differentiation Is Accompanied by EMT.  
 
TWIST1 is a known EMT effector involved in CDH1 downregulation. 
Furthermore, CDH1 downregulation is a key event accompanying the differentiation 
processes during gastrulation and CDH1 is required in mouse ES cells for LIF 
dependent self renewal. It was reported that CDH1 presence/absence has significant 
transcriptional effects independent of CTNNB1/TCF transactivation [Soncin et al., 
2009; Soncin et al., 2011] and, CDH1 cell to cell contact was found critical for 
induced pluripotent stem cells generation [Zohn et al, 2006; Chen et al, 2010].  
 
Morphological analysis of cells induced for TwE in N2B27 supplemented with 
LIF and BMP indicated that an EMT process was associated with TwE induced 
differentiation. I tested CDH1 expression by immunofluorescence. As expected, only 
cells from the clusters were positive for this marker while no signal was observed in 
the dispersing cells [Fig R3.3], indicating that only the former cells maintained an 














Figure R3.3. CDH1 is not maintained in cells differentiating under TwE 
influence.  
 
Immunofluorescence for the first two passages of TwE inducible clones under Dox 
stimulation; CDH1 – green. Left column phase contrast, right column CDH1/DAPI. 


































R3.3 Pluripotency Can only Be Maintained by Downregulating 
The TwE Transgene. 
 
R3.3.1 Expression of The TwE Transgene and POU5F1 Pluripotency 
Factor Are Negatively Correlated. 
 
To further clarify the effects of TwE on pluripotency I stained cells at passage 1 
and 2 of Dox induction for Flag and POU5F1. POU5F1 only labelled cells from tight 
clusters in the case of both clones, confirming the previous assertion that those were 
the pluripotent cells. Furthermore, for clone doTE155 there was a clear segregation 
where almost no POU5F1 positive cells stained for Flag. Thus, downregulation of the 
transgene seems to be instrumental for pluripotency maintenance for this clone. 
Interestingly, even some of the differentiating cells downregulated the transgene, as 
indicated by existence of POU5F1(-) Flag(-) cells [Fig R3.4]. There is also a 
possibility that the observed phenomenon is due to selection of the cells do not 
express the transgen. 
 
On the other hand, some colocalization of POU5F1 and Flag can be seen in the 
case of clone doTE171 although Flag is weaker in pluripotent cells. Interestingly, the 
differentiating cells express the transgene more strongly and more uniformly than in 
the case of doTE155. At any rate, downregulation of the transgene was not enough 
for this clone to safeguard the fate of pluripotent cells which were rapidly lost [Fig 
R3.4]. 
 
R3.3.2 Differentiation Positively Correlates with TwE Level of Induction. 
 
Next, I confirmed the loss of pluripotency by markers RNA expression. For all 
pluripotency markers tested downregulation is more abrupt in the case clone 
doTE171 than clone doTE155 [Fig R3.5a to c]. It should be noted that Pou5f1 is 
maintained above 50% of uninduced population even for doTE171 at passage 2 when 
very few POU5F1+ cells can be seen by staining, indicating a possible post 
transcriptional control. Fgf5 an epiblast marker, in contrast is upregulated and, as 








Figure R3.4. TwE transgene is not maintained in pluripotent cells.  
 
Immunofluorescence for the first two passages of TwE inducible clones under Dox 
stimulation; Flag – red, POU5F1 – green. Left column phase-contrast, middle column 
















































Figure R3.5. TwE induces transition from pluripotency to differentiation.  
 
qPCR showing expression of ES markers Pou5f1 (a), Nanog (b), Esrrb (c), epiblast 
marker Fgf5 (d), EMT marker Zeb2 (e), early neural marker Zfp521 (f) and 
neural/neural crest marker Pax3 (g), while passaging cells in self renewal conditions 
under the continuous influence of Dox. For each gene the average expression in the 
two clones before Dox induction has been arbitrarily set to 1. For each clone one 



































When markers, which have been previously shown to be upregulated in clone 
doTE77 during neural differentiation (Zeb2, Zfp521, Pax3), were tested, they were all 
found to be upregulated in self renewal conditions as well. Furthermore, doTE171 
upregulated all these markers at higher levels, indicating a correlation with the level 
of induction [Fig R3.5e to g]. 
 
 
R3.4 Immediate TwE Influences on Gene Expression 
 
R3.4.1 Early TwE Induction 
 
In the previous section I showed that TwE transgene is silenced in a significant 
number of cells soon after induction: i.e. passage 1 [Fig R3.4]. This indicates that at 
24 hours, when induction was previously tested important variation in respect to 
initial levels of induction may have already occurred. Preliminary data indicated that 
the transgene might be expressed at the protein level already at 6 hours post 
induction. I estimated, that testing the induction not too long after that time point, a 
good indication could be obtained regarding baseline induction levels between the 
two analysed clones. 
 
When TwE expression was tested in self renewal conditions at 9 hour post 
induction it was observed that the two clones responded similarly to Doxycyclin [Fig 
R3.6], in contrast with induction at 24 hours [Fig R3.1b]. This confirms the 
importance of transgene silencing in clonal response to TwE and indicates that by 24 
hours, already important phenotypical changes have occurred. 
 
R3.4.2 Early TwE Response for Pluripotency and Differentiation Markers  
 
Regulation of differentiation by TwE had been assessed in the previous chapters 
by gene expression at days 2 to 5 of differentiation, when, most likely, the observed 
effects represented global cell fate changes. Here, I took advantage of the induction at 
9 hours to investigate the TwE early response genes. 
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For this experiment cells adapted in N2B27 supplemented with LIF and BMP4, 
a condition further called as LIF + BMP, were used. Induction with Dox was 
performed either in these conditions or in N2B27 alone, which is the same as neural 
differentiation medium. The experiment is described in material and methods M2.2.7. 
 
R3.4.2.1 Early TwE Influence on Pluripotency 
 
First, I investigated the early effects of TwE induction on pluripotency markers. 
Klf4 is one of the earliest markers to be downregulated when ES cells are placed in 
differentiating condition. In this experiment, TwE had a significant negative effect on 
Klf4 in self renewal condition. In differentiating condition, on the other hand, Klf4 
had already been markedly downregulated by 9 hours and, TwE did not influence it 
any further [Fig R3.7a]. 
 
Id1 is another anti-differentiating effector which is downregulated at the early 
steps of differentiation. TwE has a minor effect of upregulation of Id1 in self renewal 
conditions. The effect becomes more obvious in differentiating conditions where Id1 
is very low [Fig R3.7b and c]. Since ID1 prevents the formation of Tw-E dimers this 
can be interpreted as a negative feed-back mechanism, through which TwE limits its 
own effects. 
 
R3.4.2.2 Early TwE Influence on EMT 
 
Next I looked at the EMT process. Previously, I observed that Zeb2, is one of 
the earliest EMT markers to be influenced by TwE [Fig R1.14b]. Here this marker is 
upregulated at 9 hours by TwE both in self-renewing and differentiating conditions 
[Fig R3.7d]. Interestingly, Cdh1 which is practically eliminated by TwE during 
differentiation is not influenced during this short induction. Furthermore, Cdh2 whose 
upregulation is facilitated by TwE after three days of differentiation, is actually 
downregulated by 9 hours treatment with Dox [Fig R3.7e and f]. Together these data 
indicate that TwE role on Cadherins is chiefly an indirect one resulting from 








Figure R3.6. Early TwE induction 
 
qPCR showing Twist1 expression after 9 hours induction with Dox in self renewing 
conditions. Expression in uninduced cells for clone doTE171 has been arbitrarily set 
to 1. For each clone one experiment performed in duplicates is shown. Error bars 
























































Figure R3.7. TwE early influence on self renewal and differentiation 
 
Cells were induced with Dox 800ng/ml for 9 hours either in self renewal condition 
N2B27 supplemented with Lif and BMP4 or in differentiation conditions N2B27 
alone. qPCR showing expresion of Klf4 (a), Id1 (b and c), Zeb2 (d), Cdh1 (e) and 
Cdh2 (f). In (c) Id1 expression is shown in differentiating conditions alone, for a 
better appreciation of modulation of the lower Id1 levels in this conditions. For each 
gene the average expression in the two clones in uninduced self-renewal conditions 
has been arbitrarily set to 1. For each clone one experiment performed in duplicates is 
































R3.4.2.3 Early TwE Influence on Neural Differentiation 
 
Regarding early neural differentiation markers, Zfp521 is not influenced by 
TwE in a consistent manner, indicating that for this marker too, any reported 
influences may be indirect. On the other hand, Sox1 is downregulated for all clones 
and conditions tested [Fig R3.8a and b]. While this explains the consistent Sox1 
downregulation, I have seen across experiments, it comes into conflict with the notion 
that Sox1 downregulation is a later event involved in premature exit from neural 
progenitor state. Integrating all the results, I conclude, that TwE is most likely a direct 
negative regulator of Sox1, but that this effect could be counterbalanced for a limited 
time by other changes in cell differentiation. However, TwE negative effect on Sox1 
must in the end win, in the case of continuous TwE induction, resulting in ultimate 
suppression of this marker. Furthermore, direct Sox1 downregulation by TwE could 
also explain why it is possible to rescue the expression of Zfp521 without rescuing the 
expression of Sox1. 
 
R3.4.2.4 Early TwE Influence on Other Differentiation Markers 
 
In other differentiation systems TwE has been reported to act by influencing 
Fgfr2 expression [Connerney et al., 2006]. When short induction of TwE was tested, 
upregulation of Fgfr2 expression for all conditions tested was observed [Fig R3.8c]. 
Interestingly, TwE had been found previously to downregulate Fgfr2 expression 
[Connerney et al., 2006]. This is an indication that TwE may have repressive or 
activating roles depending on cell context. 
 
Pax3 is a dorsal neural marker for which I have reported an early TwE role. 
Pax3 was upregulated by short Dox induction in all conditions although, the effect in 
clone doTE171 was strong, while in clone doTE155 was minimal [Fig R3.8d]. 
 
Gli1 is one of the SHH effectors and has been proposed to be non-cell 
autonomously regulated by Twist1 [Soo et al., 2002]. It is negatively influenced by 








Figure R3.8. TwE early influence on neural markers 
 
Cells were induced with +Dox for 9 hours either in self renewal condition N2B27 
supplemented with Lif and BMP4 or in differentiation conditions N2B27 alone. 
qPCR showing expresion of Zfp521 (a) Sox1 (b) FgfR2 (c), Pax3 (d) and Gli1 (e).  
For each gene the average expression in the two clones in uninduced self-renewal 
conditions has been arbitrarily set to 1. For each clone one experiment performed in 





































In summary, TwE has early negative effects on pluripotency and neural 
differentiation as shown by the negative regulation of Klf4 and Sox1 at 9 hours post 
induction. Other complex differentiation events might be the combined result of early 
and late TwE effects, but it is also possible that some of the reported genes like: Zeb2, 
Pax3 and Gli1, have an early role in this process. 
 
 
R3.5 TwE Can Block Neural Differentiation. 
 
In Results_1 I correlated premature downregulation of Sox1 in response to TwE 
with early formation of post mitotic neurons as indicated by formation of TUBB3 
positive cells. Here I asked the question if formation of such early neurons can result 
in response to higher levels of TwE as well. 
 
When TwE high expressing clones were subject to 4 days neural differentiation, 
a marked difference, between the two clones tested, could be observed. While, in the 
case of doTE155, microscopic fields with premature neurites could be observed, for 
clone doTE171 neuron formation was inhibited compared to –Dox control. Fig R3.9 
presents the fields with the highest number of TUBB3 positive cells for each 
condition. 
 
R3.6. High TwE Effects on Neural Differentiation 
 
R3.6.1 TwE Induction during Neural Differentiation 
 
The above experiment supports the idea that perhaps high TWIST1 activity 
favours non-neural fates as, indicated by suppression of neuron formation in the clone 
with the highest TwE expression and lowest silencing. Such a hypothesis is consistent 
with the Twist1 pattern of expression, which was observed at high levels only in the 
mesenchyme and not in the neural tissue. However, there was a possibility that the 
reported suppression was only the result of early effects of high level TwE. This 
might have biological significance considering that in the embryo I could only 
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observe Twist1 in the neural tissue after the head fold stage, a time point when neural 
fate is already protected against other suppressive signals, like BMP.  
 
To test whether high levels of TwE could no longer suppress neural fate after 
the initial differentiation events an experiment was designed where Dox was added 
only after the first two days of differentiation. This time point was chosen considering 
the fact that in the in vitro system I was using, at day 3, few postmitotic neurons 
could already be observed [Fig R1.8]. Moreover, at day 3 of differentiation 
upregulation of neural markers had been reported [Kamiya et al., 2011], indicating 
that neural fate was established. As control, were used the conditions where Dox was 
either not added at all, or added throughout the experiment. Differentiation was 
assessed by marker expression at day 4. 
 
First, Twist1 induction was tested. It was observed that in this context for clone 
doTE155 induction does not decrease as severely as in self renewal condition, 
indicating that during differentiation the selective pressure against TwE expressing 
cells is less important [Fig R3.10]. 
 
Next, neural differentiation was assessed based on four classes of markers: early 
neural markers Sox1 and Zfp521, late neural marker Atoh1, EMT marker Zeb1 and, 
neural crest markers Sox9 and Msx1. 
 
R3.6.2 High TwE Induction Effects on Neural Differentiation Markers 
 
In the previous experiments involving lower TwE induction level in clone 
doTE77 suppression of Sox1 and enhancement of Zfp521 upregulation during neural 
differentiation was observed [Fig R1.10b and c]. In the present experiments these 
observation were generally confirmed [Fig R3.11a and b]. Interestingly, Sox1 
upregulation was curbed, but still permitted to some extent in both Dox treatments in 
the case of clone doTE155. On the other hand, for doTE171 expression was 
completely blocked in Dox continuous treatment and, almost completely blocked in 
Dox late treatment [Fig R3.11a] and, this complete block of Sox1 correlates with the 






Figure R3.9. TwE induction has clonal dependent effects on neural 
differentiation.  
 
4 days of monolayer neural differentiation in N2B27 under Dox induction: lower row; 
and in the absence of Dox: upper row. Left panels: phase contrast, right panels 
immunofluorescence: TUBB3 staining: green; with nuclei counterstained with DAPI. 


























































Figure R3.10. TwE induction during neural differentiation 
 
qPCR showing Twist1 expression in ES cells and cells at day 4 of neural 
differentiation in monolayer protocol. Cells were either not induced: -Dox, induced 
for the last 2 days of differentiation: +Dox Day 2-4, or induced throughout 
differentiation: +Dox Day 0-4. Expression of clone doTE171 in uninduced self-
renewal conditions has been arbitrarily set to 1. For each clone one experiment 




















































Figure R3.11. Time of TwE induction influence on differentiation 
markers expression 
 
qPCR showing expression of Sox1 (a), Zfp521 (b), Atoh1 (c), Sox9 (d), Msx1 (e) and 
Zeb1 (f) in ES cells and cells at day 4 of neural differentiation in monolayer protocol. 
Cells were either not induced: -Dox, induced for the last 2 days of differentiation: 
+Dox Day 2-4, or induced throughout differentiation: +Dox Day 0-4. For each gene 
the average expression in the two clones at ES cell stage has been arbitrarily set to 1. 



































The later marker Atoh1 was not upregulated in either clone in the absence of 
Dox. Atoh1 was highly upregulated only by continuous Dox treatment and, only in 
the case of clone doTE155. Its expression was completely blocked for doTE171 in the 
case of continuous Dox treatment [Fig R3.11c]. This correlates with the complete 
block of Sox1 for that clone and condition. Thus, it can be concluded that Atoh1 
requires for its upregulation, in this in vitro protocol, both prolonged TwE stimulation 
and Sox1 presence. 
 
Collectively the data presented above indicates that formation of neurons 
correlates well with Sox1 and Atoh1 expression but not with that of Zfp521. It seems 
that this latter marker responds to TwE even when differentiation is diverted from the 
neural pathway.  
 
It should be noted that high TwE blocks overt neural differentiation by 
accentuating Sox1 suppression, as it can be observed in clone doTE171. On the other 
hand in clone doTE77 where TwE is induced at lower levels and in clone doTE155 
where TwE is downregulated Sox1 expression is permitted and TUBB3 positive 
neurons can be observed. 
 
R3.6.3 High TwE Induction Effects on EMT 
 
Zeb2 is an EMT effector specifically expressed in the developing 
neuroepithelium and neural crest [Van de Putte et al., 2003]. In previous experiments 
I found that this gene’s expression is upregulated by TwE. However, this 
enhancement tended to plateau towards the end of the differentiation [Fig R1.14b]. 
The related gene Zeb1 (also known as δEF1) is less specific, being expressed only in 
a subset of neural progenitors, as well as in neural crest and axial and paraxial 
mesoderm. I found this marker to be enhanced by TwE during neural differentiation 
and the difference between +Dox and –Dox conditions was maintained throughout 
the experiment [Fig R1.14a]. For this reason I tested Zeb1 expression in this 
experiment, at day 4 of differentiation. Zeb1 was enhanced in both clones by Dox 
treatment, the highest level being observed for the late Dox treatment in the case of 
doTE171 [Fig R3.11f]. This data indicates that Zeb1 stimulation stands in direct 
relation with TwE and is not a consequence of neural facilitation.  
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R3.6.4 High TwE Induction Effects on Dorsal Neural Markers 
 
The neural crest marker Sox9 [Sauka-Spengler and Bronner-Fraser, 2008, Lee 
and Saint-Jeanette, 2011] was upregulated in both clones and in both induction 
conditions. It was highest in continuous Dox treatment [Fig R3.11d]. This may 
indicate that Sox9 upregulation in response to TwE is independent of progression 
through neural differentiation. 
 
Msx1 (also known as Hox-7) is a neural crest marker [Hill et al., 1989; Robert et 
al., 1989]  which was not upregulated in the previous experiments involving clone 
doTE77 (data not shown). In the current experiment it was upregulated strongly by 
clone doTE155, especially in the continuous treatment condition. On the other hand 
in the case of clone doTE171 it was only upregulated in the late induction condition 
[Fig R3.11e]. This inconsistency between clones might indicate that this marker 
requires other unpredictable differentiation events in order to respond to TwE. 
 
In conclusion, the data presented here confirms the idea that high levels of TwE 
are detrimental to neural induction and that delaying the time of induction at 48 hours 
after the start of in vitro differentiation is not enough to preserve the neural fate. 
However, most transcriptional effects observed previously for low TwE induction 
could also be observed in the case of high TwE induction. Divergent differentiation 
effects could be ascribed to levels of regulation. Most notably, the block on neural 










R3.7 TwE Block on Neural Differentiation Is Dose and Not 
Clone Dependent. 
 
R3.7.1. Modulating The Levels of TwE Induction 
 
The previous experiments indicated that the neural differentiation can only be 
preserved if TwE induction is reduced to lower levels, as is the case of clone 
doTE155. There was a possibility that this phenomenon was dependent on some 
individual clonal phenotypical adaptations and not directly connected with TwE 
levels. However, based on Twist1 levels of expression in the embryo, as well as on 
TwE effects of neural differentiation reported in Results_1 I am proposing that: “low 
levels of TwE help induce a dorsal neural fate whilst higher levels of TwE induce a 
mesenchymal fate”. If this hypothesis is correct, than low levels of TwE, should 
replicate the observed effects on neural differentiation in all clones. 
 
In order to establish the optimal level of induction I carried a dose dependence 
test, as shown in Fig R3.12. Considering the results shown and the fact that clone 
doTE77 had a usual induction pattern of 7 fold or more, I concluded that the Dox 
doses which would be most likely to produce the desired induction are 10 and 30 
ng/ml Dox.  
 
However, for the next experiments, I modified the doses to 10 and 40 ng/ml 
Dox, for the following reasons. I thought important to have a very low dose of Dox, 
for the possibility that the tiniest amount of TwE might have a phenotypic effect. On 
the other hand, if a higher dose was required 40 ng/ml was a minimal increase which 
would enhance the chances of unravelling the active dimer effects. As controls, 0 and 
800 ng/ml Dox were used. The treatment was carried for the entire duration of the 













Figure R3.12. Correlation of TwE induction with Dox concentration 
 
qPCR showing Twist1 expression after 9 hours induction with Dox in self renewing 
conditions at stated concentrations. Expression in uninduced cells for clone doTE171 
has been arbitrarily set to 1. For each clone one experiment performed in duplicates is 
















































R3.7.2 Premature Neurons Can Be Observed in All Clones in The Case 
of Low TwE Induction. 
 
When cells were differentiated for four days in the described conditions and 
neural differentiation assessed by TUBB3 staining the two clones (doTE155 and 171) 
behaved consistently for 0, 10 and 40 ng/ml Dox conditions. Thus, the presence of 
TUBB3 cells was minimal on day 2 for all conditions tested. Then, on days 3 and 4, 
premature neurites could be observed especially at 40 ng/ml for both clones. At 800 
ng/ml TUBB3 upregulation is almost completely blocked for clone doTE171. 
Furthermore, even for clone doTE155, where neurons can be observed, there is a 
suppression of formation of TUBB3 positive neurites compared to 40 ng/ml [Fig 
R3.13]. 
 
R3.7.3. Quantification of Neurite Formation in Response to TwE 
 
To better assess these effects of TwE on neuronal differentiation, I developed a 
system for quantifying neurite number and length as described in Material and 
Methods (M4.1.2); at day four of neural differentiation, a time point when neurites 
could be best observed. Briefly, total cell numbers were counted using a nuclear 
segmentation algorithm based on DAPI nuclear staining. Then, neurons were counted 
and the length of the neurites for each neuron were measured based on TUBB3 
staining. 
 
 Regarding efficiency of neuronal formation no difference was observed 
between 0 and 10 ng/ul of Dox for both clones studied. However, a dose dependent 
suppression of neuron formation could be observed for 40 and 800 ng/ml Dox. The 
only notable difference between clones could be observed at 800 ng/ml Dox, a 
treatment for which neural formation as assessed by TUBB3 was completely blocked 
in the case of clone doTE171, while for doTE155 rare neurons could still be observed 
[Fig R3.14]. 
 
Furthermore, when TUBB3 positive cells were separated between immature 
neurons with short processes and, more mature neurons, with longer processes, it was 
observed that up to 40 ng/ml Dox neural suppression, for both clones, was generated 
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solely on the expense of immature neurons, while formation of more mature neurons 
was slightly increased. At 800 ng/ml Dox formation of all neurons was suppressed 
[Fig R3.14].  
 
These data is consistent with the idea that at high levels TwE blocks neural 
differentiation while at lower levels it is permissive for this process and, accelerates 
it. Furthermore, it should be noted that reduction in total neuron numbers at 40 ng/ml 
Dox, does not refute my hypothesis, as acceleration of neural differentiation reduces 
the pool of proliferating progenitors and thus, the final number of differentiated cells. 
 
Since there was a high degree of correlation between the two clones, the data 
was pooled together for statistical analysis. Using One-way ANOVA, followed by 
Tukey HSD post hoc test, as described in M4.1.2, it was determined that suppression 
of neural formation was significant both at 40 ng/ml Dox compared with 0 and 10 
ng/ml Dox as well as, at 800 ng/ml Dox compared with 40 ng/ml Dox [Fig R3.15a]. 
Furthermore, formation of neurons with short neurites was significantly suppressed at 
40 ng/ml Dox compared with 0 and 10 ng/ml and, at 800 ng/ml compared with 0 and 
10 ng/ml [Fig R3.15b]. On the other hand there was a significant enhancement of 
generation of neurons with long neurites at 40 ng/ml Dox compared with 0 ng/ml and 
a significant suppression of at 800 ng/ml compared with 40 ng/ml [Fig R3.15c]. It 
should be noted that the large error bars in this case represent normal field to field 
variation.  
 
R3.7.4 Neural Marker Expression Modulation by Different Levels of TwE 
Induction 
 
In the previous section I inferred transcriptional effects of different levels of 
TwE based on results obtained in different clones. I wanted to confirm these 
observations by assessing the influence on neural differentiation of different levels of 
TwE within the same clones. By using this method I was able to confirm all the 
previous observations, namely that Sox1 downregulation and, Zfp521, Zeb2, Sox9 and 









Figure R3.13. Only high TwE induction blocks neural differentiation.  
 
Immunofluoresce for TUBB3: green, with nuclei counterstained with DAPI of cells 
differentiated for 4 days in monolayer protocol and induced with the stated 
concentration of Dox. Cells were fixed at Day 2 of differentiation (a), Day 3 (b) and 


































Figure R3.14. Quantification of neuron formation under TwE influence 
 
Representation of total number of TUBB3 positive cells per 100 cells: clone doTE155 
(a) and doTE171 (b). Representation of neurons with short and long neurites 
respectively per 100 cells: clone doTE155 (c) and doTE171 (d). An arbitrary 
threshold has been set considering a neurite as being long if its length equalled or 
exceeded 7 mean nuclear diameters. Data collected at day four of neural 
differentiation. Dox doses used: 0, 10, 40 and 800 ng/ml respectively. Error bars 












































Figure R3.15. Statistical analysis of neuron formation quantification 
 
For statistical analysis data from the two clones has been pooled together. Total 
neurons quantification (a). 40 ng/ml Dox significantly suppress neuron formation 
both compared to no Dox p = 0.043 and to 10 ng/ml Dox p = 0.007. 800 ng/ml Dox 
induced a further supression compared to 40 ng/ml Dox condition p = 0.011. 
Furthermore, suppression at 800 ng/ml Dox was highly significant compared to 0 and 
10 ng/ml Dox; p = 2x10-5 and p = 3x10-6 respectively. Short and Long neurite 
formation (b) and (c) respectively. Formation of neurons with short neurites has been 
significantly suppressed by 40 ng/ml Dox compared to the lower induction doses 0 
and 10 ng/ml p = 2x10-7 and p = 4x10-8 respectively. It was also highly significant for 
800 ng/ml Dox compared with 0 and 10 ng/ml, p = 1x10-7 for both conditions. 
Formation of neurons with long neurites has been significantly stimulated by 40 
ng/ml Dox compared with no Dox induction p = 0.042. At 800 ng/ml it was 
significantly suppressed compared with 40 ng/ml p = 0.002 Data collected at day four 
of neural differentiation. Dox doses used: 0, 10, 40 and 800 ng/ml respectively. Error 
































For both clones 40 ng/ml produced an induction of TwE within desired levels: 
above 10 fold. 800 ng/ml produced a high induction, while 10 ng/ml produced a very 
weak induction [Fig R3.16]. Interestingly, for this experiment, a steep reduction in 
induction was observed for both clones for both 800 and 40 ng/ml Dox. 
 
When neural differentiation was investigated it was observed that for clone 
doTE171, 800 ng/ml completely blocked Sox1, at all time points tested. On the other 
hand, 40 ng/ml produced only a mild downregulation, more notable on day 4. By 
contrast, clone doTE155 suffered only downregulation, but not block, at 800 ng/ml 
Dox for Sox1 expression and, no influence for 10 and 40 ng/ml doses. These data 
confirm the previous results and explains neural inhibition by high levels of TwE 
through block in Sox1 upregulation. Furthermore, the differences in Sox1 expression 
at 40 ng/ml Dox, a dose at which induction was similar for both clones points to the 
fact that not only doTE155 can silence the transgene more efficiently, but that it is 
also less sensitive to lower levels of induction [Fig R3.17a and b]. 
 
The early marker Zfp521 had an expression which correlated directly with the 
level of induction for both clones, though upregulation by TwE was very moderate. 
This is in line with previous data, showing that important upregulation of Zfp521 in 
response to TwE in the case of clone doTE77 was observed as a rescue against BMP 
inhibition, while in basal neural conditions this effect was less obvious [Fig R3.17c, 
d; see also Fig R1.10b and Fig 1.17b]. 
 
Furthermore, for the EMT marker Zeb2 both clones the highest upregulation 
was seen at day 2. Interestingly, the most important difference was seen for doTE155 
when shifting Dox dose from 40 to 800 ng/ml, while for doTE171 when shifting from 
10 to 40 ng/ml [Fig R3.18a and b]. 
 
The upregulation of the neural crest marker Sox9 was for both clones was 
directly dependent on Dox dose. However, it should be noted that 40 ng/ml Dox for 
clone doTE171 achieved an upregulation similar with 800 ng/ml for doTE155. The 
upregulation of the nest neural crest marker Wnt1 was less consistent. For clone 








Figure R3.16. Induction of TwE during neural differentiation in response 
to various concentrations of Dox 
 
qPCR showing Twist1 expression in self renewal conditions, or during differentiation 
at the stated time points and Dox concentrations. Clone doTE155 (a and c), clone 
doTE171 (b and d). Bottom row shows expression only for lower Dox concentrations. 
Twist1 expression for clone doTE171 in self renewal conditions was arbitrarily set to 
1. For each clone one experiment performed in duplicates is shown. Error bars 













































Figure R3.17. Upregulation of early neural markers in response to 
various concentrations of Dox 
 
qPCR showing Sox1 and Zfp521 expression in self renewal conditions, or during 
differentation at the stated time points and concentrations of Dox. Sox1 (a and b), 
Zfp521 (c and d). For each gene the average expression in the two clones at ES cell 
stage has been arbitrarily set to 1. For each clone one experiment performed in 











































Figure R3.18. Upregulation of EMT and neural crest markers in response 
to various concentrations of Dox 
 
 
qPCR showing Zeb2 (a and b), Sox9 (c and d) and Wnt1 (e and f) expression in self 
renewal conditions, or during differentiation at the stated time points and 
concentrations of Dox for clone doTE155 and doTE171 respectively. For each gene 
the average expression in the two clones at ES cell stage has been arbitrarily set to 1. 



































However, for doTE171 800 ng/ml was inhibitory almost completely blocking 
the expression of this marker. By contrast, 40 ng/ml Dox induced a good upregulation 
of Wnt1, superior to the upregulation produce by the same dose in doTE155. These 
data indicate that while Wnt1 is responsive to TwE, it is also dependent of neural 
differentiation and that cellular context can alter TwE effect on this marker [Fig 
R3.18c to f]. 
 
Together the data presented in this section indicate that the levels of TwE are 
more important than the time of induction and that, high levels of TwE are 
incompatible with neural differentiation. 
 
 
R3.8 TWIST1 Dimer Choice Relevance 
 
R3.8.1 Generation and Characterization of Tw-Tw Inducible Clones 
 
Since as shown in the previous chapter Twist1 is expressed in the dorsal region 
of the neural folds there is a possibility that BMP signalling is strong enough in that 
region to bias TWIST1 towards homodimer formation. Previously, it was proposed 
that TW-E and TW-TW dimers have opposing roles, at least in the certain fate choice 
decisions [Connerney et al., 2006]. Furthermore, TW-E and TW-TW dimers regulate 
different genes [Laursen et al., 2007]. Considering that ID proteins block formation of 
TW-E dimers and thus favour TW-TW dimers, and that IDs act downstream neural 
negative regulator BMP, it is conceivable that TW-TW should block neural 
differentiation. On the other hand TW-TW formed under the BMP influence in the 
dorsal neural fold could participate in inducing the neural crest fate. Therefore, the 
influence of TWIST1-TWIST1 forced dimer on neural differentiation should be 
investigated.  
 
For this reason I generated a plasmid similar with the TetO-TwE plasmid 
described in Results_1, in which Twist1-linker-E construct has been replaced with 
Twist1-linker-Twist1 construct [Fig R3.19]. The active dimer produced by this 
plasmid will be called in this thesis TwTw. 
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TwTw clones were isolated as before for TwE using PD0325901 as an anti-
differentiating molecule. Using this method, stable inducible clones, expressing the 
transgene at high levels, could be obtained [Fig R3.20]. 
 
R3.8.2 Tw-Tw Influence on Neuron Formation 
 
First, I tested TwTw influence on neural differentiation and its dependence on 
induction levels. For this purpose I used the same doses of Dox as in the TwE 
experiment: 0 ng/ml, 10 ng/ml, 40 ng/ml and 800 ng/ml respectively. Neural 
differentiation was assessed by TUBB3 staining form day 2 to day 4. It can be seen 
that in the case of 800 ng/ml Dox, neurites are never formed, indicating a very 
efficient block in neural differentiation. However, at 10 and 40 ng/ml rare TUBB3 
positive neurites are formed, but they are never bundled around the originating 
colony, as in control, but rather have a tendency to connect to the neighbouring 
colony, as is the case for TwE induced neurons [Fig R3.21]. 
 
When neural formation was quantified, as described in M4.1.2, the same genral 
pattern as for TwE clones was observed. Namely, there was a dose dependent 
suppression of neural formation, with complete neural block at 800 ng/ml Dox [Fig 
R3.22a]. Furthermore, up to the dose of 40 ng/ml Dox neural suppression was 
produced on the expense of neurons with short neurites, while formation of neurons 
with long neurites was slightly increased compared to no Dox treatment [Fig 
R3.22b].  
 
R3.8.3 Tw-Tw Influence on Neural Marker Expression 
 
Next, I tested TwTw influence on neural differentiation based on marker 
expression. Again, I considered the possibility that after the initial differentiation 
events TwTw could be more permissive for neural fate. Thus, Dox was added either 
throughout the experiment or only at day 2. The differentiation was assessed by 
marker expression at day 4. 
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It was observed that in these conditions the transgene is expressed at higher 
level than TwE, while some downregulation was present after four days of induction, 
compared to two days [Fig R3.23]. 
 
When neural markers were tested, Sox1 upregulation at day 4 of differentiation 
was strongly suppressed by Dox treatment in all conditions [Fig R3.24a]. On the 
other hand, Zfp521 was not significantly influenced, except for a slight 
downregulation induced by late Dox treatment [Fig R3.24b]. The recovery of this 
marker expression to control level in the case of Dox continuous treatment indicates 
that the observed downregulation does not have major influence on cell fate. Atoh1 is 
expressed in all conditions, including control, at levels significantly lower than in the 
ES cells [Fig R3.24c]. Together, these data indicates that TwTw has a negative 
influence on neural differentiation regardless of the moment of expression. 
 
 
When other markers upregulated by TwE were investigated a more consistent 
picture appeared. TwTw upregulated Sox9, and the upregulation depended directly on 
the length of induction [Fig R3.24d]. Furthermore, Msx1 was upregulated, but only 
by stimulation for the entire differentiation [Fig R3.24e]. Zeb1 was upregulated in all 
conditions in a manner very similar with the upregulation induced by TwE [Fig 
R3.24f]. These data indicates that while TwE and TwTw are considered 
transcriptional effectors with divergent roles they might share at least some of their 
actions in certain contexts. 
 
The data presented here is somewhat in agreement with my initial hypothesis, in 
the sense that at high levels Tw-Tw a dimer though to be favoured by BMP/ID 
signalling, has a negative influence on neural differentiation. However, since no 
striking difference can be observed between TwTw and TwE I have to conclude that 
BMP/ID influence on TWIST1 dimer choice is not a major mechanism for regulating 
the neural fate. Moreover, the level of Twist1 expression holds the fundamental fate 
choice decision, with high levels favouring mesenchymal fates and low levels 
favouring dorsal neural fates. It can also be inferred that Twist1 upregulation might be 









Figure R3.19. Schematics of Doxycyclin inducible TWIST1 homodimer 
 


























































Figure R3.20. Screening of TWIST-TWIST cell lines 
 
Immunofluorescence for two clones: doTT202 and doTT219, after 24 hours of 
induction showing heterogeneous expression, including brightly stained cells. Red: 
Flag staining, blue DAPI. Scale bars represent 50 µm (a). qPCR showing expression 
of Twist1 after  24 hours of induction compared to parental cell line. Expression in 
parental cell line has been arbitrarily set to 1. For each clone one experiment 
performed in duplicates is shown. Error bars represent value range (b). Western blot 













































Figure R3.21. TwTw effects on neural differentiation based on induction 
levels 
 
Immunofluorescence for TUBB3: green; nuclei counterstained with DAPI for cells 
from clone doTT202 differentiated for 4 days in monolayer protocol and induced with 
the stated concentration of Dox. Cells were fixed at Day 2 of differentiation (a), day 3 

















































Figure R3.22. Quantification of neuron formation under TwTw influence 
 
Representation of total number of TUBB3 positive cells per 100 cells for clone 
doTT202 (a). Representation of neurons with short and long neurites respectively per 
100 cells (b). An arbitrary threshold has been set considering a neurite as being long 
if its length equalled or exceeded 7 mean nuclear diameters. Data collected at day 
four of neural differentiation. Dox doses used: 0, 10, 40 and 800 ng/ml respectively. 






















































Figure R3.23. TwTw induction during neural differentiation 
 
qPCR showing Twist1 expression in ES cells and cells at day 4 of neural 
differentiation in monolayer protocol. Cells were either not induced: -Dox, induced 
for the last 2 days of differentiation: +Dox Day 2-4, or induced throughout 
differentiation: +Dox Day 0-4. Expression in ES cells for clone doTE171 has been 
arbitrarily set to 1, to allow full comparison with TwE results. Then, the resulting 
levels have been divided by 2 to compensate for the presence of 2 Twist1 sequences 
in the TwTw construct. Error bars represent standard deviation of the mean for two 
biological replicates. One experiment performed in duplicates is shown. Error bars 



















































Figure R3.24. Time of TwTw induction influence on differentiation 
markers expression 
 
qPCR showing expression of Sox1 (a), Zfp521 (b), Atoh1 (c), Sox9 (d), Msx1 (e) and 
Zeb1 (f) in ES cells and cells at day 4 of neural differentiation in monolayer protocol. 
Cells were either not induced: -Dox, induced for the last 2 days of differentiation: 
+Dox Day 2-4, or induced throughout differentiation: +Dox Day 0-4. For each gene 
the average expression in the two clones at ES cell stage has been arbitrarily set to 1. 





































In this chapter I started from the observation that Twist1 is expressed at low 
levels in a subset of cells from the neuroectoderm, but is highly expressed in cells that 
have recently exited the epiblast to become mesoderm, as well as in cells which 
exited the neuroectoderm to become neural crest. Therefore I proposed that Twist1 
might regulate fate decisions depending on its levels; namely, that at low levels it 
favours dorsal neural fates and at high levels it favours mesenchymal fates. 
 
When I tested relatively high TwE expressing clones I found out that they have 
a variable phenotype. I assigned this variability to a process of adaptation due to 
selective pressure. I showed that TwE can override the selfrenewing program 
controlled by LIF and BMP. I also showed that this process of exit from pluripotency 
is accompanied by EMT and formation of a mesenchymal like cell type. 
 
Furthermore, I showed that TwE blocks neural differentiation when expressed at 
high levels and accelerates formation of postmitotic neurons when expressed at low 
levels. I confirmed the fact that TwE upregulates neural crest markers and that, for 
clone doTE171 which is more responsive to TwE, moderate levels of expression are 
sufficient for the upregulation of these markers. 
 
I indicate a number of early responsive genes, which most likely, cooperate in 
generating the later effects. TwE has an early effect on pluripotency and EMT genes 
though not on Cadherins. On neural differentiation TwE is a two edge sword, 
upregulating some dorsal neural markers while having a marked negative effect on 
more genral neural markers, most notably Sox1. Furthermore, Sox1 has been shown to 
maintain the pool of undifferentiated neural progenitors by counteracting pro-neural 
bHLH factors [Bylund et al., 2003]. Here, I report the complementary effect, where a 
bHLH factor accelerates neural differentiation by inhibiting Sox1. 
 
Next I investigated the putative roles of TwTw on neural differentiation. The 
significance of this question had already been weakened by the observation that high 
TwE blocks neural differentiation. Thus, it could no longer be argued that we are 
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dealing with a binary fate switch were TwE favours neural differentiation while 
TwTw blocks it. 
 
Surprisingly, there was a high level of similarity between TwE and TwTw. 
TwTw, just like TwE blocks neural differentiation when expressed at high levels. At 
moderate levels, again, it promotes formation of premature neurons, while 
upregulating similar EMT and neural crest markers. Thus, it is possible that Twist1 
roles in CNS depend primarily of its expression, while being protected against BMP 
dynamic by the irrelevance of dimer choice in this context, independent of the battle 






























Figure R3.25. Schematic Conclusions 
 
TwE induction of cell fate depends on its level of activity. Both high and low TwE 
divert a cell from the pluripotent compartment, but at high levels a cell is directed 
towards non-neural fates, while at low levels neural differentiation is permitted and 
accelerated. Furthermore, both high and low levels of TwE induce EMT, including 
upregulation of Zeb2, a neural EMT marker. It should be noted that Twist1, Zfp521, 
Pax3 and Sox9 are expressed both in certain neural and mesenchymal cells, and could 

































D1 Finding a Place in Time: TWIST1 and Neural 
Differentiation 
 
From a large body of work which started with Spemann and Mangold's seminal 
experiments of axis induction by the organizer and culminated with the discovery of 
BMP antagonists as the key effectors of the organizer, BMP has been firmly 
established as the most important anti-neural signalling molecule [Spemann and 
Mangold, 1924; Smith and Harland, 1992; Sasai et al, 1994; Hemmati-Brivanlou and 
Melton, 1994; Bouwmeester et al, 1996]. As is always the case in science, here too, 
the situation has been proven to be more complicated, with many signalling pathways 
collaborating to correctly establish the neural fate [Streit et al, 2000; Lowell et al, 
2006; Stavridis et al, 2007; Marchal et al, 2009]. Nevertheless, these later 
investigations could not challenge the importance of BMP inhibition in neural 
specification, while ID proteins have been proposed as the main antineural effectors 
downstream BMP [Ying et al, 2003a]. 
 
Our lab continued the work presented above aiming at defining more precisely 
the events associated with the entry to neural progenitor fate. Owen Davies identified 
TWIST1, TCF15 and NEUROD1 as partners of E proteins in ES cells, which might 
be subject to ID inhibition.  
 
Judging TWIST1 as the most likely candidate I tested it under the form of an ID 
insensitive, E forced partner: TwE. The results presented in this thesis, while exciting 
in certain aspects do not support the notion that TWIST1 and, more notably, 
TWIST1-E dimer is the key transcription factor required for neural induction; TwE at 
high levels was incompatible with neural differentiation and at low levels accelerated 
it. However, acceleration was not the expected outcome; rather induction and 
maintenance of the neural progenitor pool should be the roles of an early neural gene. 
Furthermore, experimental knockdown of Twist1 does not seem to impair neural 
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differentiation, while gene expression analysis indicated that Twist1 is expressed only 
at later stages of development in the prospective neural tissue. It should also be noted, 
that Twist1 expression in ES and early differentiating cells could be entirely 
artifactual, a consequence of specific culture conditions. 
 
What then might be the ID target, relevant to neural induction? The other two 
proposed bHLH factors have been tested in the Lowell lab (manuscripts in 
preparation). NEUROD1 does not seem to be the appropriate choice for this task, as it 
is very poorly tolerated by pluripotent cells and has been implicated in the terminal 
differentiation of mature neurons [Lee et al., 1995]. Tcf15 is expressed at higher 
levels in ES cells and seems to be a very early facilitator of neural induction. 
However, induction of TCF15-E forced dimer could not be shown yet to overcome 
neural BMP inhibition. Overall, no ID target found so far has a comparable strong 
effect with either ID1 or BMP. 
 
One confounding issue might be that we are not aware of the exact moment of 
neural induction [Di Gregorio et al., 2007; Stern C.D., 2006]. Since ES cells can be 
maintained undifferentiated by LIF and BMP4, it was assumed that, at this stage, 
BMP4 already acts to inhibit neural inducing factors. However, this is not necessarily 
the case. It is possible that BMP4 has a dual role, one in ES cells where it inhibits 
priming factors, and another in epiblast like cells, where it inhibits the true neural 
inducers, which might be present only at this stage. It should also be noted that the 
term “epiblast cells” encompasses a rather large pool of cell fates and stages. In the 
embryo epiblast cells undergo rapid changes, both in marker expression and spatial 
position. Furthermore, there is no guarantee, that differentiation in the tissue culture 
dish, progresses at the same rate as in the embryo. In fact, we can almost be sure of 
the contrary. Thus, we are the victims of a double uncertainty: for one we are not 
entirely sure when neural specification starts in vivo [Puelles et al, 2005] and, for the 
other, the limited knowledge we have from the embryo can not be easily extrapolated 
to our in vitro models. The data presented here for early TwE induction argue that key 
events take place in the first 24 hours of withdrawal of pluripotency factors, an idea 
which correlates with the previous finding that FGF signalling is critical for neural 
induction in the first 24 hours of differentiation [Kunath et al., 2007; Stavridis et al., 
2007]. However, since Twist1 physiological roles might be pertinent to later stages, 
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the phenomenon observed could represent just a rapid phenotypic change of the cells 
towards a stage when Twist1 should normally act. 
 
 
D2 TWIST1 a Surprising Neural Effector 
 
 
D2.1 Can TWIST1 Be Neural? 
 
TwE was consistently found to hasten the exit from neural progenitor state. An 
effect which can be explained by its negative influence on transcription factors 
associated with neural progenitors like Sox1 and SOX2 [Fig R1.11c; Fig R1.12]. This 
could be consistent with the idea that Twist1 might not be a neural factor at all, in the 
sense, that it should not be normally active in neural progenitors and, that its forced 
expression deeply perturbs the neural program.  
 
However data from multiple directions contradict such a simplistic hypothesis. 
First, I found Twist1 to be expressed in a subset of neural progenitors in vivo. 
Second, TwE induces early upregulation of Sox1. This is most likely an indirect 
effect and, probably represents an indication that the cells have entered the neural 
program, as pointed out by upregulation of other early neural markers: Zfp521, Pax3 
and Zeb2 [Fig R1.15; Fig R1.16].  
Third, TwE upregulates Zfp521, a molecule reported to induce Sox1 [Kamiya et 
al., 2011]. Importantly, TwE most clear effect on Zfp521 expression can be observed  
against BMP inhibition [Fig R1.20b]. Thus, Twist1 could act to safeguard neural 
differentiation in very specific contexts, for instance, in the lateral regions of the 








D2.2 TWIST1 Joins The Fight for Neural against BMP. 
 
Previous worked showed that BMP signalling from the surface ectoderm 
specifies neural crest cells in the lateral most regions of the neural plate. One idea 
would be that neural crest cells act as a buffer region between surface ectoderm and 
the “strictly neural cells”, as defined by Puelles and colleagues, namely cells which 
are fated to become part of CNS [Puelles et al, 2005]. Thus, the “strictly neural cells” 
are spatially determined in the region where BMP signalling is low enough for their 
fate to be permitted. Nevertheless, it is more reasonable to think that once the neural 
fate has been initiated, specific effectors start to act, which stabilize this program 
against inherent fluctuations in signalling levels. We know that at early stages, neural 
progenitors are still responsive to antineural BMP signalling [Yang and 
Klingensmith, 2006], but this does not deny the very likely possibility, that some 
resistance against low BMP levels is set in place. 
 
The in vitro data presented here, argues that TWIST1 could be one of the factors 
involved in such stabilization [Fig D1]. On one hand, TwE can rescue neural program 
against moderate levels of BMP. On the other hand, high levels BMP can still block 
neural differentiation. This is consistent with the idea that TwE is not part of the 



















Figure D1. Schematics of the proposed role of TWIST1 in neural plate 
 
A BMP gradient decreasing from lateral to medial influences the epiblast. Medial 
from the point where this gradient is low enough to be permissive for neural induction 
(dotted line A) neural plate is being specified. Medial from dotted line B, the BMP 
signalling is so low that it has no biologic significance. In between lines A and B 



















































D2.3 TWIST1, EMT and The Neural Program 
 
One question raised by the current project is: what role, if any, might TWIST1 
have in the neural program? An obvious idea would be to connect TWIST1 role in 
epithelial to mesenchymal transition (EMT) with neural differentiation. Epiblast cells 
start as an epithelial sheet and early neural markers are upregulated before any 
morphological changes can be observed [Puelles et al., 2005; Arnold & Robertson, 
2009]. Then, before the formation of the closed neural tube, neural cells undergo an 
EMT like event when OCCLUDIN is lost and CDH1 is replaced with CDH2 at the 
cell surface, resulting in the loss of tight junctions [Aaku-Saraste et al., 1996; Van de 
Putte et al., 2003]. Nevertheless, at this stage, cells maintain morphological and 
structural epithelial characteristics, based on the presence of adherens junctions. “This 
change may represent the first step in a program by which neuroepithelial cells 
gradually loose their epithelial characteristics, culminating in the generation of 
nonepithelial cells, the neurons.” [Aaku-Saraste et al., 1996] 
 
It is conceivable that CDH1 downregulation, which is one of the actions for 
which TWIST1 is known [Yang et al, 2004], facilitates the neural program and thus 
explains, at least in part, the observed effects of TwE. However, previously Zeb2 and 
not Twist1 has been implicated in Cdh1 downregulation during neural differentiation 
[Van de Putte et al., 2003]. Interestingly, TwE was found to enhance Zeb factors 
upregulation during in vitro neural differentiation [Fig R1.16a and b]. From the data 
presented here it is not possible to distinguish if CDH1 is downregulated in response 
to TWIST1 or, as a consequence of ZEB factors induction. Perhaps, it is more useful 
to simply consider the phenomenons observed: namely that during neural 
differentiation, both in vitro and in vivo. CDH1 is downregulated and Zeb2 is 
upregulated and that TwE facilitates both this processes. Thus, TwE induces EMT 
associated events during early in vitro differentiation of pluripotent cells, in a manner 
which is consistent with the neural program. 
 
It should be noted that TWIST1 early roles cannot be limited to EMT induction. 
On one hand, TwE induces the expression of early neural markers, which are 
normally present before the downregulation of CDH1, like Pax3 [Basch et al., 2006]. 
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On the other hand, TwE induces a dorsal bias in neural identity, while CDH1 is 
downregulated fully throughout the neural tube [Aaku-Saraste et al, 1996; and Lowell 
lab unpublished data]. Together these data indicate that TWIST1 could integrate EMT 
induction with specific transcriptional activities to affect neural differentiation. 
 
 
D3 Twist1 and Neural Crest 
 
 
D3.1 Neural Crest a Dorsal Cell Type and Twist1 Activity 
 
Since most of the dorsal neural markers, reported here, are shared with the 
neural crest, an interesting question would be if TWIST1 has only a general role in 
establishing dorsal identity, or a more specific role in cell fate. Snai2 (also known as 
Slug or Snail2, in Xenopus snai2-a) marks the pre-migratory neural crest cells in 
Xenopus [Mayor et al, 1995] and is essential for the induction of these cells [Shi et al, 
2011]. However, in mouse Snai2 is only expressed in migratory neural crest cells and 
is not required for their formation [Jiang et al., 1998]. Furthermore, Snai2 and Twist1 
were found to cooperate in EMT induction [Casas et al., 2011]; hence Twist1 could 
play a role in mouse neural crest specification. 
 
Given the previously reported marker overlap [Puelles et al, 2005], it is difficult 
to distinguish a putative role for TWIST1 in establishing either the neural crest or 
dorsal neural fate, by means of in vitro neural differentiation. However, prospective 
dorsal neurons and neural crest cells, are both neural in a larger sense, and there is 
yet, no conclusive evidence, to show that this two fates are strictly separated before 
neural crest delamination. Therefore, it can be proposed that TWIST1 imparts a 
dorsal identity to cells residing in the neural folds and, that specific signals which 
further segregate the cell fates within this developmental niche are to be uncovered by 





D3.2 Could Twist1 Be an Early Neural Crest Marker? 
 
A role for Twist1 in establishing the neural crest fate should also be considered. 
Twist1 is expressed very strongly in the neural crest cells and has functional 
significance in neural crest differentiation and migration [Bildsoe et al., 2009; Das & 
Crump, 2012; Soo et al., 2002; Vincentz et al., 2008; Zhang et al., 2012]. However, 
since Twist1 was thought not to be expressed at the level of neural plate/neural tube 
its relevance in neural crest specification and delamination was less studied. 
 
The only direct, albeit not very strong evidence, regarding Twist1 expression in 
early neural crest comes from Fuchtabauer’s in situ data [Fuchtabuer E.M., 1995]. 
The author found that Twist1 is expressed in a few cells in the neural tube and since, 
those cells seemed to have a round morphology, with little cell to cell contact with the 
surrounding cells, they were deemed as delaminating neural crest cells. If this 
observation is correct, it indicates that Twist1 is upregulated in neural crest before or, 
to the very least, at the time of delamination and points to a possible role Twist1 
might have in the process of delamination. 
 
One question here would be: why wasn’t this process described more 
consistently? It would be reasonable to infer that if Twist1 is indeed upregulated in all 
delaminating neural crest cells this would have been reported and clearly 
documented. On the other hand, neural crest cells do delaminate from the neural tube 
in Twist1 null mice [Soo et al., 2002]. Furthermore, Twist1-negative neural crest cells 
migrate relatively normally when directed by Twist1 expressing mesoderm. 
Collectively, these observations make a strong argument against a role for Twist1 in 
neural crest specification and delamination. At minimum they indicate that even if 
Twist1 has a role in these processes, it can be well compensated by other factors. 
 
Interestingly, challenging the above arguments, evidence for a role of Twist1 in 
neural crest delamination was presented by Firulli and colleagues [Vincenz et al, 
2008]. They found that in the case of Twist1 null mice dorsal neural tube becomes 
enlarged, being populated with Wnt1 expressing cells which fail to migrate out of the 
neural tube. Thus, it seems that indeed neural crest delamination is impaired in the 
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absence of Twist1 even if it is not completely blocked. The point, should also be 
considered, that due to growth retardation in Twist1 null embryos an overall reduction 
in neural crest domain would have been difficult to assess. Consequently, one can 
imagine, that in this context, only a fraction of neural crest cells delaminate and 
possibly, that this partial failure in delamination contributes to the global growth 
retardation.  
 
Nevertheless, the above proposition does not clarify why Twist1 has not been 
consistently observed in the neural tube residing neural crest, although it seems to 
have an influence on delamination. There are three possible explanations and I will 
discuss them in turn. 
1. The neural tube surrounding mesenchyme, which expresses Twist1 at high 
levels, has a positive influence on neural crest delamination. However, such an 
influence cannot be achieved by cell to cell contact, since if that were the case, only 
the cells placed at the very edge of the neural tube/mesenchyme interface would be 
able to enter this process, which is not the case [Nichols D.H., 1981]. Consequently, it 
follows, that mesenchymal cells would have to secrete chemotactic factors to which 
neural crest and neural crest cells alone could respond. On one hand, there is no 
evidence for the existence of such factors, on the other hand, there is positive 
evidence that neural crest specified cells can delaminate in the absence of any 
inductive signals [Basch et al., 2006].  
2. Twist1 acts specifically on cranial neural crest cells. Such a possibility would 
explain many, as yet, unanswered questions. Twist1 knockout has a striking cranial 
phenotype, resulting in exencephaly while the neural tube forms normally at the level 
of spinal cord. Furthermore, patterning defects were identified only at the level of 
forebrain and midbrain [Soo et al., 2002]. Thus, Twist1 role seems to be limited to 
rostral regions of the neural tube. This notion can further be corroborated with the 
idea that most likely neural crest cells employ different mechanism to delaminate 
from the rostral and caudal regions respectively, as indicated by the different manners 
in which this process is produced. Twist1 acting only at the level of prospective brain 
neural crest delamination would explain how it could have easily been missed in 
expression studies. At this level, delamination is an abrupt process, limited in time 
and neural crest cells could upregulate Twist1 only shortly before their delamination. 
However, a migration defect was found in the spinal cord, at a level where neural 
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tube formed and closed apparently normally [Vincenz et al, 2008]. Therefore, this 
explanation is not completely satisfactory either. 
3. Twist1 is expressed at very low levels in neural crest cells before 
delamination. This explanation is consistent with the Twist1 expression pattern 
reported here at the level of the spinal cord. I cannot draw any conclusions for the 
cranial neural crest as all embryos sectioned were at a stage either before or after the 
time of cranial neural crest delamination. The fact that low levels of Twist1 
expression could be observed in the dorsal parts of spinal cord correlates with the 
reported role in neural crest delamination at this level. However, a careful analysis on 
neural crest delamination and correlation with Twist1 expression needs to be carried 
out before the question of Twist1 role in early neural crest can be clearly answered.  
 
 
D3.3 Neural Crest Specification: Lessons from Evolution 
 
Cephalochordates, represented by the extant amphioxus, considered a living 
fossil, are closely related with the vertebrata subphylum. They lack the vertebrate 
characteristic tissue: neural crest. However, in this model organism, cells at the neural 
plate border express homologues of some of the neural crest related markers like 
Pax3, Pax7 [AmphiPax3/7; Holland et al., 1999], Msx [AmphiMsx; Sharman et al., 
1999], Snai [amphioxus snail; Langeland et al., 1998] and Zic  genes [AmphiZic; 
Gostling & Shimeld, 2003]. In chick, Ids are expressed in the pre-migratory neural 
crest (Id1 and Id2) and migratory neural crest (Id2 and Id4) [Kee et al., 2001]. 
Notably, Id homologues are not expressed in the neural plate border of the 
amphioxus, but they are expressed in the same region of lamprey, one of the most 
basic extant vertebrate [Meulemans et al., 2003]. This indicates that Id genes are 
essential for neural crest specification, as Id expression and neural crest formation 
appear together in evolution and, points to a role for bHLH factors in this process. 
 
Twist1 homologue is absent from the neural plate border in amphioxus [Yasui et 
al., 1998], but present in Xenopus [Hopwood et al., 1989]. Interestingly, a more 
recent report, proposed based on genomic sequencing, that the urochordates 
(tunicates) and, not the cephalochordate, are most closely related to vertebrates 
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[Delsuc et al., 2006], a finding which suggests that the simpler structure of tunicates 
might be a result of a process of involution [Gee H., 2006]. A critical study, reports 
the finding in tunicates, of a rudimentary neural crest like cell line, which express Id 
but not Twist homologues [Abitua et al., 2012]. These cells, which form at the neural 
plate border, differentiate into melanocytes, but do not migrate away from the dorsal 
midline. However, it is sufficient to misexpress the tunicate’s closest homologue of 
Twist1, in these cells, to reprogram them into “migrating mesenchymal cells, 
reminiscent of vertebrate ectomesenchyme” [Abitua et al., 2012]. Collectively, these 
data suggest that neural crest “invention” was a gradual process in which expression 
of Twist1 might have been the final and critical event. 
 
 
D4 Twist1 in The Patterning of The Neural Tube 
 
 
D4.1 A Putative Role for Twist1 in Specification of Dorsal 
Neurons and Neural Crest Cells 
 
A role for Twist1 in the patterning of anterior neural tube has long been 
established. Twist1 mice fail to close the neural tube in the cephalic region and, in the 
open neural tube ventral markers are displaced dorsally [Chen and Behringer, 1995; 
Soo et a, 2002]. However, until now no mechanism of action has been proposed, 
except for the diffuse idea that it acts non-autonomously from the surrounding 
mesoderm. 
 
Here, I provide in vitro evidence for a putative autonomous mechanism of 
action. I propose that low levels of Twist1 expressed in the neural progenitors can 
bias the neural program towards a dorsal phenotype. TwE induced cells, upregulate 
markers common for dorsal neural and neural crest. I also propose that the decision a 
cell has to make between remaining in the neural tube as a dorsal neural cell, or 
leaving the neural tube as a neural crest cell might be a late decision, probably taken 
not long before delamination and, might be dependent on Twist1 expression. More 
precisely, dorsal neural cells express Twist1 at low level up around the neural tube 
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closure. Cells which are to reside in the neural tube, downregulate Twist1 and, 
undergo the full neural program. Cells which are to delaminate, upregulate Twist1, at 




D4.2 TWIST1 Non-autonomous Roles 
 
I provide evidence that TWIST1 could non-autonomously stabilize the neural 
program. For instance, TwE expressing cells can downregulate surface ectoderm 
marker Gata2 in neighbouring cells [Fig R16b and d]. This is significant for two 
reasons. One, not all cells need to express Twist1 in order to be protected against 
differentiation uncertainty. Two, correlation between in vitro and in vivo data 
indicates, for the first time, how TWIST1 could act non-autonomously from within 
the neural tube. The importance of this should be considered against the old idea that 
TWIST1 acts non-autonomously from the neighbouring mesoderm. I showed here 
that Twist1 has a pattern of expression in the neural tube, limited temporally and 
spatially, which is consistent with its proposed role. On the other hand, Twist1 strong, 
but rather uniform expression throughout the mesoderm cannot easily explain its 
effects on neural tube patterning. 
 
 
D4.3 TWIST1 and Late Dorsal Progenitors 
 
The idea of TWIST1 being favourable for the neural and neural crest programs 
is strongly supported by the early in vitro neural differentiation events in response to 
TwE induction; especially, the continuous upregulation of Pax3 by early induction 
and the absence of a negative influence on Sox1 in these conditions. However, for 
upregulation of other dorsal markers, like Atoh1, the in vitro experiments showed a 
requirement for TwE induction at later time points, as well [Fig R1.15a, c and d]. 
 Atoh1 expression in the neural tube was reported starting at 9.5 dpc [Helms et 
al. 1998], a time point which coincides with the moment Twist1 stops being expressed 
in the discussed location [Fig R2.9]. Furthermore, Atoh1 has been linked with neural 
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progenitor differentiation, at least in a subset of cells [Helms et al. 1998; Lyden et al., 
1999; Flora et al., 2007]. Thus, Twist1 and Atoh1 coincide in their role in neural 
progenitor maturation, but not in their expression in time. So far, I considered 
acceleration of neural differentiation by TWIST1 as an in vitro artefact without 
physiological relevance. I concentrated on explaining how in vivo, such an 
acceleration is circumvented by timely downregulation of Twist1. Nevertheless, 
TWIST1 might have a role in generating a subset of more differentiated progenitors. 
In chick, the first post-mitotic, TUBB3 positive cells, were observed only hours after 
neural tube closure and, the majority of these cells appeared in the dorsal most 
regions of the midbrain neural tube [Aaku-Saraste et al, 1996], a region which 
coincides with the D-V domain of both Twist1 and Atoh1. Thus, it is conceivable that 
Twist1 may mark an early differentiating neuron population and, that it is present 
long enough in these cells, to be able to affect both the D-V marker expression and, to 
accelerate their differentiation.  
 
 
D4.4 Twist1 and Anterior Neural Tube Fusion 
 
One of the most striking observation reported here is that shortly before 
forebrain closure Twist1 expression is restricted within each section, to just one or 
two cells placed at the very tip of each neural fold, most likely the cells which are 
going to initiate the fusion. This may suggest, for the first time, that Twist1 role in 
cephalic neural tube closure is a very direct one and not an indirect consequence of 
dorsal patterning perturbations. While, I did not investigate the mechanism by which 
Twist1 might produce this effects it is easy to conceive that regulation of cell 
adhesion is involved. Possibly, these cells connect less tightly with their neighbours 
and have an enhanced ability to generate new intercellular contacts. It is also possible 
that these cells, placed on the two approaching neural folds, express a specific marker 






D5. Twist1 Affects Development – A Model 
 
The work presented here indicates that at early stages of development Twist1 
level of expression is the most important modulator of its actions. High levels of 
Twist1 are incompatible with the neural program. However, current evidence suggests 
that this is a mechanism not employed by the embryo to decide for or, against the 
neural fate, since Twist1 is never expressed in the epiblast. 
 
An attractive idea had been that Twist1 expressing cells are fated to become 
mesoderm. However, such a hypothesis is not supported either by Twist1 expression 
or rather lack of it, in the Primitive Streak nor, by the apparently normal formation of 
mesoderm in Twist1 mutants [Chen and Behringer, 1995; Soo et al, 2002]. It seems 
more appropriate to consider that Twist1 has a role after the mesodermal fate has been 
established as indicated by the data showing that in Twist1 null mutants the somitic 
compartments are differentially affected [Chen and Behringer, 1995] and that 
teratomas from Twist1 null cells have an altered compositions, with very little muscle, 
tooth or trabecular bone [Soo et al., 2002]. Furthermore, at the time of mesoderm 
differentiation cell fate is differentially regulated by the two main TWIST1 dimer 
choices TW-E and TW-TW [Connerney at al., 2006]. 
 
Interestingly, Zfp521, before being reported as an early neural inducer, was 
considered, just like Twist1 a mesenchymal effector [Bond et al, 2007; Wu et al, 
2009]. Nature has a well known tendency to recycle its means, to use the same 
mechanisms or molecules to achieve different goals, or to regulate various processes. 
Thus, depending on the cellular context, TWIST1 and ZFP521 could either regulate 
mesenchymal or neural differentiation. These factors could also represent means by 
which a cell could easily transit from one state to another. The example of neural 
crest cells is very significant. They start in the region of neural epithelium, from 
which initially can hardly be distinguished, then, they undergo EMT and acquire a 
mesenchymal phenotype, leave the neural tissue and migrate to the tissue of 
destination. Here, some of them undergo neural differentiation as they become part of 
the peripheral nervous system. 
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In the neural tissue Twist1 is expressed at low levels in a subset of progenitors 
which are fated to become either dorsal neurons or, neural crest cells. One could even 
speculate that the reason why Twist1 is not expressed in early mesoderm cells is that 
this transcription factor has been reserved for the induction of neural crest cells. An 
interesting experiment would be to express TwE or TwTw in a mesoderm 
differentiation protocol and see if cells are not diverted to a phenotype resembling 
more neural crest cells. 
 
From in vitro experiments I made the observation that induction of TwE leads to 
abrupt loss of epithelial integrity and formation of loose mesenchyme-like structures 
[Fig R1.19, Fig R3.2]. An interesting area of investigation, could involve the 
mechanisms employed by neural progenitors to maintain the integrity of the neural 
epithelium at the time of neural crest migration. These could involve either rapid 
proliferation of the neural progenitors to fill the gaps, or formation of new adherens 
junctions between remaining epithelial cells. Significantly, if cells fated to become 
strict neural progenitors do indeed downregulate Twist1, this would amount to a MET 
(mesenchymal to epithelial transition) event which would strengthen the epithelial 
structure in the wake of the neural crest delamination havoc. 
 
It should be noted that formation of mesenchymal like cells was observed even 
in experiments with low TwE induction. Thus the question arise how could cells 
expressing Twist1 maintain their neural fate. First, it is possible that the active 
TWIST1 levels in the embryo are even lower than the lowest levels used in the 
current in vitro experiments. Second, the observed patchy expression [Fig R2.8h and 
Fig D2] may arise from cells downregulating Twist1, after only a short exposure to 
this factor. Thus, the expression analysis could only indicate a heterogeneous 
population which expresses Twist1 for variable time lengths while this time exposure, 
could have fate consequences, similarly to the levels of expression. 
 
Another potential point of concern could be that induction of TwE, even at 
levels permissive for neural program, seems to have a differentiation acceleration 
effect. This is not necessarily detrimental, considering that some progenitors form 
post-mitotic neurons before others. Thus, the observation made here about of a few 
cells expressing Twist1 in the dorsal neural tube could be correlated with the previous 
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observation of rare postmitotic neurons in the dorsal neural tube soon after closure 
[Aaku-Saraste et al, 1996]. In this interpretation TWIST1 would be one of the factors 
which ensure that not all progenitors differentiate at the same time. 
 
A novel role, reported here for TWIST1 involves stabilization of the neural 
program at the junction between lateral neural plate and surface ectoderm. Thus, 
while expressing Twist1 might be dangerous for neural progenitors, having some 
Twist1 expressing cells might be useful for neighbouring cells. On the other hand 
Twist1 expressing cells themselves have the option to downregulate this factor early 
enough, before their differentiation would be negatively affected. Alternatively they 
could either join the pool of cells which will form the earliest differentiating neurons 
or leave the neural tube as neural crest cells. 
 
I found that Twist1 expression domain becomes restricted in the neural tube 
more and more dorsally, until at the time of fusion, only the few cells directly 
involved in this process still express Twist1, a feature which can be linked with the 
reported phenotype of Twist1 null mutants [Chen and Behringer, 1995]. 
 
In conclusion I propose four roles for TWIST1 in early development, 
summarized in Fig D2: 
 
1. To act as an anti BMP and pro EMT neural modulator; 
2. To participate in neural crest specification and delamination; 
3. To employ both autonomous and non-autonomous mechanisms to pattern the 
neural tube; 
4. To directly regulate neural tube fusion. 
 
The work presented in this thesis proposes novel mechanisms for the regulation 
of neural differentiation and neural tube formation. Each of the mechanisms put forth 
could prove to be a fruitful area of research. For instance much could be gained from 
investigating the heterogeneous expressing of transcription factors in generation of 
progenitors which differentiate with different speeds. Dissecting the induction of 
dorsal neural and neural crest phenotypes will very likely reveal interesting target 
genes. The role of TWIST1 induced EMT could bring new insights in the process of 
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neural crest delamination as well as on what makes a cells to be neural crest. Finally, 
I provided a hypothesis regarding neural tube fusion which could be used to generate 







































Figure D2. Schematic representation of TWIST1 role in neural 
development 
 
From formation of the neural folds (a) to closure (c). Initially Twist1 expression can 
be seen as gradient from future ventral to dorsal. TWIST1 participates autonomously 
in establishing the dorsal neural phenotype and in blocking the surface ectoderm fate 
by downregulating CDH1 (a). As neural folds mature, Twist1 expression becomes 
restricted to a few dorsal cells which non-autonomously block surface ectoderm fate 
in the surrounding neural cells. Some of the Twist1 positive cells further upregulate 
this marker and delaminate as neural crest (b). Just before closure only cells involved 
in the process of fusion remain Twist1 positive. All the other cells either 
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4 days of monolayer neural differentiation of rtTA parental cell line in N2B27 under Dox 
(800 ng/ml) and/or BMP4 (5 ng/ml) influence respectively (a). Left panels phase contrast, 
right panels immunofluorescence: TUBB3 staining; green. At this time point few TUBB3 
positive neurons can be seen only in the absence of BMP4 and their presence is not 
influenced by Dox. Scale bars represent 50 µm. qPCR showing expression of Twist1, Sox1 
and Zfp521 in ES cells and cells at day 3 and 4 of neural differentiation in monolayer 
protocol for rtTA parental cell line (b). The expression of the tested markers is not influenced 
by Dox in this cell line. One experiment performed in duplicates is shown. Error bars 
represent value range. Expression in ES cells has been arbitrarily set to 1. Similar control 
experiments have been performed extensively during other projects in the lab that make use 
of the same parental lines as controls for experiments where Dox is used to induce other 
transcription factors (for example Tcf15 – Davies et al., 2013). It is well established from the 
results of these experiments that Dox does not influence the rate or direction of neural 





































Appendix 2. List of markers: 
Marker Expression Used as 
Ascl1 In a subset of dorsal neural cells and 
oligodendrocytes 
Dorsal neural marker (Battiste et 
al., 2007) 
Atoh1 Dorsal neural marker, marks the DI1 
interneurons 
Dorsal neural marker (Flora et al., 
2007) 
Brachyury Primite streak Primitive streak marker (Rivera-
Perez & Magnuson, 2005) 
Cdh1 Epiblast, surface ectoderm, other epithelial 
tissues 
Epithelial marker (Aaku-Saraste et 
al., 1996; Van de Putte et al., 
2003) 
Cdh2 Neural epithelium, briefly expressed in the 
primitive streak and in certain 
subpopulations in the heart and lens 
Marker of the switch from epiblast 
to neural epithelium (Aaku-Saraste 
et al., 1996; Van de Putte et al., 
2003) 
Eomes in differentiating trophoblast cells, during 
gastrulation is expressed in the primitive 
streak and, later on it has important roles in 
the hematopoietic system 
Primitive streak marker (Arnold et 
al., 2003) 
Esrrb ES cells Marker of undifferentiated cells 
(Festuccia et al., 2012) 
Fgf5 Highly upregulated during the transition 
from ES to epiblast cells. Subsequently, 
expressed at various levels in multiple cell 
types and organs. 
Marker of epiblast cells (Pelton et 
al., 2002) 
Fgfr1 in multiple cells and organs To investigate its modulation by 
TW-E (Yamaguchi et al., 1992) 
Gata2 early in development in the surface 
ectoderm, later expressed in a subset of 
mesenchymal cells, notably hematopoietic 
progenitors 
Surface ectoderm marker (Sheng 
& Stern, 1999) 
 
 370 
Gata6 In primitive endoderm, definitive 
endoderm and a subset of mesodermal cells 
Endoderm marker (Morrisey et al., 
1998) 
Gli1 In response to SHH Readout of SHH activity 
modulation (Lee et al., 1997) 
Id1 In response to BMP4 Readout of BMP4 activity 
modulation (Lopez-Rovira et al., 
2002) 
Klf4 ES cells, later in development it is 
expressed in various cells and organs 
Marker of undifferentiated cells 
(Guo et al., 2010) 
Msx1 Early neural crest marker Neural crest marker (Hill et al., 
1989) 
Nanog ES cells Marker of undifferentiated cells 
(Chambers et al., 2003) 
Ncam1 Expressed in neural and neural crest cells Marker of the switch from epiblast 
to neural epithelium (Rutishauser 
et al., 1988) 
NESTIN Neural progenitors Neural progenitor marker 
(Dahlstrand et al., 1995) 
Pax3 Expressed early in prospective dorsal 
neural and neural crest domains, and then 
in dorsal neural and neural crest cells and 
their derivates as well as in the somites 
Dorsal neural and neural crest 
marker (Goulding et al., 1991) 
Pax6 Dorsal neural tube Dorsal neural marker immediately 
ventral to the domain specified by 
Twist1 (Liu & Niswander, 2005) 
Pou5f1 ES cells Marker of undifferentiated cells 
(Nichols et al., 1998) 
Shh In various cells and tissues. In development 
is actively involved in morphogenesis 
Marker of ventral neural 




Sox1 Neural progenitors Marker of neural progenitors 
(Pevny et al., 1998) 
SOX2 ES cells, epiblast and neural progenitors Marker of neural progenitors 
differentiation (Wood & 
Episkopou, 1999) 
Sox9 Early in neural crest precursor cells and in 
migrating neural crest cells, dorsal neural 
tube. It is also expressed in a subpopulation 
of the somitic mesoderm. 
Dorsal neural and neural crest 
marker (Cheung & Briscoe, 2003) 
Tcf15 ES cells, and early epiblast cells. During 
gastrulation its expression is restricted to 
the somitic compartment. 
Somitic marker (Burgess et al., 
1995) 
TUBB3 Postmitotic neurons Marker of postmitotic neurons 
(Tischfield et al., 2010) 
Wnt1 Prospective midbrain progenitors, pre-
delaminating and delaminating neural crest 
cells 
Marker of neural crest (Echelard et 
al., 1994) 
Zeb1 specifically expressed in the developing 
neuroepithelium 
Marker of the switch from epiblast 
to neural epithelium (Takagi et al., 
1998) 
Zeb2 a subset of neural progenitors, as well as in 
neural crest and axial and paraxial 
mesoderm 
Marker of the switch from epiblast 
to neural epithelium (Van de Putte 
et al., 2003) 
Zfp521 Early in development in neural progenitors. 
Subsequently it is expressed in various 
cells of mesenchymal origin 
Marker of neural progenitors 












Appendix 3. Twist1 expression data from the literature 
 
(a to d) published in Stoetzel et al, 1995. (a) primitive streak stage, (b) allantoic bud stage, (c) 
head fold stage, (d) somitic stage embryo. The expression pattern is very similar with the one 
reported here. The primitive streak expression can be observed in (b and c) as a very fine line 
which appears to be on top of the epiblast. (d to j) published in Fuchtbauer et al, 1995. (d to 
g) embryo considered at the primitive streak stage shown form anterio, posterior view, 
transverse and sagital section respectively. The presence of the allantois and of the head 
mesenchyme, which can be clearly seen in (a) indicate that this is probably an older embryo, 
closer to head fold. The expression is veri consistent with the present report. (h to j) 
transverse sections of somitic stage embryo. The neural tube seems clear and the signal can 
be only observed in the somites. In (j) the author reports a few positive cells in the neural 
tissue (black arrows) which he deems as delaminating neural crest. (k) published in Ang and 












































Appendix 4. Schematic map of the results presented in this thesis 
 
 
 
 
